Sentence,class,file
orgChung et al http://dx.doi.org/10.4111/kju.2015.56.6.412 e44092.,OADS,/arxiv_data1/oa_pdf/99/47/kju-56-412.PMC4462630.pdf
"Keywords:  Incidence; Kidney; Neoplasms; Prostate; Urinary bladder This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received:  10 March, 2015   •  Accepted:  10 April, 2015 Corresponding Author:  Hwang Gyun Jeon Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea TEL: +82-2-2148-9599, FAX: +82-2-3410-6992, E-mail: hwanggyun.jeon@samsung.com ⓒ The Korean Urological Association, 2015To date, urological cancer is more prevalent in the West  than in the East; however, the incidence of urological cancer  has been on the rise and in 2011 accounted for more than  8.0% of all cancers in Korea [2].",Non-OADS,/arxiv_data1/oa_pdf/42/59/kju-56-422.PMC4462631.pdf
orgKorean J Urol 2015;56:422-428. http://dx.doi.org/10.4111/kju.2015.56.6.422 pISSN 2005-6737  •  eISSN 2005-6745,OADS,/arxiv_data1/oa_pdf/42/59/kju-56-422.PMC4462631.pdf
"orgSong and Jeon http://dx.doi.org/10.4111/kju.2015.56.6.422 three folds to 16,490 cases in 201 1 (7.6% of all cancers).",Non-OADS,/arxiv_data1/oa_pdf/42/59/kju-56-422.PMC4462631.pdf
orgSong and Jeon http://dx.doi.org/10.4111/kju.2015.56.6.422 INCIDENCE OF BLADDER CANCER Bladder cancer is the 11th most frequent cancer  worldwide [17].,Non-OADS,/arxiv_data1/oa_pdf/42/59/kju-56-422.PMC4462631.pdf
orgSong and Jeon http://dx.doi.org/10.4111/kju.2015.56.6.422 to that of bladder cancer in terms of pattern and peak age.,OADS,/arxiv_data1/oa_pdf/42/59/kju-56-422.PMC4462631.pdf
"Keywords:  Neoplasm invasiveness; Recurrence; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received:  23 January, 2015   •  Accepted:  23 April, 2015 Corresponding Author:  Jae Young Park Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, Korea TEL: +82-31-412-7622, FAX: +82-31-412-2370, E-mail: jaeyoungpark@korea.ac.kr ⓒ The Korean Urological Association, 2015cancer (NMIBC) and 20% to 30% of NMIBCs invade the  lamina propria and are staged as T1 [1].",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/kju-56-429.PMC4462632.pdf
orgKorean J Urol 2015;56:429-434. http://dx.doi.org/10.4111/kju.2015.56.6.429 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/kju-56-429.PMC4462632.pdf
orgShim et al http://dx.doi.org/10.4111/kju.2015.56.6.429 NMIBC.,OADS,/arxiv_data1/oa_pdf/f0/d5/kju-56-429.PMC4462632.pdf
orgShim et al http://dx.doi.org/10.4111/kju.2015.56.6.429 appeared within 3 years (Fig.,OADS,/arxiv_data1/oa_pdf/f0/d5/kju-56-429.PMC4462632.pdf
orgShim et al http://dx.doi.org/10.4111/kju.2015.56.6.429 government (MSIP) (No.,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/kju-56-429.PMC4462632.pdf
"Keywords:  Biological markers; Blood vessels; Neoplasms; Prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received:  25 February, 2015   •  Accepted:  29 April, 2015 Corresponding Author:  Gianluigi Taverna Department of Urology, Humanitas Clinical and Research Hospital, Via Manzoni 56 20089 Rozzano, Milan, Italy TEL: +39-2-82244535, FAX: +39-2-82244590, E-mail: gianluigi.taverna@humanitas.it *These authors contributed equally to this study and should be considered co-first authors.",Non-OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
orgKorean J Urol 2015;56:435-442. http://dx.doi.org/10.4111/kju.2015.56.6.435 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
"orgTaverna et al http://dx.doi.org/10.4111/kju.2015.56.6.435 well differentiated, and the type with the most favorable  prognosis [3].",OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
orgTaverna et al http://dx.doi.org/10.4111/kju.2015.56.6.435 3.,OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
"orgTaverna et al http://dx.doi.org/10.4111/kju.2015.56.6.435 The main feature of the newly generated vasculature is the  structural diversity of  the vessel sizes, shapes, and connecting  patterns.",OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
http://dx.doi.org/10.1016/j.eururo.2015.02.038.,OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
orgTaverna et al http://dx.doi.org/10.4111/kju.2015.56.6.435 tal dimension.,OADS,/arxiv_data1/oa_pdf/95/d6/kju-56-435.PMC4462633.pdf
"Keywords:  Prostatectomy; Prostatic neoplasms; Surgical anastomosis; Urine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology  Received:  21 January, 2015   •  Accepted:  10 March, 2015 Corresponding Author:  Jong Yeon Park Department of Urology, Gangneung Asan Hospital, University of Ulsan College of Medicine, 38 Bangdong-gil, Gangneung 210-711, Korea TEL: +82-33-610-3357, FAX: +82-33-641-8070, E-mail: jypark@gnah.co.kr ⓒ The Korean Urological Association, 2015 www.kjurology.",Non-OADS,/arxiv_data1/oa_pdf/cd/25/kju-56-443.PMC4462634.pdf
orgKorean J Urol 2015;56:443-448. http://dx.doi.org/10.4111/kju.2015.56.6.443 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/cd/25/kju-56-443.PMC4462634.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.6.443 INTRODUCTION Radical prostatectomy (RP) is a challenging operation  that demands high levels of surgical expertise and experience.,Non-OADS,/arxiv_data1/oa_pdf/cd/25/kju-56-443.PMC4462634.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.6.443 the running group than in the interrupted group (15.,Non-OADS,/arxiv_data1/oa_pdf/cd/25/kju-56-443.PMC4462634.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.6.443 ment.,OADS,/arxiv_data1/oa_pdf/cd/25/kju-56-443.PMC4462634.pdf
"Keywords:  Biopsy, Pain, Patient positioning This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received:  17 February, 2015   •  Accepted:  28 April, 2015 Corresponding Author:  Phil Hyun Song Department of Urology, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea TEL: +82-53-620-3693, FAX: +82-53-627-5535, E-mail: sph04@hanmail.net ⓒ The Korean Urological Association, 2015a higher cancer detection rate [2].",Non-OADS,/arxiv_data1/oa_pdf/fd/ff/kju-56-449.PMC4462635.pdf
orgKorean J Urol 2015;56:449-454. http://dx.doi.org/10.4111/kju.2015.56.6.449 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/fd/ff/kju-56-449.PMC4462635.pdf
orgKim et al http://dx.doi.org/10.4111/kju.2015.56.6.449 nerve block (PPNB) was effective in controlling pain during  TRUS-guided prostate biopsy [7].,OADS,/arxiv_data1/oa_pdf/fd/ff/kju-56-449.PMC4462635.pdf
"orgKim et al http://dx.doi.org/10.4111/kju.2015.56.6.449 DISCUSSION As the overall number of TRUS-guided prostate biopsies  performed for the diagnosis of  prostate cancer increases, it is  essential for urologists to understand the patient tolerance  associated with this procedure.",Non-OADS,/arxiv_data1/oa_pdf/fd/ff/kju-56-449.PMC4462635.pdf
orgKim et al http://dx.doi.org/10.4111/kju.2015.56.6.449 Dis 2007;10:127-36.,OADS,/arxiv_data1/oa_pdf/fd/ff/kju-56-449.PMC4462635.pdf
"Keywords:  Diabetes mellitus; Therapeutics; Ureteral calculi; Urolithiasis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received:  6 March, 2015   •  Accepted:  27 April, 2015 Corresponding Author:  Koo Han Yoo Department of Urology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 134- 727, Korea TEL: +82-2-440-7735, FAX: +82-2-440-7744, E-mail: yookoohan@khu.ac.kr ⓒ The Korean Urological Association, 2015 www.kjurology.",Non-OADS,/arxiv_data1/oa_pdf/73/42/kju-56-455.PMC4462636.pdf
orgKorean J Urol 2015;56:455-460. http://dx.doi.org/10.4111/kju.2015.56.6.455 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/73/42/kju-56-455.PMC4462636.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.6.455 INTRODUCTION Urinary stones are one of the most common urological  problems worldwide and are actually an ancient source of  serious morbidity.,Non-OADS,/arxiv_data1/oa_pdf/73/42/kju-56-455.PMC4462636.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.6.455 failure (Table 2).,OADS,/arxiv_data1/oa_pdf/73/42/kju-56-455.PMC4462636.pdf
"orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.6.455 Saint S, Wei JT, et al.",OADS,/arxiv_data1/oa_pdf/73/42/kju-56-455.PMC4462636.pdf
"Keywords:  Erectile dysfunction; Patient satisfaction; Penile prosthesis; Survival This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Sexual Dysfunction/Infertility Received:  23 February, 2015   •  Accepted:  14 May, 2015 Corresponding Author:  Ki Hak Moon Department of Urology, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea TEL: +82-53-620-3692, FAX: +82-53-627-5535, E-mail: khmoon@med.yu.ac.kr ⓒ The Korean Urological Association, 2015the third-line treatment for ED, is one of the successful  surgical treatments for ED.",Non-OADS,/arxiv_data1/oa_pdf/ea/16/kju-56-461.PMC4462637.pdf
orgKorean J Urol 2015;56:461-465. http://dx.doi.org/10.4111/kju.2015.56.6.461 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/ea/16/kju-56-461.PMC4462637.pdf
"orgJi et al http://dx.doi.org/10.4111/kju.2015.56.6.461 injection, and intraurethral suppositories [2].",OADS,/arxiv_data1/oa_pdf/ea/16/kju-56-461.PMC4462637.pdf
orgJi et al http://dx.doi.org/10.4111/kju.2015.56.6.461 patients (81.1%) answered that the device improved their  sexual life.,Non-OADS,/arxiv_data1/oa_pdf/ea/16/kju-56-461.PMC4462637.pdf
"Keywords:  Antibiotic prophylaxis; Biopsy; Ceftriaxone; Infection; Prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Infection/Inflammation Received:  10 March, 2015   •  Accepted:  6 May, 2015 Corresponding Author:  Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea TEL: +82-2-3010-3734, FAX: +82-2-477-8928, E-mail: cskim@amc.seoul.kr ⓒ The Korean Urological Association, 2015 www.kjurology.",Non-OADS,/arxiv_data1/oa_pdf/bc/be/kju-56-466.PMC4462638.pdf
orgKorean J Urol 2015;56:466-472. http://dx.doi.org/10.4111/kju.2015.56.6.466 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/bc/be/kju-56-466.PMC4462638.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.6.466 Univariable analysis and multivariable analysis were used  with logistic regression models to evaluate the relationship  of infectious complication with variables associated with risk  factor.,OADS,/arxiv_data1/oa_pdf/bc/be/kju-56-466.PMC4462638.pdf
"orgLee et al http://dx.doi.org/10.4111/kju.2015.56.6.466 Sepsis, one of the most serious clinical sequelae, is diagnosed  in 0.1%–2.2% of  cases after biopsy [15].",OADS,/arxiv_data1/oa_pdf/bc/be/kju-56-466.PMC4462638.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.6.466 prophylaxis?,OADS,/arxiv_data1/oa_pdf/bc/be/kju-56-466.PMC4462638.pdf
"Keywords:  Indocyanine green; Nephrectomy; Robotic surgical procedures This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case Report Received:  13 April, 2015   •  Accepted:  1 May, 2015 Corresponding Author:  Daniel Eun Department of Urology, Temple University School of Medicine, 255 S 17th Street, Suite #2101, Philadelphia, PA 19103, USA TEL: +1-215-470-2530, FAX: +1-215-875-9714, E-mail: daniel.eun@tuhs.temple.edu ⓒ The Korean Urological Association, 2015Indocyanine green (ICG), a fluorescent dye that can be  visualized under near ­infrared fluorescence (NIRF), has been  utilized intraoperatively during robotic urologic procedures  to highlight relevant anatomy and assess perfusion [3].",Non-OADS,/arxiv_data1/oa_pdf/08/b1/kju-56-473.PMC4462639.pdf
orgKorean J Urol 2015;56:473-476. http://dx.doi.org/10.4111/kju.2015.56.6.473 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/08/b1/kju-56-473.PMC4462639.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.6.473 and persistent right ­sided flank pain refractory to medical  management.,OADS,/arxiv_data1/oa_pdf/08/b1/kju-56-473.PMC4462639.pdf
"orgLee et al http://dx.doi.org/10.4111/kju.2015.56.6.473 renal pelvis, and in precisely determining the margin  between compromised versus healthy renal parenchyma  would facilitate surgical management of patients with  ureteral triplication.",OADS,/arxiv_data1/oa_pdf/08/b1/kju-56-473.PMC4462639.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/fe/jiv008.PMC4462716.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1c/e4/S2048679014000718a.PMC4462761.pdf
http://www.idf.org/diabetesatlas (accessed November 2014).,Non-OADS,/arxiv_data1/oa_pdf/1c/e4/S2048679014000718a.PMC4462761.pdf
The four common polymorphisms (http://www.1000genomes.org/) identi- ﬁed in the NIH-NICHD group were in Hardy –Weinberg equilibrium (data not shown).,OADS,/arxiv_data1/oa_pdf/33/1c/ijo201517a.PMC4462767.pdf
"7,8Given that the synonymous variant rs28666870 is predicted by ESE ﬁnder (http://rulai.cshl.edu/ tools/ESE) to alter an exon splicing enhancer site for the binding of SR splicing regulators, it is plausible that rs28666870 could giverise to a new spliced isoform of FOXA3, potentially affectingmuscle mass.",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ijo201517a.PMC4462767.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Variants in FOXA3 in lean and obese children DC Adler-Wailes et al 892 International Journal of Obesity (2015) 888 –892 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ijo201517a.PMC4462767.pdf
"International Journal of Preventive Medicine 2015, 6: 45 http://www.ijpvmjournal.net/content/6/1/ 45and within countries.",Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
"International Journal of Preventive Medicine 2015, 6: 45 http://www.ijpvmjournal.net/content/6/1/ 45considered a case of MAN when she/he eventually  admitted in a hospital or dismissed by the hospital  physician because of no need for admission.",Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
"International Journal of Preventive Medicine 2015, 6: 45 http://www.ijpvmjournal.net/content/6/1/ 45participants.",Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
"International Journal of Preventive Medicine 2015, 6: 45 http://www.ijpvmjournal.net/content/6/1/ 45hospitalization and healthcare utilization rates among  patients who were never married.",Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
"International Journal of Preventive Medicine 2015, 6: 45 http://www.ijpvmjournal.net/content/6/1/ 45ethnicity or religion.",Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
http://www.siteresources.worldbank.org/INTPAH/Resources/ Publications/Quantitative‑T echniques/health_eq_tn13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/29/IJPVM-6-45.PMC4462769.pdf
"International Journal of Preventive Medicine 2015, 6:50 http://www.ijpvmjournal.net/content/6/1/50questionnaire created for the study.",Non-OADS,/arxiv_data1/oa_pdf/df/c2/IJPVM-6-50.PMC4462771.pdf
"International Journal of Preventive Medicine 2015, 6:50 http://www.ijpvmjournal.net/content/6/1/50negative correlation between WHR with FEV1, PEF and  FVC in obese females were obtained [ Table  4].",Non-OADS,/arxiv_data1/oa_pdf/df/c2/IJPVM-6-50.PMC4462771.pdf
"International Journal of Preventive Medicine 2015, 6:50 http://www.ijpvmjournal.net/content/6/1/50could suggest that estrogen and other sex hormones  may play an important role through modulation of Th2  cytokine production.",Non-OADS,/arxiv_data1/oa_pdf/df/c2/IJPVM-6-50.PMC4462771.pdf
Available from: http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/df/c2/IJPVM-6-50.PMC4462771.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49man health than other diseases such as angina, arthritis,  asthma and diabetes.",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49METHODS The most reliable references on Iranian ancient medicine  were determined on the basis of the following criteria: •	 Being	 the	most	used	books	by	ancient	physicians •	 Author’s	 credibility •	 Being	 the	most	cited	references	 in	papers	published	 in peer‑reviewed national and international journals  in recent years.",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49variations which again prove the correlation of these  emotions with heart[26,34] [Table  2].",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49In addition, considerable increase of depression disorders  in cardiac patients compared to common healthy  population on one hand,[6,39] and recurrent depression  increase following heart disease on other hand[44,45] raises  up a viewpoint that some heart diseases may bring  conditions which ultimately result in depression.",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49coward and slow‑witted (because of cold heart and blood  temperament) and has a sorrow tendency (as his blood is  turbid) and his emotional states disappear slowly (since  the blood is thick).",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:49 http://www.ijpvmjournal.net/content/6/1/49in patients with congestive heart failure.",Non-OADS,/arxiv_data1/oa_pdf/61/56/IJPVM-6-49.PMC4462772.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46whole country.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46and 59 (4.6%) stated that family physicians should  present both preventive and medical services to their  clients.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46coverage of main or supplementary insurance systems and  in whom were not under the coverage of family physician  program [Table 3].",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46 Table 3: Single variable analysis of correlates of knowledge and practice of people toward urban family physician program in Shiraz south of Iran Characteristic Knowledge Practice Mean±SD* Statistic  (P value)Characteristics Mean±SD Statistic  (P value)Characteristic Mean±SD†Statistic  (P value)Characteristics Mean±SD Statistic  (P value) Age (years) Family size Age (years) Family size 18‑29 4.8±2.7 F=4,  P=0.003≤2 4.7±2.7 F=0.5,  P=0.818‑29 2.4±0.9 F=2,  P=0.05≤2 2.2±1 F=0.5,  P=0.7 30‑39 5.3±2.6 3‑4 5.3±2.6 30‑39 2.3±0.9 3‑4 2.4±0.9 40‑49 5±2.7 ≥5 4.8±2.7 40‑49 2.2±0.9 ≥5 2.2±0.9 50‑59 5.5±2.8 Position of respondent in  the family50‑59 2.4±1 Position of respondent in  the family ≥60 4.6±2.5 Bread winner 5±2.7 t=0.09,  P=0.960≤ 2.1±1 Bread winner 2.3±1 t=−1.4,  P=0.1 Gender Other family member 5±2.7 Gender Other family member 2.3±0.9 Male 4.9±2.7 t=−2,  P=0.03Type of main insurance  coverageMale 2.2±0.9 t=−2,  P=0.04Type of main insurance  coverage Female 5.2±2.7 Under insurance coverage 5.2±2.6 t=7.4,  P<0.001Female 2.4±0.9 Under insurance coverage 2.4±0.9 t=7.1,  P<0.001 Marital status No insurance 3.2±2.6 Marital status No insurance 1.5±1 Single 4.4±2.8 t=−4.9,  P<0.001Supplementary insurance  coverageSingle 2.3±0.9 t=−0.7,  P=0.4Supplementary insurance  coverage Married 5.3±2.6 Yes 5.2±2.6 t=2,  P<0.04Married 2.3±0.9 Yes 2.3±0.8 t=1.1,  P=0.2 Education No 4.9±2.8 Education No 2.3±1 ≤8 years 4.5±2.6 F=7.2,  P=0.001Place of inquery ≤8 years 2.3±1 F=0.8,  P=0.5Place of inquiry 9‑12 years 5.2±2.7 At home 5.1±2.6 t=2.8,  P=0.0059–12 years 2.3±0.9 At home 2.3±0.9 t=1.3,  P=0.1 >12 years 5.1±2.7 Work place 4.5±3 >12 years 2.3±0.9 Work place 2.2±1 Job status Being under coverage of  family physician programJob status Being under coverage of  family physician program Having job 5±2.7 t=0.1,  P=0.8Yes 5.5±2.5 t=15.8,  P<0.001Having job 2.3±0.9 t=−1.2,  P=0.2Yes 2.6±0.7 t=29.9,  P<0.001 Jobless 5±2.6 No 2.4±2.4 Jobless 2.3±0.9 No 0.7±0.6 Income per  month ($)Being of family member  under coverage of family  physician programIncome per  month ($)Being of family member  under coverage of family  physician program ≤1000 5.1±2.7 t=−0.7,  P=0.4Yes 5.5±2.5 t=14.5,  P<0.001≤1000 2.2±0.9 t=−1.2,  P=0.2Yes 2.6±0.7 t=25.9,  P<0.001 >1000 5.3±3 No 2.9±2.5 >1000 2.4±1.1 No 1±0.7 *Of total score 19, †Of total score 7.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46coverage of one of the main insurance systems (ß =0.5,  95% CI = 0.01–1,  P = 0.04) and being married (ß =0.4,  95% CI = 0.1–0.8,  P = 0.002).",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46people’s knowledge and practice toward urban family  physician program was 24%.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:46 http://www.ijpvmjournal.net/content/6/1/46randomly and from different socioeconomic classes, the  possible discrepancy may be faded.",Non-OADS,/arxiv_data1/oa_pdf/c1/ec/IJPVM-6-46.PMC4462773.pdf
"International Journal of Preventive Medicine 2015, 6:48 http://www.ijpvmjournal.net/content/6/1/48INTRODUCTION The 1978 declaration (Alma‑Ata declaration) made  at the International Conference on Primary Health  Care, meeting in Alma‑Ata highlighted the importance  of primary health care and the critical role played  by Community Health Workers (CHWs) to link  communities to the health system.",Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
"International Journal of Preventive Medicine 2015, 6:48 http://www.ijpvmjournal.net/content/6/1/48affect “information provided on various diseases.” Factors  such as demographic factors and training in tobacco  control were included in the analyses.",Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
"International Journal of Preventive Medicine 2015, 6:48 http://www.ijpvmjournal.net/content/6/1/48about two‑thirds of ASHAs believed that patients equate  counselling as nagging and patients may not revisit if  counselled on reducing tobacco.",Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
"International Journal of Preventive Medicine 2015, 6:48 http://www.ijpvmjournal.net/content/6/1/48Accredited Social Health Activist plays a vital role in  providing counselling services to the community.",Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
3. http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.mohfw.nic.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
[Last cited on 2013 Apr 20].4. http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.mohfw.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
6. http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
8. http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.whoindia.org/LinkFiles/T obacco_Free_Initiative_ GATS2010_Chapter‑08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
11. http://www.mha.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from:  http://www.censusindia.gov.in/PopulationFinder/Population_Finder.aspx.,OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
12. http://www.health.bih.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.health.bih.nic.in/Docs/Guidelines/ Guidelines‑Sub‑Centers‑%28Revised%29‑2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
18. http://www.who.int/en/.T uberculosis and T obacco.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.who.int/tobacco/resources/ publications/factsheet_tb_tobacco_sep09.pdfAc.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
20. http://www.who.int/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available  from: http://www.who.int/fctc/reporting/Annexoneindia.pdf; http://www.who.,OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from:  http://www.who.int/tobacco/surveillance/gats_india/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
22. http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
Available from: http://www.nhsrcindia.org/pdf_fi les/  resources_thematic/Community_Participation/NHSRC_Contribution/ Asha_Update_July_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/4d/IJPVM-6-48.PMC4462774.pdf
"International Journal of Preventive Medicine 2015, 6:52  http://www.ijpvmjournal.net/content/6/1/52MPH is that it binds the dopamine, norepinephrine,  and lesser extent serotonin transporter and inhibit reuptake of these amine into synaptic terminals, thus stimulates their receptors.",Non-OADS,/arxiv_data1/oa_pdf/aa/92/IJPVM-6-52.PMC4462776.pdf
"International Journal of Preventive Medicine 2015, 6:52  http://www.ijpvmjournal.net/content/6/1/52were evaluated by ANOVA.",Non-OADS,/arxiv_data1/oa_pdf/aa/92/IJPVM-6-52.PMC4462776.pdf
"International Journal of Preventive Medicine 2015, 6:52  http://www.ijpvmjournal.net/content/6/1/52noticeable difference in comparison with MPH  (10  mg/kg)  treated group  [Figure  7].",Non-OADS,/arxiv_data1/oa_pdf/aa/92/IJPVM-6-52.PMC4462776.pdf
"International Journal of Preventive Medicine 2015, 6:52  http://www.ijpvmjournal.net/content/6/1/5211.",Non-OADS,/arxiv_data1/oa_pdf/aa/92/IJPVM-6-52.PMC4462776.pdf
"International Journal of Preventive Medicine 2015, 6:51 http://www.ijpvmjournal.net/content/6/1/51Received:  19 Aug 14 Accepted:  16 Apr 15   Published:  04 Jun 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/86/5a/IJPVM-6-51.PMC4462810.pdf
"VHL gene  mutations have been reported in more than 900 disease kindreds (http://www.umd.be/VHL/W_VHL, Last  access on January, 20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ac/ff/NAJMS-7-176.PMC4462812.pdf
"162200, http://www.omim.org/entry/162200, accesses February, 19, 2015), formerly known as von Recklinghausen disease, is an autosomal dominant disorder that affects approximately 1 in 3,500 persons.",Non-OADS,/arxiv_data1/oa_pdf/ac/ff/NAJMS-7-176.PMC4462812.pdf
At http://www.acr.org/~/ 6 media/ACR/Documents/AppCriteria/Diagnostic/ IncidentallyDiscoveredAdrenalMass.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/60/NAJMS-7-212.PMC4462817.pdf
At http://www.alz.org/downloads/Facts_Figures_2014.pdf.,OADS,/arxiv_data1/oa_pdf/49/10/NAJMS-7-220.PMC4462818.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"RVA PCV1 PAdV PBoV1 PBoV2 PBoV3 P1 /C28 /C28 /C28 /C28/C28/C28 P2 /C28 /C28 /C28 /C28/C28/C28 P3 /C27 /C28 /C28 /C28/C28/C28 P4 /C28 /C28 /C28 /C28/C28/C28 P5a/C27/C27 /C28 /C28 /C28 /C27 P6 /C27/C28 /C28 /C28 /C28 /C27 P7 /C27 /C28 /C28 /C28/C28/C28 P8 /C27 /C28 /C28 /C28/C28/C28 P9a/C28/C28 /C28 /C27 /C28 /C27 P10a/C27/C28 /C28 /C28 /C27 /C27 P11a/C27/C28/C27 /C28 /C28 /C27 P12a/C27/C28 /C28 /C28 /C28 /C27 P13a/C28/C28 /C28 /C28 /C27 /C27 P14 /C28/C28 /C28 /C27 /C28 /C27 P15a/C27/C28 /C28 /C28 /C27 /C27 P16 /C28/C28 /C28 /C28 /C27 /C27 P17 /C27/C28 /C28 /C28 /C27 /C28 P18a/C28/C28 /C27 /C28 /C27 /C27 P19 /C28/C28 /C27 /C28 /C27 /C27 P20 /C28/C28 /C27 /C28 /C27 /C27 P21a/C28/C28 /C27 /C28 /C27 /C27 P22 /C28/C28 /C27 /C28 /C27 /C27 P23a/C28/C28 /C27 /C28 /C27 /C27 P24 /C28 /C28 /C28 /C28/C28/C28 P25 /C28/C28 /C28 /C28 /C28 /C27 P26a/C28/C28 /C27 /C28 /C28 /C27 Total 10 1 8 2 13 18 aDenotes pooled specimens were investigated.Bocaparvovirus in Ireland Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"Isolates from this study are indicated with a ﬁlled circle ( m).Bocaparvovirus in Ireland Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"Isolates from this study are indicated with a ﬁlled circle ( m).Bocaparvovirus in Ireland Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"Isolates from this study are indicated with a ﬁlled circle ( m).Bocaparvovirus in Ireland Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
Availabl e from: http://ictvonline.org/ proposals/2013.001a-aaaV .A.v4.Parvoviridae.pdf [cited 2 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
Available from: http://www.afbini.gov.uk/all-island_ animal__disease_surveillance_report_2012.pdf [cited 8 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"J Gen Virol 2011; 92: 784 /C18.Bocaparvovirus in Ireland Citation: Infection Ecology and Epidemiology 2015, 5: 27270 - http://dx.doi.org/10.3402/iee.v5.27270 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5b/62/IEE-5-27270.PMC4462827.pdf
"1 The signs of PMD are abrupt onset of symptoms, unusual neurological involvement, presence of secondary gain, female gender,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/47/3e/tre-05-297-6792-1.PMC4462832.pdf
"http://dx.doi.org/10.1002/mds.22114 2.The Diagnostic and Statistical Manual of Mental Disorders, 5th ed.",Non-OADS,/arxiv_data1/oa_pdf/47/3e/tre-05-297-6792-1.PMC4462832.pdf
Nine Years with Munchausen Syndrome Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/47/3e/tre-05-297-6792-1.PMC4462832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 313–323ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  313ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7593 5Clinical trial simulation methods for estimating  the impact of DPP-4 inhibitors on cardiovascular  disease Charles andy schuetz1 siew hwa Ong2 Matthias Blüher3 1Evidera inc., Bethesda, MD, Usa;   2novartis Pharma ag, Basel,   switzerland; 3Department of Medicine,   University of leipzig, leipzig,   germany Correspondence: siew hwa Ong   novartis Pharma ag, Postfach,   Ch-4002 Basel, switzerland   Tel +41 61 324 4580   Email siew_hwa.ong@novartis.co mIntroduction:  Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of oral antidiabetic agents  for the treatment of type 2 diabetes mellitus, which lower blood glucose without causing severe  hypoglycemia.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
Available from: http://www.med.,Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
Available from: http://archimedesmodel.com /.,Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/f6/ceor-7-313.PMC4462855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/57/ijn-10-3855.PMC4462856.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3855–3863International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3855ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7791 9Effects of graphene plates’ adoption on the  microstructure, mechanical properties, and in vivo  biocompatibility of calcium silicate coating Y outao Xie Hongqin Li Chuanxian Ding Xuebin Zheng Kai Li Shanghai Institute of Ceramics, Key  Laboratory of Inorganic Coating  Materials, Chinese Academy of  Sciences, Shanghai, People’s Republic  of ChinaAbstract:  Calcium silicate (CS) ceramic is a good coating candidate for biomedical implants  to improve biocompatibility and accelerate early osseo-integration.",Non-OADS,/arxiv_data1/oa_pdf/c8/57/ijn-10-3855.PMC4462856.pdf
"They are suitable coating material  candidates for load-bearing implants.9,10 Silicon, one of the main components of CS, is  an essential trace element in animal nutrition and has very important functions in the  early stage of bone and ligament tissue formation.11 Hydrated silica gel can enhance Correspondence: Youtao Xie Shanghai Institute of Ceramics, Key  Laboratory of Inorganic Coating  Materials, Chinese Academy of Sciences,  1295 Dingxi Road, Shanghai, 200050,  People’s Republic of China Tel +86 21 5241 4102 Email xieyoutao@mail.sic.ac.c n  Xuebin Zheng Shanghai Institute of Ceramics, Key  Laboratory of Inorganic Coating  Materials, Chinese Academy of Sciences,  1295 Dingxi Road, Shanghai, 200050,  People’s Republic of China Tel +86 21 5241 4104 Email xbzheng@mail.sic.ac.c n Journal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Xie et al Running head recto: Graphene plates’ adoption on calcium silicate coating DOI: http://dx.doi.org/10.2147/IJN.S77919",Non-OADS,/arxiv_data1/oa_pdf/c8/57/ijn-10-3855.PMC4462856.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c8/57/ijn-10-3855.PMC4462856.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/57/ijn-10-3855.PMC4462856.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/21/ijn-10-3865.PMC4462857.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3865–3878International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3865OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8352 0Development and optimization of a   self-microemulsifying drug delivery system  for ator  vastatin calcium by using d-optimal  mixture design  correspondence: Young Wook choi college of Pharmacy, chung-ang  University, 221 heuksuk-dong,  Dongjak-gu, seoul 156-756, Korea Tel +82 2 8205 609  Fax +82 2 8263 781 email ywchoi@cau.ac.k r Dong Woo Yeom1 Ye seul song1 sung rae Kim1 sang gon lee1 Min hyung Kang1 sangkil lee2 Y oung Wook choi1 1college of Pharmacy, chung- ang   University, seoul, 2college of  Pharmacy, Keimyung University,    Daegu, republic of KoreaAbstract:  In this study, we developed and optimized a self-microemulsifying drug delivery system  (SMEDDS) formulation for improving the dissolution and oral absorption of atorvastatin calcium  (ATV), a poorly water-soluble drug.",Non-OADS,/arxiv_data1/oa_pdf/1a/21/ijn-10-3865.PMC4462857.pdf
"Keywords:  atorvastatin, SMEDDS, d-optimal mixture design, optimization, dissolution,  bioavailability  Introduction Atorvastatin calcium (ATV), a selective inhibitor of 3-hydroxy-3-methylglutaryl  coenzyme A reductase, is used in patients with hyperlipidemia to decrease plasma  levels of cholesterol and low-density lipoprotein by increasing the number of low- density lipoprotein receptors and subsequently accelerating the uptake and degrada - tion of low-density lipoprotein cholesterol.1 ATV is insoluble in aqueous solution at  pH 4 and is only slightly soluble in water and phosphate buffer at pH 7.4, indicating  pH-dependent solubility.2 ATV shows high intestinal permeability at relevant pH.3  After oral administration, absolute bioavailability of ATV is approximately 14%.4 This  is because of its low solubility, presystemic clearance in the gastrointestinal mucosa,  and/or extensive first-pass metabolism in the liver.4 To enhance the solubility and oral  absorption of ATV, various approaches have been investigated, including nanosuspen - sions, polymeric nanoparticles, polymorphs, solid dispersions, cyclodextrin complexes,  micronization, and microemulsion formulations.5–11Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Y eom et al Running head recto: Development and optimization of atorvastatin calcium-loaded SMEDDS DOI: http://dx.doi.org/10.2147/IJN.S83520",Non-OADS,/arxiv_data1/oa_pdf/1a/21/ijn-10-3865.PMC4462857.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1a/21/ijn-10-3865.PMC4462857.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/21/ijn-10-3865.PMC4462857.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/18/ijn-10-3879.PMC4462858.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3879–3886International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3879OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8025 3Formulation optimization of galantamine  hydrobromide loaded gel drug reservoirs in  transdermal patch for alzheimer’s disease Fong Yen Woo1 Mahiran Basri1,2 hamid reza Fard Masoumi1 Mansor B ahmad1 Maznah Ismail2 1Department of chemistry, Faculty  of science, 2laboratory of Molecular  Biomedicine, Institute of Bioscience,   Universiti Putra Malaysia, serdang,   selangor, MalaysiaAbstract:  Galantamine hydrobromide  (GH) is an effective drug for Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/e4/18/ijn-10-3879.PMC4462858.pdf
"The neu - rotransmitter acetylcholine (ACh) is not hydrolyzed into inactive molecules and thus  carries out its cognitive functions in the brain.3,4 Kumar et al and Suh et al reported that correspondences: Mahiran Basri;  Fong Yen Woo Basl 105, Department of chemistry,  Faculty of science, Universiti Putra  Malaysia, 43400 UPM serdang,  selangor, Malaysia Tel +60 3 8946 7266 email mahiran@upm.edu.m y;  fongyenwoo@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Woo et al Running head recto: Optimization of gel loaded in transdermal patch DOI: http://dx.doi.org/10.2147/IJN.S80253",OADS,/arxiv_data1/oa_pdf/e4/18/ijn-10-3879.PMC4462858.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e4/18/ijn-10-3879.PMC4462858.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/18/ijn-10-3879.PMC4462858.pdf
"Copenhagen: World Health Organization, Regional Office for Europe; 2006. http://www.euro.who.int/__data/assets/pdf_file/0010/74737/E89383.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Copenhagen: World Health Organization, Regional Office for Europe; 2006.http://www.euro.who.int/_data/assets/pdf_file/0018/103824/ E89384.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2013. http://ec.europa.eu/health/social_determinants/ docs/healthinequalitiesineu_2013_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2014. http://www.euro.who.int/__data/assets/pdf_file/0004/251878/Review-of-social-determinants- and-the-health-divide-in-the-WHO-European-Region-FINAL- REPORT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2012. http://greylitstrategies.info/sites/default/files/docs/Grey_Lit_Strategies_ProjectOverview_August2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
http://www.instituteofhealthequity.org/projects/fair- society-healthy-lives-the-marmot-review/fair-society-healthy- lives-full-report.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
London: Royal Col- lege of Paediatrics and Child Health; 2008. http://www.gmc-uk.org/Advocating_for_Children.pdf_49586796.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: Opportunity Agenda and Health PolicyInstitute; 2009. http://opportunityagenda.org/files/field_file/ Community%20Mapping%20for%20Health%20Equity%20- %20Treuhaft.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: International Council of Nurses; 2008.http://www.whpa.org/ppe_advocacy_guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: RobertWood Johnson Foundation; 2010. http://www.rwjf.org/content/",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Washington, DC: Innovation Network and Atlantic Philanthropies; 2009. http://www.innonet.org/client_docs/File/advocacy/pathfinder_evaluator_web.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
London: Voluntary Service Overseas; 2012. http://www.vsointernational.org/Images/advocacy-toolkit_tcm76--25498.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Durban: Health Systems Trust and University of the Western Cape; 2004. http://www.gega.org.za/download/ResearchtoAction04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2012. http://www.solidar.org/IMG/,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Washington, DC: National Association for the Education of Young Children; 2004. http://www.naeyc.org/files/naeyc/file/policy/toolkit.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: World Health Organization; 2008. http://www.who.int/social_determinants/media/sdhe_csw_final_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Los Angeles, CA: National Health Equity Coalition; 2009. http://www.national healthequitycoalition.org/FileStorage%5C351d0b49-0c63-4e9c-aa80-5e2c77f8bda2.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: World Health Organization; 1992. http://apps.who.int/iris/ bitstream/10665/70051/1/HED_92.4_eng.pdf.,OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: United Nations Children’s Fund; 2010. http://www.unicef.org/evaluation/files/Advocacy_Toolkit.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Inde-pendent Commission on Public Education; 2004. http://cesr.org/ downloads/practical_uses.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Bethesda, MD: Global Equity Gauge Al- liance; 2003. http://www.gega.org.za/download/gega_gauge.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Washington, DC: Grantmak- ers in Health; 2010. http://www.gih.org/usr_doc/Building_ Capacity_for_Health_Advocacy_at_the_State_and_Local_Level_.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Federal Way, WA: World Vision; 2006. http://www.worldvision.org/reso- urces.nsf/main/advocacy-handbook.pdf/$file/advocacy-handbook.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Helsinki: Ministry of Social Affairs and Health; 2013. http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Madrid: Ministry of Health and Social Policy; 2010. http://www.msssi.gob.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Brussels: European Anti-Poverty Network andEurochild; 2013. http://www.eapn.eu/images/stories/docs/eapn- books/2013_Child_poverty_EN_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: International Labour Organization; 2003. http://www.ilo.org/public/english/protection/download/lifecycl/lifecycle.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Bangkok: United Nations; 2011. http://www.unescap.org/commission/67/documents/theme- study-Promise-of-Protection.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: United States Human Rights Fund at Public Interest Projects and the Atlantic Philanthropies; 2008.http://www.thesunriseinitiative.org/Resources/Voices_from _the_Field.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: World Civil Society Fo- rum; 2002. http://wp.cedha.net/wp-content/uploads/2011/05/ Guidelines-for-Civil-Society-Advocacy-on-Human-Rights-and-corporate-behavior.htm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Edinburgh: Scottish Government; 2010. http://www.scotland.gov.uk/Resource/Doc/920/0107869.pdf.Accessed February 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: Legal Momentum; 2005. http://web.mit.edu/workplacecenter/docs/Full%20Report.pdf.Accessed February 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"New York, NY: United Nations Population Fund; 2004. http://www.yesweb.org/docs/YCN/Advocacy%20Tool%20Investing%20 in%20Youth.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Sheffield: Collaboration for Leader-ship in Applied Health Research and Care for South Yorkshire; 2010. http://clahrc-sy.nihr.ac.uk/images/papers/ CLAHRC%20SY%20Briefing%20Paper%201.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
York: Joseph Rowntree Foun-dation; 2009. http://www.jrf.org.uk/publications/implications- economic-inequality.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: World Health Orga-nization; 2010. http://www.jrf.org.uk/publications/implications- economic-inequality.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Geneva: World Health Organization; 2003. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
London: University College of London Institute of Health Equity; 2013. http://www.instituteofhealthequity.org/projects/working-for-health-equity-the-role-of-health-professionals.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Sacramento, CA: First 5 Association of California; 2004.http://www.cadca.org/files/First5AdvocacyToolkit.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2007. http://www.who.int/social_determinants/resources/csdh_ framework_action_05_07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
"Published August 28, 2008. http://www.economist.com/node/12009974.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
2014. http://www.euractiv.com/sections/eu-priorities-2020/de-gucht-ngos-trade-accusations- after-anti-ttip-protestors-kettled.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
http://wearethe99percent.tumblr.com/post/9289779051/we- are-the-99-percent.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
http://newint.org/books/reference/world-development/case- studies/social-networking-in-the-arab-spring/.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
https://secure.avaaz.org/ en/.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Supplementary Material Additional supporting information may be found in the online ver- sion of this article at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-0009: Appendix Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/milq0093-0392.PMC4462882.pdf
Available at: http://www.cdc.gov/drugresistance/threat-report .,OADS,/arxiv_data1/oa_pdf/6c/2f/ofv051.PMC4462889.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/9c/ofv061.PMC4462890.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/83/8c/2151.PMC4462934.pdf
"Students’ performance on the group exam has been shown to  improve (Gilley and Clarkston, 2014; Rieger and Heiner, 2014), and  the exam itself becomes a time to learn, as students debate scien - tific ideas (visit http://blogs.ubc.ca/wpvc/two-stage-exams for  guidance and to see this in action).",Non-OADS,/arxiv_data1/oa_pdf/83/8c/2151.PMC4462934.pdf
"Finally, writing assignments can be managed in courses with  many students by using Calibrated Peer Review (http://cpr.molsci   .ucla.edu; Pelaez, 2002; Schinske and Tanner, 2014).",Non-OADS,/arxiv_data1/oa_pdf/83/8c/2151.PMC4462934.pdf
", 2013; Problem-Based  Learning at the University of Delaware: www.udel.edu/inst), • Process-oriented guided-inquiry learning (https://pogil.org), • Course-based undergraduate research experiences (Auchincloss  et al.",Non-OADS,/arxiv_data1/oa_pdf/83/8c/2151.PMC4462934.pdf
", 2014; http://curenet.cns.utexas.edu), and • Project-based applied learning (www.pal.uga.edu).",Non-OADS,/arxiv_data1/oa_pdf/83/8c/2151.PMC4462934.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/1e/2156.PMC4462935.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/57/b0/2168.PMC4462936.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/11/dc/2181.PMC4462937.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/52/f6/2190.PMC4462938.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5b/97/2205.PMC4462939.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f4/82/2217.PMC4462940.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/bync-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/86/45/2227.PMC4462941.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/38/80/2242.PMC4462942.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/50/2252.PMC4462943.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0c/be/2263.PMC4462944.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f4/3a/2279.PMC4462945.pdf
Available at http://www.ncbi.nlm.nih.gov/books/ NBK51965/ (accessed November 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/3a/2279.PMC4462945.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9b/83/2311.PMC4462947.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a2/e3/2321.PMC4462948.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/6e/2333.PMC4462949.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/dd/f6/2343.PMC4462950.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c6/0b/2357.PMC4462951.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5b/15/2375.PMC4462952.pdf
"LRP6, a member of the LDLR family, has  been demonstrated to be an indispensable coreceptor for the Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> Received 11 February 2015 | Accepted 10 June 2015 | Published 12 June 2015© 2015 Molecular Vision 665Elevated LRP6 levels correlate with vascular endothelial growth  factor in the vitreous of proliferative diabetic retinopathy Xinxiao Gao,1,2 Kai Ma,3 Ning Lu,3 Yongsheng Xu,4 Tingting Hong,2 Xiaoyan Peng1 1Beijing Institute of Ophthalmology, Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Eye Center, Beijing  Tongren Hospital, Capital Medical University, Beijing, China; 2Department of Ophthalmology, Beijing Anzhen Hospital, Capital  Medical University, Beijing, China; 3Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital,  Capital Medical University, Beijing, China; 4Clinical Lab of Tissue&Cell Research Center, Department of Biotech Treatment,  Logistics College of Chinese People’ s Armed Police Force, Tianjin, China Purpose:  To measure intravitreal low-density lipoprotein receptor-related protein 6 (LRP6) and vascular endothelial  growth factor (VEGF) levels in the eyes of patients with proliferative diabetic retinopathy (PDR) and to observe their  correlation with PDR activity.",Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  666canonical Wnt pathway.,Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  667U test or independent Student t test was used to analyze  the differences between two groups after the data were  checked for normal distribution.,Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
"Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  668Concentrations of LRP6 in plasma samples of all patients:   LRP6 levels were detected in all plasma samples from the  patients with PDR, as well as from the control group without  diabetes (Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  669 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  670PDR group.,Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
"Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  671In conclusion, our findings demonstrated that LRP6  levels were increased in the vitreous body from patients with  PDR and there was a positive correlation between LRP6  and VEGF.",Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
Molecular Vision  2015; 21:665-672 <http://www.molvis.org/molvis/v 21/665> © 2015 Molecular Vision  672of kallistatin through interactions with the canonical Wnt  pathway.,Non-OADS,/arxiv_data1/oa_pdf/9a/0f/mv-v21-665.PMC4462953.pdf
"Analyses of concomitant changes of the oxidative  stress markers LPO, MDA, SOD, and GSH, as well as other Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> Received 31 July 2014 | Accepted 10 June 2015 | Published 12 June 2015© 2015 Molecular Vision 649Levels of selected oxidative stress markers in the vitreous and  serum of diabetic retinopathy patients Vlatka Brzović-Šarić,1 Irena Landeka,2 Borna Šarić,1 Monika Barberić,3 Lidija Andrijašević,1 Branimir  Cerovski,4 Nada Oršolić,5 Domagoj Đikić5 1Department of Ophthalmology, Sveti Duh Clinical Hospital, Sveti Duh 64, 10000 Zagreb, Croatia; 2Laboratory of Food  Chemistry and Biochemistry, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia; 3Medical  Diagnostics Laboratory, Sveti Duh Clinical Hospital, Zagreb, Croatia; 4School of Medicine, University of Zagreb, Croatia;  5Department of Animal Physiology, Faculty of Science, University of Zagreb, Zagreb, Croatia Purpose:  In diabetes, an impaired antioxidant defense system contributes to the development of diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
"Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  650markers, such as VEGF or AOPP, can be found in the litera - ture, individually presented in different studies, assayed by  different methods on a different number of examined subjects,  thus preventing the examination of possible correlations and  ties between all of the assayed parameters in both physiologic  fluids from the same patients [ 15-20].",Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  651horseradish peroxidase was added to samples.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
"Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  652correlation (p≤0.05) of serum MDA and SOD activity with  increased age in PDR patients, and serum VEGF was posi - tively correlated with increasing age.",Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  653Table  2.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  654The Spearman correlation coefficients of the measured  parameters in the NDED subjects are presented in Table 4  and for PDR patients in Table 5.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  655Table  3. c orrela Tion of Measured  para MeTers wiTh seru M glucose  in non-diabe Tic paTienTs  wiTh eye disorders  (nded ) and prolifera Tive diabe Tic reTinopa Thy (pdr ) paTienTs.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  656 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  657 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  658and p=0.001; Table 5) was found between the vitreous and  serum VEGF in the PDR group.,OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  659Table  4. c orrela Tion analysis  of Measured  para MeTers in viTreous  and seru M of non-diabe Tic paTienTs wiTh eye disorders  (nded ) paTienTs.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  660Table  5. c orrela Tion analysis  of Measured  para MeTers in viTreous  and seru M of prolifera Tive diabe Tic reTinopa Thy (pdr ) paTienTs.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  661MDA.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
"Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  662findings of candidate markers [ 26,40,45].",Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  663retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
Molecular Vision  2015; 21:649-664 <http://www.molvis.org/molvis/v 21/649> © 2015 Molecular Vision  66443.,Non-OADS,/arxiv_data1/oa_pdf/28/af/mv-v21-649.PMC4462954.pdf
"Specifically, cells Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> Received 11 February 2015 | Accepted 10 June 2015 | Published 12 June 2015© 2015 Molecular Vision 673Characterization of cells from patient-derived fibrovascular  membranes in proliferative diabetic retinopathy Leo A. Kim,1,2 Lindsay L. Wong,1 Dhanesh S. Amarnani,1 Alexander A. Bigger-Allen,1 Yang Hu,1 Christina  K. Marko,1 Dean Eliott,2 Vinay A. Shah,3 Declan McGuone,4 Anat O. Stemmer-Rachamimov,4 Xiaowu Gai,5  Patricia A. D’Amore,1,6 Joseph F. Arboleda-Velasquez1 1Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston,  MA; 2Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston,  MA; 3Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK; 4C.S.",Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
"Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  674from diabetic sources have been shown to have “metabolic  memory,” implicating potential epigenetic changes from  continual exposure to a high-glucose environment [ 30,31].",Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  675K was used as the antigen retrieval method for GFAP.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  676cellular concentration of 5.0 × 105 cells/ml.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  677extracted from the blood of the same donor using comparative  genomic hybridization (CGH) analysis.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  678 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
"Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  679cells versus case 6 (51.44 and 10.82 nuclei/10 µm2, respec - tively), and fewer GFAP-positive cells (6.93 and 51.58  nuclei/10  µm2, respectively).",Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  680 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  681presence of 6 ng/ml VEGF (Figure 5D).,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
"Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  682DISCUSSION In this work, we report the isolation, culture, and character - ization of cells from FVMs or C-FVMs derived from patients  with proliferative diabetic retinopathy, the most prevalent  cause of vision loss in working-age adults in developed coun - tries [ 44].",Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  683 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  684Tsp-1 within the diabetic environment may further contribute  to aberrant angiogenesis.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
"Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  685Mark Consugar and DanYi Wang for help with conducting  the SNP array analysis, Maria Ericsson and the Electron  Microscopy Facility at Harvard Medical School for assis - tance with electron microscopy, and Patricia Houlihan, Anne  Marie Lane, and Meredith Ryan for assistance with the IRB  protocols and clinical coordination.",Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  686of diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Molecular Vision  2015; 21:673-687 <http://www.molvis.org/molvis/v 21/673> © 2015 Molecular Vision  687in mice transgenically overexpressing angiopoietin-1.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/mv-v21-673.PMC4462955.pdf
Available at http://www.hindawi.com/journals/crp/2011/254321/.,Non-OADS,/arxiv_data1/oa_pdf/5e/0c/rbccv-30-02-0148.PMC4462959.pdf
Available from: http://www.ibge.gov.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/rbccv-30-02-0219.PMC4462968.pdf
"Available at: http://jdc.jefferson.edu/tmf/vol14/iss1/4 32 Herbst M, Wattjes MP, Urbach H, Inhetvin-Hutter C, Becker D,  Klockgether T, et al.",OADS,/arxiv_data1/oa_pdf/b6/98/rbccv-30-02-0225.PMC4462969.pdf
Availabe at: http://www.theiaforum.,Non-OADS,/arxiv_data1/oa_pdf/b6/98/rbccv-30-02-0225.PMC4462969.pdf
Via Pubmed Research in Pubmed website (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/b7/2f/rbccv-30-02-0246.PMC4462971.pdf
"- Endnote Web tutorial for BJCVS/RBCCVYou do not have to enter username and password each  time the Word® is open, if you click on “preferences”,  “application”; “enter your Endnote Online Subscription”  type “ http://www.myendnoteweb.com:80/ ” login and  password and click “remember my address and pass - word” (Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/b7/2f/rbccv-30-02-0246.PMC4462971.pdf
Available from: http://www.myendnoteweb.com/help/ pt_br/ENW/help.htm,Non-OADS,/arxiv_data1/oa_pdf/b7/2f/rbccv-30-02-0246.PMC4462971.pdf
SNIP index ( Source Normalized Impact per Paper ) (http://www.journalindicators.com)  The SNIP index can be quickly checked online and it is  free.,OADS,/arxiv_data1/oa_pdf/5b/8c/rbccv-30-02-0254.PMC4462972.pdf
"The SJR index ( SCImago Journal Rank )  (http://www.scimagojr.com) As SNIP, the SJR is also a free index.",Non-OADS,/arxiv_data1/oa_pdf/5b/8c/rbccv-30-02-0254.PMC4462972.pdf
The WEBQUALIS (http://qualis.capes.gov.br) The CAPES (Coordenação de Aperfeiçoamento de Pes - soal de Nível Superior) is a Brazilian government agency  for research support and offers its own system of journals  qualification where can be found Brazilian post graduation  programs scientific production.,Non-OADS,/arxiv_data1/oa_pdf/5b/8c/rbccv-30-02-0254.PMC4462972.pdf
Available at: http://InformationR.net/ir/paper111.html 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/8c/rbccv-30-02-0254.PMC4462972.pdf
Available at: http://www.publications.,Non-OADS,/arxiv_data1/oa_pdf/5b/8c/rbccv-30-02-0254.PMC4462972.pdf
Available from: http://www.hindawi.,Non-OADS,/arxiv_data1/oa_pdf/0d/ff/rbccv-30-02-0266.PMC4462974.pdf
Available from: http://my.clevelandclinic.org/heart/ medical-professionals/case-studies/ischemic-stroke.aspx 23.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/rbccv-30-02-0276.PMC4462975.pdf
Available from: http://www.mayomedicallaboratories.com/test- catalog/Clinical+and+Interpretive/83873 37.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/rbccv-30-02-0276.PMC4462975.pdf
"Image processing The quantitative image analysis was performed in a blinded manner using image-processing software tools available from the University of Oxford FMRIB Centresoftware library (version 4.0, http://www.fmrib.ox.ac.uk/).In this manner the ADC images were registered to eachpatients corresponding CE T1-weighted MRI image usinga linear (afﬁne) registration.",OADS,/arxiv_data1/oa_pdf/13/3e/jmrs0062-0092.PMC4462980.pdf
"Radiographic learning is morepractical in nature, for example, accredited radiographydegrees in Australia have many more weeks of clinicalplacement (approximately 48 –60) than other similar health degrees such as physiotherapy (approximately 20 –25 weeks) (http://www.medicalradiationpracticeboard.gov.au/Accreditation.aspx, http://www.physiotherapyboard.gov.",Non-OADS,/arxiv_data1/oa_pdf/a2/dd/jmrs0062-0132.PMC4462985.pdf
Available from: http://apps.who.int/bmi/index.jsp?,OADS,/arxiv_data1/oa_pdf/a2/dd/jmrs0062-0132.PMC4462985.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/72/jev001.PMC4463003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/79/jev055.PMC4463004.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/ca/civ231.PMC4463007.pdf
Available at: http://www.uptodate.com/contents/bacterialvaginosis?source=search_result&search=bacterial+vaginosis+sobel&selectedTitle=1%7E72.,Non-OADS,/arxiv_data1/oa_pdf/18/96/olq-42-376.PMC4463027.pdf
"Available at: http://www.cdc.gov/ std/treatment/2014/2014-std-guidelines-peer-reviewers-08-20-2014.pdf.Accessed August 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/96/olq-42-376.PMC4463027.pdf
Available at: http://clinicaltrials.gov/showclinicalTrails.gov identifier NCT01996436.,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ana-27-222.PMC4463029.pdf
"For all analyses, we used the software package R version 2.11.1 (R Foundation for Statistical Computing; http://www.r-project.org/foundation/).",OADS,/arxiv_data1/oa_pdf/55/58/indhealth-53-260.PMC4463184.pdf
http://www.cdc.gov/niosh/topics/chestradiography/interpretation.html.,Non-OADS,/arxiv_data1/oa_pdf/55/58/indhealth-53-260.PMC4463184.pdf
"For the first time, nonanatomic Korean J Thorac Cardiovasc Surg 2015;48:157-163 □ Review  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.157",Non-OADS,/arxiv_data1/oa_pdf/ab/a5/kjtcv-48-157.PMC4463223.pdf
"Since the mortal- i t y  r a t e  o f  s e v e r e  A R D S  i s  s t i l l  h i g h e r ,  e v e n  w h e n  state-of-the-art medical treatme nt is deployed, extracorporeal  membrane oxygenation has emer ged as a promising technique  that allows patients to circumvent the period of profound hy-poxemia and hypercarbia associ ated with severe ARDS and  increases the likelihood of survival.Korean J Thorac Cardiovasc Surg 2015;48:180-186 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.180",Non-OADS,/arxiv_data1/oa_pdf/79/b8/kjtcv-48-180.PMC4463224.pdf
Postoperative com-Korean J Thorac Cardiovasc Surg 2015;48:206-209 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.206,Non-OADS,/arxiv_data1/oa_pdf/9a/dc/kjtcv-48-206.PMC4463225.pdf
"Pathological examination reveal ed a malignant cartilaginous  tumor showing hypercellularity, moderate nuclear atypia, and Korean J Thorac Cardiovasc Surg 2015;48:199-201 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.199",Non-OADS,/arxiv_data1/oa_pdf/55/39/kjtcv-48-199.PMC4463226.pdf
Korean J Thorac Cardiovasc Surg 2015;48:228-230 □ How to Do It  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.228,Non-OADS,/arxiv_data1/oa_pdf/65/98/kjtcv-48-228.PMC4463227.pdf
"However, afte r ICD insertion, the patient Korean J Thorac Cardiovasc Surg 2015;48:220-224 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.220",Non-OADS,/arxiv_data1/oa_pdf/60/b9/kjtcv-48-220.PMC4463228.pdf
Due to Korean J Thorac Cardiovasc Surg 2015;48:193-198 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.193,Non-OADS,/arxiv_data1/oa_pdf/bb/73/kjtcv-48-193.PMC4463229.pdf
A chest CT scan demonstrated mediastinal shift Korean J Thorac Cardiovasc Surg 2015;48:217-219 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.217,Non-OADS,/arxiv_data1/oa_pdf/81/1a/kjtcv-48-217.PMC4463230.pdf
Postoperative val- ues of the ankle-brachial index and a postoperative computed tomography angiogram showed good patency.Korean J Thorac Cardiovasc Surg 2015;48:214-216 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.214,Non-OADS,/arxiv_data1/oa_pdf/5c/80/kjtcv-48-214.PMC4463231.pdf
"A  2 1 - F r   inflow catheter (DLP; Medtronic Inc., Minneapolis, MN, Korean J Thorac Cardiovasc Surg 2015;48:210-213 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.210",Non-OADS,/arxiv_data1/oa_pdf/6d/53/kjtcv-48-210.PMC4463232.pdf
"However, many  centers in South Korea use  the traditional open method due to the high cost of EVH, Korean J Thorac Cardiovasc Surg 2015;48:174-179 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.174",Non-OADS,/arxiv_data1/oa_pdf/ff/4f/kjtcv-48-174.PMC4463233.pdf
The objective of the present study was to explore the efficacy and mid-term resu lts of extraanatomical bypass  procedures used in the treatment of total aortic occlusion.Korean J Thorac Cardiovasc Surg 2015;48:187-192 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.187,Non-OADS,/arxiv_data1/oa_pdf/db/47/kjtcv-48-187.PMC4463234.pdf
The resected mediastinal mass was Korean J Thorac Cardiovasc Surg 2015;48:225-227 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.225,Non-OADS,/arxiv_data1/oa_pdf/dd/47/kjtcv-48-225.PMC4463235.pdf
RetrogradeKorean J Thorac Cardiovasc Surg 2015;48:164-173 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.164,Non-OADS,/arxiv_data1/oa_pdf/48/75/kjtcv-48-164.PMC4463236.pdf
2) and an echocardiogram.Korean J Thorac Cardiovasc Surg 2015;48:202-205 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.3.202,Non-OADS,/arxiv_data1/oa_pdf/a7/ef/kjtcv-48-202.PMC4463237.pdf
Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Overall survival (OS) for women with metastatic breast cancer (MBC) has improved over recent de-cades.,Non-OADS,/arxiv_data1/oa_pdf/70/91/zlj594.PMC4463422.pdf
"For a detailed description of the disclosurecategories, or for more information about ASCO’s conﬂict of interest policy,please refer to the Author Disclosure Declaration and the Disclosures ofPotential Conﬂicts of Interest section in Information for Contributors.Employment or Leadership Position: Martin S. Olivo, Eisai (C); Corina E. Dutcus, Eisai (C) Consultant or Advisory Role: Peter A. Kaufman, Eisai (C); Ahmad Awada, Eisai (C); Chris Twelves, Eisai (C); GalinaVelikova, Eisai (U); Javier Cortes, Roche, Novartis, Celgene (C) Stock Ownership: None Honoraria: Peter A. Kaufman, Eisai; Chris Twelves, Eisai; Galina Velikova, Eisai; Javier Cortes, Roche, Novartis, Celgene,Eisai Research Funding: Peter A. Kaufman, Eisai; Louise Yelle, Eisai Expert Testimony: None Patents, Royalties, and Licenses: None Other Remuneration: Galina Velikova, Eisai AUTHOR CONTRIBUTIONS Conception and design: Peter A. Kaufman, Chris Twelves, Corina E. Dutcus, Javier CortesProvision of study materials or patients: Javier Cortes Collection and assembly of data: Peter A. Kaufman, Ahmad Awada, Chris Twelves, Louise Yelle, Edith A. Perez, Corina E. Dutcus, Javier CortesData analysis and interpretation: All authors Manuscript writing: All authors Final approval of manuscript: All authors REFERENCES 1.American Cancer Society: Cancer facts and ﬁg- ures 2011. http://www.cancer.org/Research/ CancerFactsFigures/CancerFactsFigures/cancer-facts-ﬁgures-2011 2.National Cancer Institute: SEER Cancer Sta- tistics Review, 1975-2010, National Cancer Insti-tute.",Non-OADS,/arxiv_data1/oa_pdf/70/91/zlj594.PMC4463422.pdf
"http://seer.cancer.gov/csr/1975_2010 3.Andreopoulou E, Sparano JA: Chemotherapy in patients with anthracycline- and taxane-pretreatedmetastatic breast cancer: An overview.",Non-OADS,/arxiv_data1/oa_pdf/70/91/zlj594.PMC4463422.pdf
"Mayo Clin Proc 84:533-545, 2009 5.National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Breast CancerVersion 3. http://www.nccn.org/professionals/ physician_gls/PDF/breast.pdf6.Geyer CE, Forster J, Lindquist D, et al: Lapa- tinib plus capecitabine for HER2-positive advancedbreast cancer.",Non-OADS,/arxiv_data1/oa_pdf/70/91/zlj594.PMC4463422.pdf
Vitamin D and CVD in diabetes 1–8 4:128 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 2–8 4:129 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 3–8 4:130 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 4–8 4:131 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 5–8 4:132 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 6–8 4:133 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 7–8 4:134 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Vitamin D and CVD in diabetes 8–8 4:135 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0034/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/44/6d/ec-04-128.PMC4463474.pdf
Chapter 14 Available at http://www.ncbi.nlm.nih.gov/books/NBK1920/#ch14.s1.,Non-OADS,/arxiv_data1/oa_pdf/af/56/UPS-120-104.PMC4463483.pdf
"To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2014- 000226) Received 2 December 2014 Revised 17 April 2015Accepted 6 May 2015 Dr Gabriel M Khan MB, BCh,MD (Queen ’s Belfast), FRCP (London) FRCP C, FACP, FACC, Associate Professor,Department of Medicine and Division of Cardiology, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada Correspondence to Dr Gabriel M Khan; DrKhanBooks@gmail.comABSTRACT Objective: Worldwide, more than 50 million ECGs are carried out annually.",Non-OADS,/arxiv_data1/oa_pdf/14/12/openhrt-2014-000226.PMC4463488.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/12/openhrt-2014-000226.PMC4463488.pdf
http://linkinghub.elsevier.com/retrieve/ pii/S073510970400796X http://dx.doi.org/10.1016/j.jacc.2004.03.0623.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/ eutils/elink.fcgi?dbfrom=pubmed&id=7641364&retmode=ref&cmd=prlinks http://dx.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
fcgi?dbfrom=pubmed&id=2330896&retmode=ref&cmd=prlinks http://dx.doi.org/10.1016/0002-9149(90)90323-S 5.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8800114&retmode=ref&cmd=prlinks 6.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://www.sciencedirect.com/science/ article/pii/S0002870305004631 doi:10.1016/j.ahj.2005.04.031 7.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eurheartj.oxfordjournals.org/cgi/doi/10.1093/ eurheartj/ehn499 http://dx.doi.org/10.1093/eurheartj/ehn499 8.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://content.onlinejacc.org/article.aspx?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
articleid=1742655 http://dx.doi.org/10.1016/j.jacc.2013.08.1622 11.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
J Am Coll Cardiol 2006;47:2357 – 63. http://linkinghub.elsevier.com/ retrieve/pii/S0735109706008606 http://dx.doi.org/10.1016/j.jacc.2006.02.048 13.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
dbfrom=pubmed&id=7710749&retmode=ref&cmd=prlinks http://dx.doi.org/10.1016/S0894-7317(05)80356-6 14.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://linkinghub.elsevier.com/retrieve/pii/ S0735109705029219 http://dx.doi.org/10.1016/j.jacc.2005.08.077 15.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17129510&retmode=ref&cmd=prlinks http://dx.doi.org/10.1007/s11897-006-0018-6 16.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
3346/jkms.2012.27.3.236 http://dx.doi.org/10.3346/jkms.2012.27.3.236 18.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
ajconline.org/article/S0002 –9149(04)00136 –5/fulltext http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http:// eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8198044&retmode=ref&cmd=prlinks http://dx.doi.org/10.1016/0002-9149(94)90298-4 20.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://www.informaworld.com/openurl?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
genre=article&doi=10.1080/10976640500295516&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3 http://dx.doi.org/10.1080/10976640500295516 21.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://ajpheart.physiology.org/cgi/doi/10.1152/ajpheart.00365.2012http://dx.doi.org/10.1152/ajpheart.00365.2012 22.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
dbfrom=pubmed&id=10556226&retmode=ref&cmd=prlinks http://dx.doi.org/10.1161/01.CIR.100.19.1992 23.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
jcmr-online.com/content/13/1/50 http://dx.doi.org/10.1186/1532-429X-13-50 24.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://www.springerlink.com/index/10.1007/ s10554 –011 –9952 –9 http://dx.doi.org/10.1007/s10554-011-9952-9 25.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
dbfrom=pubmed&id=23178864&retmode=ref&cmd=prlinks http://dx.doi.org/10.1093/ehjci/jes271 27.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
oxfordjournals.org/cgi/doi/10.1093/eurheartj/ehr309 http://dx.doi.org/10.1093/eurheartj/ehr309 28.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/ entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22496084&retmode=ref&cmd=prlinks http://dx.doi.org/10.1161/CIRCINTERVENTIONS.,OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://linkinghub.elsevier.com/ retrieve/pii/S0894731711004755 http://dx.doi.org/10.1016/j.echo.2011.06.017 31.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
"dbfrom=pubmed&id=10595406&retmode=ref&cmd=prlinks http://dx.doi.org/10.1023/A:1006276513186 8 Kyhl K, Vejlstrup N, Lønborg J, et al.Open Heart 2015; 2:e000223.",OADS,/arxiv_data1/oa_pdf/1c/95/openhrt-2014-000223.PMC4463489.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/ab/rjv038.PMC4463491.pdf
Available from: http://www.icoph.org/downloads/ icoethicalcode.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/IJO-63-306.PMC4463553.pdf
Papillary diameters were measured by ImageJ  software (http://www.rsbweb.nih.gov/ij/)[7] based on the SLM  photos or confocal images.,OADS,/arxiv_data1/oa_pdf/a4/25/IJO-63-327.PMC4463557.pdf
"But since 1980 a veritable zoo of more than 200 genes  causing human retinal pathologies  (Retnet, http://www.sph.",Non-OADS,/arxiv_data1/oa_pdf/26/4b/IJO-63-353.PMC4463566.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/5b/tinv-59-011.PMC4463768.pdf
"S1, 11 –16, http://dx.doi.org/10.1080/07924259.2014.927805",Non-OADS,/arxiv_data1/oa_pdf/a9/5b/tinv-59-011.PMC4463768.pdf
"Among 259 human aging genes retrieved from The Human Ageing Genomic Resources ( http://genomics.senescence.info ), we found that 207 (80%) were conserved in Hydra (E-value of the best BLAST hit of Hydra below 1E-10).",OADS,/arxiv_data1/oa_pdf/a9/5b/tinv-59-011.PMC4463768.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/1b/jpr-8-269.PMC4463777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 269–276Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  269ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8087 2a prospective multi-site registry study of a  specific protocol of autologous bone marrow  concentrate for the treatment of shoulder  rotator cuff tears and osteoarthritis christopher J centeno1  hasan al-sayegh1  Jamil Bashir1  shaun goodyear2  Michael D Freeman3 1centeno-schultz clinic,  Broomfield,  cO, Usa; 2Forensic Research  and analysis, Portland, OR , Usa;  3Department of Public Health and  Preventive Medicine and Psychiatry,  Oregon health and  science  University, Portland, OR,  Usa correspondence: Jamil Bashir    centeno-schultz clinic,   403 summit Blvd suite  201,   Broomfield, CO  80021, Usa   T el +1 303 429 6448   email jbashir@centenoschultz.",Non-OADS,/arxiv_data1/oa_pdf/21/1b/jpr-8-269.PMC4463777.pdf
"The registry was designed as an ongoing prospective  survey system, using an automated questionnaire generated  at 1 month,  3 months,  6 months, and  12 months and then  annually post treatment, via an electronic database system  using ClinCapture software (Clinovo Clinical Data Solutions,  Sunnyvale, CA, USA; http://www.clinovo.com/clincaptur e).",OADS,/arxiv_data1/oa_pdf/21/1b/jpr-8-269.PMC4463777.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/21/1b/jpr-8-269.PMC4463777.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/1b/jpr-8-269.PMC4463777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/f0/prbm-8-153.PMC4463778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 153–160Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  153Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PRBM.S8241 7Quantifying biopsychosocial aspects in everyday  contexts: an integrative methodological approach  from the behavioral sciences Mariona Portell1 M teresa Anguera2 Antonio hernández- Mendo3 gudberg K Jonsson4 1department of Psychobiology and  Methodology of health Sciences,   Universitat Autònoma de Barcelona,   Cerdanyola del Vallès, Spain;   2department of Methodology of  Behavioral Sciences, University  of Barcelona, Barcelona, Spain;   3department Social Psychology, Social  Anthropology, Social Work and Social  Services, University of Málaga, Málaga,   Spain; 4human Behavior laboratory,   University of Iceland, Reykjavík,   Iceland Correspondence: Mariona Portell   department of Psychobiology and  Methodology of Health Sciences, Edifici  B – Campus de Bellaterra, Universitat  Autònoma de Barcelona, 08193  Cerdanyola del Vallés, Barcelona, Spain   tel +34 93 581 1623   email mariona.portell@uab.ca tAbstract:  Contextual factors are crucial for evaluative research in psychology, as they provide  insights into what works, for whom, in what circumstances, in what respects, and why.",Non-OADS,/arxiv_data1/oa_pdf/35/f0/prbm-8-153.PMC4463778.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/35/f0/prbm-8-153.PMC4463778.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/35/f0/prbm-8-153.PMC4463778.pdf
"http://www.orpha.net/data/patho/GB/uk -Turner.pdf   4 Legre V, Azulay JP, Serratrice J: Syndrome de Pa rsonage et Turner (névralgie amyotrophiante).",Non-OADS,/arxiv_data1/oa_pdf/3b/02/crn-0007-0110.PMC4463779.pdf
http://dx.doi.org/ 10.1016/j.lpm.2014.10.017 .,OADS,/arxiv_data1/oa_pdf/3b/02/crn-0007-0110.PMC4463779.pdf
http://www.pharmaceutical -journal.com/learning/learning -article/drug -induced -eosinophilia/   20000049.article.,Non-OADS,/arxiv_data1/oa_pdf/05/68/crg-0009-0142.PMC4463786.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/d4/dsv003.PMC4463843.pdf
Candidate gene selection and annotation We initially detected the genes in the causal region according to thefunctional annotation of the mei genome (http://prunusmumegenome.bjfu.edu.cn).,OADS,/arxiv_data1/oa_pdf/7c/d4/dsv003.PMC4463843.pdf
Genes within the candidateregion were then detected based on a nnotation of the mei genome (http://prunusmumegenome.bjfu.edu.cn./).,OADS,/arxiv_data1/oa_pdf/7c/d4/dsv003.PMC4463843.pdf
"The research  protocol was approved by the Animal Care Committee of the Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> Received 8 March 2015 | Accepted 10 June 2015 | Published 12 June 2015© 2015 Molecular Vision 688Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal  neovascularization after alkali burns in mice Peng Zeng,1 Rong-biao Pi,2 Peng Li,3 Rong-xin Chen,1 Li-mian Lin,1 Hong He,4 Shi-you Zhou1 (The first three of the authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  689Zhongshan Ophthalmic Center at Sun Yat-sen University in  China.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  690created by incubating sections with PBS instead of the  primary antibody.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
"Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  691Thermo Fisher Scientific, Waltham, MA) for 5 min at room  temperature.",Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
"Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  692that of ROS production in the normal cornea (all p<0.01, n=5/ group, Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
"Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  693Inflammation is heavily involved in CNV, especially in  chemical burn-induced CNV.",Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  694 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  695such as N-acetyl-L-cysteine for six consecutive days begin - ning from day 3 before the alkali burn can significantly  reduce ROS production [ 10].,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  696activated downstream effectors like mDia may negate the  effect of ROCK activation.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  69720.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
Molecular Vision  2015; 21:688-698 <http://www.molvis.org/molvis/v 21/688> © 2015 Molecular Vision  698the rabbit cornea.,Non-OADS,/arxiv_data1/oa_pdf/db/2d/mv-v21-688.PMC4463969.pdf
"We also assessed the role of endothelium- derived relaxing factors (EDRF), i.e., prostaglandins (PG), Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> Received 12 July 2014 | Accepted 10 June 2015 | Published 12 June 2015© 2015 Molecular Vision 699Vasodilatory mechanisms of unoprostone isopropyl in isolated  porcine retinal arterioles Ichiro Tanano, Taiji Nagaoka, Shinji Ono, Tsuneaki Omae, Shinichi Otani, Akitoshi Yoshida Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Japan Purpose:  To clarify the vasodilatory mechanism of unoprostone isopropyl (UI), we examined its effects on the retinal  microvascular diameter to determine the dependence on the endothelium and/or smooth muscle to reveal the signaling  mechanisms involved in this vasomotor activity.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  700Table  1.,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
"Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  701nitric oxide (NO), and cytochrome P450 metabolites, in medi - ating the vascular response in the presence of known effective  concentrations of the speciﬁc enzyme inhibitors indomethacin  (10 µM) [ 10,15], NG-nitro-L-arginine methyl ester (L-NAME;  10 µM) [ 9,10], and sulfaphenazole (10  µM) [ 16], respectively.",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
"Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  702dilation [ 9,11].",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
"Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  703dilation of the retinal arterioles (88.3 ±2.5 versus 88.8 ±2.2,  86.8 ±3.3, 90.2 ±4.2, 88.7 ±2.8, 88.7 ±2.8 µm; Table 1).",Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  704vasodilation via NO production from the endothelium in the  retinal arterioles.,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
Molecular Vision  2015; 21:699-705 <http://www.molvis.org/molvis/v 21/699> © 2015 Molecular Vision  705nitric oxide and mevalonate-rho kinase pathways.,Non-OADS,/arxiv_data1/oa_pdf/c1/3b/mv-v21-699.PMC4463970.pdf
T reatment administered by resident village recruiters with little previous medical knowl- edge and no research experience; they got monitored by ﬁeld sup ervisors Data for participants > 72 months old were from one site Access to and quality of available care at referral hospital was notably different between African and Asian sites Determination of alternative diagnosis was ruled out by exp ert opinion T rial Regis- tration: http://www.controlled-trials.com/ISRCTN83979018 ;http://www.controlled- trials.com/ISRCTN46343627 ;http://www.controlled-trials.com/ISRCTN76987662 Risk of bias 16 Pre-referral rectal artesunate for severe malaria (Review ) Copyright © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/8d/CD009964.PMC4463986.pdf
"Searching other resources We also searched clinical trial registries ( https://clinicaltrials.gov/ , the WHO International Clinical T rials Registry Platform (ICTR P , http://www.who.int/ictrp/en/ ), both searched 11/02/2014) and websites of relevant organisations (Helping Babies Breathe ,http:/ /www.helpingbabiesbreathe.org/ , searched 11/02/2014).",Non-OADS,/arxiv_data1/oa_pdf/cb/0f/CD007071-0001.PMC4463987.pdf
"4 http://www.choosingwisely.org/doctor -patient -lists/society -of-gynecologic -oncology (accessed January 6,  2015 ).",Non-OADS,/arxiv_data1/oa_pdf/a0/db/cro-0008-0217.PMC4464040.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/27/63/10.1177_2058460115588099.PMC4464058.pdf
"2015;3(2):104-108.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Sohrab Keyhani, MD; Mohammad Reza Abbasian, MD; Nasim Siatiri, MD; Ali Sarvi, MD; Mohsen Mardani Kivi, MD; Ali Akbar Esmailiejah, MD Research performed at Akhtar Orthopedic Hospital, Tehran, Iran IntroductionArthroscopic meniscal repair was first introduced  by Ikeuchi in Tokyo, in 1979 (  1).",Non-OADS,/arxiv_data1/oa_pdf/0a/93/ABJS-3-104.PMC4464318.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/42/8b/ircmj-17-05-21934.PMC4464369.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c3/fc/ircmj-17-05-19000.PMC4464374.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/dd/d3/ircmj-17-05-27676.PMC4464375.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0d/fd/ircmj-17-05-18320.PMC4464376.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ae/5b/ircmj-17-05-18373.PMC4464378.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/86/11/ircmj-17-05-18342.PMC4464379.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ircmj-17-05-21509.PMC4464380.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3f/9a/ircmj-17-05-28090.PMC4464381.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4d/00/ircmj-17-05-17594.PMC4464382.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/57/25/ircmj-17-05-24779.PMC4464383.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9f/7a/ijhrba-04-01-23028.PMC4464502.pdf
"The second is based on os- mium-mediated diastereoselective dihydroxylation of an un- [a] Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, United KingdomE-mail: christian.stanetty@durham.ac.uk Supporting information for this article is available on theWWW under http://dx.doi.org/10.1002/ejoc.201500024.",Non-OADS,/arxiv_data1/oa_pdf/d6/71/ejoc2015-2718.PMC4464551.pdf
"The reaction we chose to investigate was the generation of ketenes by thermal sigmatropic rearrangement of alk- [a] Chemistry, University of Southampton, Southampton, HANTS, SO17 1BJ, UKE-mail: rjw1@soton.ac.ukhttp://www.southampton.ac.uk/ [b] Bioengineering Group, Faculty of Engineering and the Environment, University of Southampton,Southampton, HANTS, SO17 1BJ, UK [c] GlaxoSmithKline R&D Ltd., Medicines Research Centre, Gunnels Wood Road, Stevenage, HERTS, SG1 2NY , UK Supporting information for this article is available on theWWW under http://dx.doi.org/10.1002/ejoc.201403603.",Non-OADS,/arxiv_data1/oa_pdf/bc/ce/ejoc2015-1491.PMC4464552.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/af/dd/ijhrba-04-02-23424.PMC4464573.pdf
Available from: http://seer.cancer.gov/statfacts/html/ colorect.html.,Non-OADS,/arxiv_data1/oa_pdf/af/dd/ijhrba-04-02-23424.PMC4464573.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Helicobacter pylori  (H. pylori ) is a Gram-negative bacil - lus responsible for one of the most commonly diag - nosed infections in humans worldwide.",Non-OADS,/arxiv_data1/oa_pdf/6c/26/ijhrba-04-02-26155.PMC4464574.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9a/6d/ijhrba-04-02-22381.PMC4464575.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fa/a7/ijhrba-04-02-23819.PMC4464576.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.Disease-Modifying Treatment of Disability Progression in MS 971",Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014.https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.accessdata.fda.gov/drugsatfda_ docs/label/2014/022527s009lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002202/WC500104528.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002514/WC500148682.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://products.sanoﬁ.us/aubagio/ aubagio.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002601/WC500162069.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/ 003718/WC500150521.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://products.sanoﬁ.us/lemtrada/lemtrada.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000603/WC500044686.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/ 019297s035lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.accessdata.fda.gov/drugsatfda_ docs/label/2009/020622s057lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. https://www.medicines.org.uk/emc/ medicine/17516 .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
1993. http://www.accessdata.fda.gov/drugsatfda_ docs/nda/pre96/103471s0000_APPROV.pdf .,OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2013. http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/medicines/000081/human_med_000673.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000102/WC500029425.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000136/WC500048681.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.pharma.us.novartis.com/product/pi/pdf/extavia.,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000933/WC500034701.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://labeling.bayerhealthcare.com/html/ products/pi/Betaseron_PI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000081/ WC500053225.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2014. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002827/ WC500170302.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
2007. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Scientiﬁc_Discussion/human/000603/ WC500044690.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/b7/40265_2015_Article_411.PMC4464731.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c1/d2/40265_2015_Article_410.PMC4464860.pdf
Available from: http://apps.who.int/iris/bitstream/ 10665/148114/1/9789241564854_eng.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/c1/d2/40265_2015_Article_410.PMC4464860.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c1/d2/40265_2015_Article_410.PMC4464860.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/c1/d2/40265_2015_Article_410.PMC4464860.pdf
Available from: https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/c1/d2/40265_2015_Article_410.PMC4464860.pdf
"Chromatin immunoprecipitation (ChIP) amplicon primersequences are provided in Table S2, Supplemental Digital Content,http://links.lww.com/MPA/A363.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S1A, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S1B, Supplemental Digital Content, http://links.lww.com/MP A/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S2, Supplemental Digital Content, http://links.lww.com/MP A/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S3, Supplemental Digital Content,http://links.lww.com/MPA/A363), revealing that temporary in-duction of E47 activity was sufficient to arrest cells for prolonged periods.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S4B, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"1D, E, S4C, Supplemental Digital Con- tent, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S5, Supplemental Digital Content, http://links.lww.com/MP A/A363), revealing uni-versally conserved effects of E47 in PDA cells.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S4B, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"2A, S6, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S7A, B, Supplemen- tal Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S4B, Supplemental Dig-ital Content, http://links.lww.com/MPA/A363) and confirmatoryqRT -PCR studies revealed that E47 activity also markedly induced expression of the stress response protein TP53INP1 (tumor protein p53 inducible nuclear protein 1) in all PDA lines tested (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S4, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S8A, Supplemental DigitalContent, http://links.lww.com/MPA/A363).31Strikingly, E47 induced 28% of the most highly specific acinar genes (genes enriched ≥50-fold in primary acinar tissue vs other primary tissues) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S8B, Supplemental Digital Con- tent, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S8C, Supplemental Digital Content, http://links.lww.com/MP A/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"4A, B, S6, Supple- mental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S9A, Supplemental Digital Content, http://links.lww.com/MPA/A363).6,7,14,23Consistent with this ob- servation, E47-induced PDA cells accumulated both Cx32 mRNA and gap junction complexes (Figs.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S9, Supplemental Digital Content, http://links.lww.com/MPA/A363) .",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S10, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S1B, Supplemental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S3, Supple-mental Digital Content, http://links.lww.com/MP A/A363), the in vivo findings are most consistent with a model in which a minor- ity of cells, which do not contain the E47 MERvector (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S1, Supplemental Digital Content, http://links.lww.com/MP A/A363) form small tumors.",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"S11, Supple-mental Digital Content, http://links.lww.com/MPA/A363).",Non-OADS,/arxiv_data1/oa_pdf/7c/90/mpa-44-718.PMC4464938.pdf
"Microarray data are reported in Dataset 1,and raw gene expression array data are stored at theGene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo,accession #GSE61143).",OADS,/arxiv_data1/oa_pdf/72/a3/MMI-96-1226.PMC4464956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC4465115.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.009 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC4465115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/13/main.PMC4465115.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/7f/main.PMC4465122.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.016 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/7f/main.PMC4465122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/7f/main.PMC4465122.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/54/main.PMC4465182.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.007 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/54/main.PMC4465182.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/54/main.PMC4465182.pdf
"Tuberculosis, a global infectious disease caused by the intracellular bacteriumMycobacterium tuberculosis remains a worldwide health problem(http://www.who.int ).",Non-OADS,/arxiv_data1/oa_pdf/83/54/main.PMC4465182.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/1/e1400121/DC1 Materials and Methods Table S1.,Non-OADS,/arxiv_data1/oa_pdf/46/95/1400121.PMC4465185.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ HHS Public Access Author manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/9d/57/nihms-690954.PMC4465270.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/40/main.PMC4465500.pdf
http://dx.doi.org/10.1016/j.abrep.2015.05.004 2352-8532/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/40/main.PMC4465500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/40/main.PMC4465500.pdf
"Developmental Cognitive  Neuroscience  13  (2015)  21–31 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Forgetting the best  when  predicting  the  worst:  Preliminary observations  on neural circuit  function  in  adolescent  social  anxiety Johanna M.  Jarchoa,∗,  Adrienne  L.  Romerb,  Tomer  Shechnerc,  Adriana  Galvand, Amanda E.  Guyere,  Ellen  Leibenluftf,  Daniel  S.  Pinea,  Eric  E.  Nelsona aSection  on  Development  and  Affective  Neuroscience,  National  Institute  of  Mental  Health,  United  States bDepartment of  Psychology  and  Neuroscience,  Duke  University,  United  States cDepartment  of  Psychology,  University  of  Haifa,  Israel dDepartment  of  Psychology,  University  of  Los  Angeles,  CA,  United  States eDepartment  of  Human  Ecology,  Center  for  Mind  and  Brain,  University  of  Davis,  CA,  United  States fSection  on  Bipolar  Spectrum  Disorders,  National  Institute  of  Mental  Health,  United  States a  r t i  c  l  e  i  n  f  o Article  history: Received  24  October  2014 Received  in  revised  form  19  February  2015 Accepted  16 March 2015 Available online  23  March  2015 Keywords:DevelopmentStriatumMedial prefrontal  cortex Prediction  error Peer  feedback Learninga b s  t  r  a  c  t Social  anxiety  disorder  typically  begins  in  adolescence,  a  sensitive  period  for  brain  development,  when increased complexity  and  salience  of  peer  relationships  requires  novel  forms  of  social  learning.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
A  Prediction  Error  (PE)  model  may  explain  how  brain http://dx.doi.org/10.1016/j.dcn.2015.03.002 1878-9293/Published by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online version,  at  http://dx.doi.org/10.1016/j.dcn.2015.03.002 References Blakemore, S.J.,  2008.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"9  (4), 267–277,  http://dx.doi.org/10.1038/nrn2353 Blakemore,  S.J.,  Burnett,  S.,  Dahl,  R.E.,  2010.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"31  (6),  926–933,  http://dx.doi.org/10.1002/ hbm.21052 Blakemore, S.J.,  Mills,  K.L.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"65,  187–207,  http://dx.doi.org/10.1146/ annurev-psych-010213-115202 Britton,  J.C.,  Grillon,  C.,  Lissek,  S.,  Norcross,  M.A.,  Szuhany,  K.L.,  Chen,  G.,  Pine,  D.S., 2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"J.  Psychiatry  170  (10),  1195–1204,  http://dx.doi.org/10.1176/appi.ajp.2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"13  (6),  669–671,  http://dx.doi.org/10.1038/nn.2558 Cohen,  M.S.,  1997.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"NeuroImage  6  (2),  93–103,  http://dx.doi.org/10.1006/Nimg.1997.0278 Cox,  R.W., 1996.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"29  (3),  162–173,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"13  (9),  636–650, http://dx.doi.org/10.1038/nrn3313 Dickstein,  D.P.,  Finger, E.C., Brotman,  M.A.,  Rich, B.A., Pine,  D.S.,  Blair,  J.R.,  Leiben- luft,  E.,  2010.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"40 (7), 1089–1100, http://dx.doi.org/10.1017/ S0033291709991462 Fitzgerald,  K.D.,  Welsh, R.C., Stern,  E.R.,  Angstadt, M., Hanna, G.L., Abelson,  J.L.,  Taylor, S.F.,  2011.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Psychiatry  50  (9), 938–948,  http://dx.doi.org/10.1016/J.Jaac.2011.06.011 Forbes,  E.E.,  Dahl,  R.E.,  2010.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Psychiatry  53  (1),  3–15, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"NeuroImage  6  (3), 218–229,  http://dx.doi.org/10.1006/Nimg.1997.0291 Gitelman, D.R.,  Penny,  W.D.,  Ashburner,  J.,  Friston,  K.J.,  2003.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"26  (1),  229–243,  http://dx.doi.org/10.1017/S0954579413000941 Guyer, A.E., Caouette, J.D.,  Lee,  C.C.,  Ruiz,  S.K.,  2014b.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"38  (2),  155–163, http://dx.doi.org/10.1177/0165025413515627 Guyer,  A.E.,  Choate,  V.R.,  Pine,  D.S.,  Nelson,  E.E.,  2012.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"7  (1), 81–92,  http://dx.doi.org/10.1093/scan/nsr043 Guyer, A.E.,  Lau,  J.Y.,  McClure-Tone,  E.B.,  Parrish,  J.,  Shiffrin,  N.D.,  Reynolds,  R.C., Nelson,  E.E.,  2008.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Gen.  Psychiatry  65 (11),  1303–1312,  http://dx.doi.org/10.1001/archpsyc.65.11.1303 Guyer,  A.E.,  McClure-Tone,  E.B.,  Shiffrin,  N.D.,  Pine,  D.S.,  Nelson,  E.E.,  2009.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"80  (4),  1000–1015,  http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"26 (32),  8368–8376,  http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"J.  Psychiatry  167  (7),  748–751,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Neuron  58  (2),  284–294,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"3 (1),  14,  http://dx.doi.org/10.1186/2045-5380-3-14 Jones,  R.M.,  Somerville,  L.H.,  Li,  J.,  Ruberry,  E.J.,  Powers,  A.,  Mehta,  N.,  Casey,  B.J., 2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"64  (2),  314–322, http://dx.doi.org/10.1016/j.yhbeh.2013.03.012 Lau, J.Y.,  Guyer,  A.E.,  Tone,  E.B.,  Jenness,  J.,  Parrish,  J.,  Pine,  D.S.,  Nelson,  E.E., 2011.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"2  (1),  7,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"8 (6),  720–722, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"23  (5), 1042–1051,  http://dx.doi.org/10.1162/jocn.2010.21520 McLaren,  D.G.,  Ries,  M.L.,  Xu,  G.,  Johnson,  S.C.,  2012.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"NeuroImage  61  (4),  1277–1286,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Psychiatry  66  (12),  1075–1082,  http://dx.doi.org/10.1016/ j.biopsych.2009.06.026 Milad,  M.R.,  Wright,  C.I.,  Orr,  S.P.,  Pitman,  R.K.,  Quirk,  G.J.,  Rauch,  S.L.,  2007.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Psychiatry  62  (5),  446–454,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"26  (5),  1075–1084, http://dx.doi.org/10.1162/jocn a  00535 Moutsiana,  C.,  Garrett,  N.,  Clarke,  R.C.,  Lotto,  R.B.,  Blakemore,  S.J.,  Sharot,  T.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"18  (2),  99–108,  http://dx.doi.org/ 10.1016/j.tics.2013.11.003 Nelson, E.E., Leibenluft, E.,  McClure,  E.B.,  Pine,  D.S.,  2005.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"14  (6), 769–776,  http://dx.doi.org/10.1016/J.Conb.2004.10.016 O’Reilly, J.X.,  Woolrich,  M.W.,  Behrens,  T.E.,  Smith,  S.M.,  Johansen-Berg,  H.,  2012.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"7  (5),  604–609,  http://dx.doi.org/10.1093/scan/ nss055 Ordaz,  S.J.,  Foran,  W.,  Velanova,  K.,  Luna,  B.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Nature  442  (7106),  1042–1045,  http://dx.doi.org/10.1038/nature05051 Pfeifer,  J.H.,  Kahn,  L.E.,  Merchant,  J.S.,  Peake,  S.J.,  Veroude,  K.,  Masten,  C.L., Dapretto,  M.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Psychiatry  52  (3),  290–299, http://dx.doi.org/10.1016/J.Jaac.2012.12.010 Rubia,  K.,  Smith,  A.B.,  Woolley,  J.,  Nosarti,  C.,  Heyman,  I.,  Taylor,  E.,  Brammer,  M., 2006.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"14  (6),  268–276,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"8,  86–95,  http://dx.doi.org/10.1016/j.dcn.2014.01.004 Stanley,  D.A.,  Sokol-Hessner,  P.,  Fareri,  D.S.,  Perino,  M.T.,  Delgado,  M.R.,  Banaji,  M.R., Phelps, E.A., 2012.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"367  (1589),  744–753,  http://dx.doi.org/10.1098/rstb.2011.0300 Steinberg,  L.,  Morris,  A.S.,  2001.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"52, 83–110, http://dx.doi.org/10.1146/annurev.psych.52.1.83 Telzer,  E.H.,  Flannery,  J.,  Shapiro,  M.,  Humphreys,  K.L.,  Goff,  B.,  Gabard-Durman,  L., Tottenham,  N.,  2013a.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"33  (33),  13484–13488,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"25  (2),  234–244,  http://dx.doi.org/10.1162/jocn  a  00311 van den Bos, W.,  Cohen,  M.X.,  Kahnt,  T.,  Crone,  E.A.,  2012.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Cortex  22  (6),  1247–1255,  http://dx.doi.org/10.1093/cercor/bhr198 Visser,  R.M.,  Scholte,  H.S.,  Beemsterboer,  T.,  Kindt,  M.,  2013.",OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"16  (4),  388–390,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"33  (4),  448,  http://dx.doi.org/10.1037/H0027806 Wheelock, M.D.,  Sreenivasan,  K.R.,  Wood,  K.H.,  Ver  Hoef,  L.W.,  Deshpande,  G., Knight,  D.C.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"12  (3),  333–341,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/main.PMC4466042.pdf
"Material and methods The Bio:Fiction international call for short films in 2010 (final deadline 1 December 2010, see Appendix A at http://pus.sagepub.com/) yielded 130 film entries from 25 countries, of which 52 films were selected for the two-day festival (see Appendix B at http://pus.sagepub.com/).",Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
A short description of each film is available at http://www.bio-fiction.com/pdf/biofiction_programm_web.pdf and the films can be watched at www.bio-fiction.com/videos.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
See Appendix B (available at http://pus.sagepub.com) for an overview of the films.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
"The oldest film was  from 2004, the same year that the first international synthetic biology conference Synthetic Biology 1.0  took place (http://syntheticbiology.org/Synthetic_Biology_1.0.html).",Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
See: http://www.robertmusil.net/musil/works/If%20there%20is%20a%20sense%20of%20reality.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
See: http://www.esquire.com/features/75-most-influential/drew-endy-1008 or http://longnow.org/sem- inars/02008/nov/17/synthetic-biology-debate/  4.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
See: http://www.spiegel.de/international/zeitgeist/george-church-explains-how-dna-will-be-construc- tion-material-of-the-future-a-877634.html or the Long Now Foundation’s Revive and Restore project to  bring back the woolly mammoth and the passenger pigeon: http://longnow.org/revive/  5.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
See: http://www.fastcompany.com/3000040/rise-and-fall-company-was-going-have-us-all-using-biofuels  6.,Non-OADS,/arxiv_data1/oa_pdf/38/9e/10.1177_0963662513503772.PMC4466099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/nihms-664403.PMC4466128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/e4/nihms667626.PMC4466143.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/8d/ehu504.PMC4466154.pdf
http://www.R-project.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/8d/ehu504.PMC4466154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/c2/nihms678807.PMC4466156.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/ j.expneurol.2015.03.010 .,OADS,/arxiv_data1/oa_pdf/56/c2/nihms678807.PMC4466156.pdf
The SNP annotations  and identification of the genes within 10 kb or the closest  gene to the detected SNP were confirmed by the SNP info  web server26 and the dbSNP ( http://www.ncbi.nlm.nih.gov/ snp).,OADS,/arxiv_data1/oa_pdf/fc/c9/sbu171.PMC4466179.pdf
A functional gene-network analysis was performed  using GeneMANIA software (Multiple Association  Network Integration Algorithm; http://www.genemania.,OADS,/arxiv_data1/oa_pdf/fc/c9/sbu171.PMC4466179.pdf
"This gene is a vital dual regulator of cellular senescence  and apoptosis.28 Because the SNP is located on the 5 ′ side  of the CDKN2AIP  gene, we searched for potential tran - scription factor binding sites in sequences that included  rs4315839 with the pattern search program (P-Match 1.0)  using TRANSFAC 6.0 public sites ( http://www.gene-reg- ulation.com/cgi-bin/pub/programs/pmatch/bin/p-match.",Non-OADS,/arxiv_data1/oa_pdf/fc/c9/sbu171.PMC4466179.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.243 ORIGINAL ARTICLE Efficacy of Slimming Cream Containing 3.5%  Water-Soluble Caffeine and Xanthenes for the Treatment of Cellulite: Clinical Study and Literature Review Sang-Young Byun1,*, Soon-Hyo Kwon1,*, Su-Hak Heo2,3, Jae-Seong Shim2, Mi-Hee Du1, Jung-Im Na1 1Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 2Skin & Tech  Incorporation, Seongnam, 3Soonchunhyang Medical Research Institute, Soonchunhyang University College of Medicine, Cheonan, Korea Background:  Cellulite is a ‘cottage cheese-like’ cutaneous  change caused by subcutaneous fat bulging into the dermis  that usually leads to cosmetic problems.",Non-OADS,/arxiv_data1/oa_pdf/5d/4f/ad-27-243.PMC4466275.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.250 ORIGINAL ARTICLE Tranexamic Acid Diminishes Laser-Induced  Melanogenesis Myoung Shin Kim, Seung Hyun Bang1, Jeong-Hwan Kim2, Hong-Ju Shin2, Jee-Ho Choi1,  Sung Eun Chang1 Department of Dermatology, Inje University, Sanggye Paik Hospital, 1Department of Dermatology, University of Ulsan College of Medicine,  Asan Medical Center, Seoul, 2Aesthetic Research Team, Amore Pacific Corporation Research and Development Center, Yongin, Korea Background:  The treatment of post-inflammatory hyper- pigmentation (PIH) remains challenging.",Non-OADS,/arxiv_data1/oa_pdf/a5/3a/ad-27-250.PMC4466276.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.257 ORIGINAL ARTICLE HR-1 Mice: A New Inflammatory Acne Mouse Model Yong Hyun Jang, Kyou Chae Lee, Seok-Jong Lee, Do Won Kim, Weon Ju Lee Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea Background:  There is no appropriate in vivo  animal model  that reflects the inflammatory response of human acne.",Non-OADS,/arxiv_data1/oa_pdf/68/d6/ad-27-257.PMC4466277.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.265 ORIGINAL ARTICLE Screening for Psoriatic Arthritis in Korean Psoriasis  Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire Hyang-Suk You1, Gun-Wook Kim2, Hyun-Ho Cho2, Won-Jeong Kim1, Je-Ho Mun2, Margaret Song1,  Hoon-Soo Kim1, Hyun-Chang Ko2, Moon-Bum Kim1,5, Seung-Geun Lee3, In-Sook Lee4, Byung-Soo Kim1,5 1Department of Dermatology, Pusan National University School of Medicine, Busan, 2Department of Dermatology, Pusan National  University Yangsan Hospital, Yangsan, Departments of  3Rheumatology and 4Diagnostic Radiology, Pusan National University,  5Biomedical Research Institute, Pusan Nati onal University Hospital, Busan, Korea Background:  Psoriatic arthritis (PsA) is chronic seronegative  inflammatory arthritis that causes irreversible joint damage.",Non-OADS,/arxiv_data1/oa_pdf/3e/ac/ad-27-265.PMC4466278.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.269 ORIGINAL ARTICLE Esterase Activity and Intracellular Localization in  Reconstructed Human Epidermal Cultured Skin Models Yoshihiro Tokudome, Mishina Katayanagi, Fumie Hashimoto Laboratory of Dermatological Physiology, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan Background:  Reconstructed human epidermal culture skin  models have been developed fo r cosmetic and pharmaceut- ical research.",OADS,/arxiv_data1/oa_pdf/b4/25/ad-27-269.PMC4466279.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.275 ORIGINAL ARTICLE Are Podoplanin Gene Polymorphisms Associated  with Atopic Dermatitis in Koreans?",Non-OADS,/arxiv_data1/oa_pdf/e1/7e/ad-27-275.PMC4466280.pdf
"Marker selection  The SNP information was retri eved from the dbSNP (build  141, http://www.ncbi.nlm.nih.gov/SNP; accessed 12 Sep  2014).",OADS,/arxiv_data1/oa_pdf/e1/7e/ad-27-275.PMC4466280.pdf
"On the basis  of these genotype results, we selected SNPs by using the  linkage disequilibrium bin appr oach in the Tagger pro- gram (http://www.broad.mit.edu /mpg/tagger).",OADS,/arxiv_data1/oa_pdf/e1/7e/ad-27-275.PMC4466280.pdf
"For the haplotype scan, the haplo.score func- tion in the R package (http://www.r-project.org) was used;  this function is a haplotype association test method that  enables the simultaneous mode ling of haplotype effects  including various cont rolling covariates, and statistical sig- nificance is determined according to score test statistics 16.",OADS,/arxiv_data1/oa_pdf/e1/7e/ad-27-275.PMC4466280.pdf
"9.1 (SAS Institute Inc., Cary, NC, USA) and the R statistical lan- guage (http://www.r-project.org; accessed 31 Mar 2009).",OADS,/arxiv_data1/oa_pdf/e1/7e/ad-27-275.PMC4466280.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.283 ORIGINAL ARTICLE Usefulness of Skin Explants for Histologic Analysis  after Fractional Photothermolysis Gyeong-Hun Park, Sung Eun Chang1, Seunghyun Bang2, Kwang Hee Won1, Chong Hyun Won1,  Mi Woo Lee1, Jee Ho Choi1, Kee Chan Moon1 Department of Dermatology, Dongtan Sacred Heart Hospit al, Hallym University Colle ge of Medicine, Hwaseong, 1Department of  Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 2Asan Institute for Life Sciences, Seoul, Korea Background:  Fractional laser resurfacing treatment has been  extensively investigated and is widely used.",Non-OADS,/arxiv_data1/oa_pdf/af/b6/ad-27-283.PMC4466281.pdf
Available at: http://www.sinclairbioresources.com/Downloads/ TechnicalBulletins/Porcine%20Integumentary%20System  %20Model-Part%201.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/ad-27-283.PMC4466281.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.291 ORIGINAL ARTICLE mRNA Expression Level of Interleukin Genes  in the Determining Phases of Behçet’s Disease Serpil Taheri, Murat Borlu1, Cem Evereklioglu2, Sevda Yesim Ozdemir3, Yusuf Ozkul3 Department of Medical Biology, Betul Ziya Eren Genome and Stem Cell Center, Departments of 1Dermatology, 2Ophthalmology, and  3Genetics, Erciyes University, Medical Faculty, Kayseri, Turkey Background:  Behçet’s disease (BD), first described in 1937 as  a triadic complex of symptoms (oral aphthae, genital ulcers,  and hypopyon uveitis), is a chronic, relapsing, multisystemic idiopathic inflammatory disease.",Non-OADS,/arxiv_data1/oa_pdf/d3/bf/ad-27-291.PMC4466282.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.298 ORIGINAL ARTICLE Economic Impact of Atopic Dermatitis in Korean  Patients Chulmin Kim, Kui Young Park1, Seohee Ahn, Dong Ha Kim1, Kapsok Li1, Do Won Kim2,  Moon-Beom Kim3, Sun-Jin Jo4, Hyeon Woo Yim4, Seong Jun Seo1 Department of Family Medicine, School of Medicine, The Catholic University of Korea, 1Department of Dermatology, Chung-Ang  University College of Medicine, Seoul, 2Department of Dermatology, Kyungpook National University School of Medicine, Daegu,  3Department of Dermatology, Pusan National University School of Medicine, Busan, 4Department of Preventive Medicine, School of  Medicine, The Catholic University of Korea, Seoul, Korea Background:  Atopic dermatitis is a global public health con- cern owing to its increasing prevalence and socioeconomic  burden.",Non-OADS,/arxiv_data1/oa_pdf/b0/d3/ad-27-298.PMC4466283.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.306 CASE REPORT Cowden Syndrome with a Novel Germline PTEN  Mutation and an Unusual Clinical Course Jung Eun Seol, In Ho Park, Wonkyung Lee, Hyojin Kim, Jong Keun Seo, Seung Hwan Oh1 Departments of Dermatology and 1Laboratory Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea Here, we report a case of Cowden syndrome with an unusual  clinical course of late-onset oral papillomatosis and a novel  germline PTEN mutation.",Non-OADS,/arxiv_data1/oa_pdf/df/88/ad-27-306.PMC4466284.pdf
Sequen ce variation was described  according to the recommendations of the Human Ge-nome Variation Society (http://www.hgvs.org/mutnomen/)  using a cDNA reference sequence (NM.000314.4).,OADS,/arxiv_data1/oa_pdf/df/88/ad-27-306.PMC4466284.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.310 CASE REPORT Cutaneous Metastatic Undifferentiated Pleomorphic  Sarcoma from a Mediastinal Sarcoma Do Seon Jeong, Dong Hwa Park, Chi Yeon Kim Department of Dermatology, Institute of Health Sciences, Gyeongsa ng National University Hospital, Gyeongsang National Universit y  School of Medicine, Jinju, Korea Undifferentiated pleomorphic sarcoma, known as malignant  fibrous histiocytoma, is a malignant neoplasm that arises in  both soft tissue and bones.",Non-OADS,/arxiv_data1/oa_pdf/56/b0/ad-27-310.PMC4466285.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.315 CASE REPORT Concurrent Drug-Induced Linear Immunoglobulin A  Dermatosis and Immunoglobulin A Nephropathy Ji Seok Kim, Misoo Choi, Chan Hee Nam, Jee Young Kim, Byung Cheol Park, Myung Hwa Kim,  Seung Phil Hong  Department of Dermatology, Dankook University Medical College, Cheonan, Korea Diseases associated with im munoglobulin A (IgA) antibody  include linear IgA dermatosis , IgA nephropathy, Celiac dis- ease, Henoch-Schönlein purpura, etc.",Non-OADS,/arxiv_data1/oa_pdf/9f/ca/ad-27-315.PMC4466286.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.319 CASE REPORT Infundibulocystic Squamous Cell Carcinoma So Min Kim, Hyeree Kim, Hei Sung Kim, Sang Hyun Cho, Jeong Deuk Lee Department of Dermatology, Incheon St. Mary’s Hospital, School of Medicine, The Catholic University of Korea, Incheon, Korea Infundibulocystic squamous cell carcinoma was first reported  in 2008 as a subset of squamous cell carcinoma arising from  the infundibulum of the hair follicle and exhibiting infundi-bular differentiation.",Non-OADS,/arxiv_data1/oa_pdf/79/28/ad-27-319.PMC4466287.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.322 CASE REPORT Polycyclic Annular Lesion Masquerading as Lupus  Erythematosus and Emerging as Tinea Faciei Incognito Heesang Kye, Dai Hyun Kim, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Jae Eun Choi Department of Dermatology, Korea University College of Medicine, Seoul, Korea Tinea incognito is a dermatophy tic infection induced by im- munosuppressive agents that lack s the classic features of a  typical fungal infection.",Non-OADS,/arxiv_data1/oa_pdf/79/cf/ad-27-322.PMC4466288.pdf
"3, 2015 http://dx.doi.org/10.5021/ad.2015.27.3.326 LETTER TO THE EDITOR Received January 28, 2014, Accepted for publication March 3, 2014 Corresponding author:  Byung Cheol Park, Department of Dermatology,  Dankook University Hospital, 201 Manghyang-ro, Dongnam-gu, Cheon- an 330-715, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a3/70/ad-27-326.PMC4466289.pdf
"http://dx.doi.org/10.5021/ad.2015.27.3.328 Variable Sized Cellular Remnants in the Nail Plate  of Longitudinal Melanonychia: Evidence of Subungual Melanoma Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Subungual melanoma (SUM) is a rare variant of melanoma  that occurs in the nail unit.",Non-OADS,/arxiv_data1/oa_pdf/a3/70/ad-27-326.PMC4466289.pdf
"http://dx.doi.org/10.5021/ad.2015.27.3.328 Variable Sized Cellular Remnants in the Nail Plate  of Longitudinal Melanonychia: Evidence of Subungual Melanoma Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Subungual melanoma (SUM) is a rare variant of melanoma  that occurs in the nail unit.",Non-OADS,/arxiv_data1/oa_pdf/00/37/ad-27-328.PMC4466290.pdf
"A relatively well-demarcated pale blue-grayish round  patch on the interscapular area.http://dx.doi.org/10.5021/ad.2015.27.3.330 Acquired Dermal Melanocytosis of the Dorsum  in a Middle-Aged Asian Woman Gyeong-Hun Park, Kwang Hee Won1, Myeong Shin Kim2, Young Hee Choi3, In Ho Kwon,  Young In Ha4, Mi Woo Lee1 Department of Dermatology, Dongtan Sacred Heart Hospit al, Hallym University Colle ge of Medicine, Hwaseong, 1Department of  Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2Department of Dermatology, Sanggye Paik Hospital,  Inje University College of Medicine, Seoul, 3Departments of Pathology, 4Plastic and Reconstructive Su rgery, Dongtan Sacred Heart  Hospital, Hallym University College of Medicine, Hwaseong, Korea Dear Editor: Here, we describe a case of acquired dermal melanocy-tosis involving the dorsum in an Asian woman.",Non-OADS,/arxiv_data1/oa_pdf/dd/6e/ad-27-330.PMC4466291.pdf
"Tel: 81-27-220-8284, Fax: 81-27-220-8284, E-mail: smotegi@gunma-u.ac.jp This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.332 Poorly Differentiated Squamous Cell Carcinoma  in an Atomic Bomb Survivor Akihiko Uchiyama, Sei-ichiro Motegi, Osamu Ishikawa Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan Dear Editor: Many epidemiological studies of atomic bomb survivors in Japan demonstrate that ex posure to radiation increases  the risk of cancers, especially leukemia, in most organs 1.",Non-OADS,/arxiv_data1/oa_pdf/0e/72/ad-27-332.PMC4466292.pdf
"Int J Dermatol 2013;52:605-607. http://dx.doi.org/10.5021/ad.2015.27.3.334 Bupropion-Induced Erythema Multiforme Alper Evrensel, Mehmet Emin Ceylan Department of Psychology, Uskudar University, İstanbul, Turkey Dear Editor: Drug reactions affecting the skin are more common than other parts of the body.",Non-OADS,/arxiv_data1/oa_pdf/0e/72/ad-27-332.PMC4466292.pdf
"Int J Dermatol 2013;52:605-607. http://dx.doi.org/10.5021/ad.2015.27.3.334 Bupropion-Induced Erythema Multiforme Alper Evrensel, Mehmet Emin Ceylan Department of Psychology, Uskudar University, İstanbul, Turkey Dear Editor: Drug reactions affecting the skin are more common than other parts of the body.",Non-OADS,/arxiv_data1/oa_pdf/b2/de/ad-27-334.PMC4466293.pdf
"(A) Several brownish-viola- ceous angiomatous nodules and slightly raised plaques on both the  labia majora and minora, (B)  magnified image of the lesions on the right labia majora.http://dx.doi.org/10.5021/ad.2015.27.3.336 Primary Classic Kaposi’s Sarcoma Confined to the Vulva  in an HIV-Negative Patient Enzo Errichetti, Giuseppe Stinco, Enrico Pegolo1, Pasquale Patrone Department of Experimental and Clinical Medicine, Institute of Dermatology, University of Udine, 1Department of Medical and Biological  Sciences, Institution of Anatomic Pathology, Azienda Ospedali ero-Univeristaria Santa Maria della Misericordia, Udine, Italy Dear Editor: Kaposi’s sarcoma (KS) is a vascular neoplasm associated with human herpesvirus-8 (HHV-8 ) infection that is primar- ily categorized into 4 different types: endemic (African), ia- trogenic (associated with immunosuppressive therapy), AIDS-associated (rapidly progressive form in HIV-infected  patients), and classic.",Non-OADS,/arxiv_data1/oa_pdf/9b/1c/ad-27-336.PMC4466294.pdf
"com This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.338 A Pediatric Case of Spitzoid Melanoma with Subsequent  Large Lymph Node Metastasis Kenji Hayashida, Hiroto Saijo, Shin Morooka, Masaki Fujioka Department of Plastic and Reconstructive Surgery, National Hospital Organization , Nagasaki Medical Center, Ohmura, Japan Dear Editor: The lack of reliable pathological criteria for distinguishing between benign and malignant melanocytic lesions makes  it very difficult for clinicians and pathologists to diagnosis  melanoma.",Non-OADS,/arxiv_data1/oa_pdf/42/0c/ad-27-338.PMC4466295.pdf
"Tel: 82-31-219-5190, Fax: 82-31-219-5189,E-mail: hykang@ajou.ac.kr This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.340 Changes in Melanin and Melanocytes in Mottled  Hypopigmentation after Low-Fluence 1,064-nm Q-Switched Nd:YAG Laser Treatment for Melasma  Yong Hyun Jang, Ji-Youn Park1, Young Joon Park1, Hee Young Kang1 Department of Dermatology, Kyungpook National University School of Medicine, Daegu, 1Department of Dermatology, Ajou University  School of Medicine, Suwon, Korea Dear Editor: Melasma is a common acquired hyperpigmentary disorder of the face, but its treatment remains challenging.",Non-OADS,/arxiv_data1/oa_pdf/c9/9b/ad-27-340.PMC4466296.pdf
"*Significantly higher intensity vs. corresponding ICG applicati on without fractional RF and  sonophoresis pre-treatment ( p<0.0001).http://dx.doi.org/10.5021/ad.2015.27.3.343 Ablative Fractional Radiofrequency Combined  with Sonophoresis Increases Skin Penetration of Indocyanine Green Hee-Kyeong Lim, Ki-Heon Jeong, Min Kyung Shin Department of Dermatology, Kyung Hee University College of Medicine, Seoul, Korea Dear Editor: Indocyanine green (ICG) is a water-soluble tricarbocya-nine dye with peak spectral absorption at 780 nm.",Non-OADS,/arxiv_data1/oa_pdf/85/f0/ad-27-343.PMC4466297.pdf
"Int  J Dermatol 2013;52:367-370. http://dx.doi.org/10.5021/ad.2015.27.3.345 A Case of Kaposi 's Varicelliform Eruption in a Patient  with Psoriasis Receiving Cyclosporine Therapy Seray Külcü Çakmak, Nuran Alli, Emrah Yilmaz, Ferda Artüz Dermatology Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey Dear Editor: Kaposi’s varicelliform eruption (KVE) is a disseminated cu- taneous infection caused by several viruses such as herpes simplex virus (HSV) type 1 a nd 2, and coxsackievirus A16  in patients with an underlying dermatosis.",Non-OADS,/arxiv_data1/oa_pdf/85/f0/ad-27-343.PMC4466297.pdf
"Int  J Dermatol 2013;52:367-370. http://dx.doi.org/10.5021/ad.2015.27.3.345 A Case of Kaposi 's Varicelliform Eruption in a Patient  with Psoriasis Receiving Cyclosporine Therapy Seray Külcü Çakmak, Nuran Alli, Emrah Yilmaz, Ferda Artüz Dermatology Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey Dear Editor: Kaposi’s varicelliform eruption (KVE) is a disseminated cu- taneous infection caused by several viruses such as herpes simplex virus (HSV) type 1 a nd 2, and coxsackievirus A16  in patients with an underlying dermatosis.",Non-OADS,/arxiv_data1/oa_pdf/02/cc/ad-27-345.PMC4466298.pdf
"Tel: 82-2-870-2385, Fax: 82-2-870-3866, E-mail: sycho@snu.ac.kr This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.347 A Case of Psoriasis Accompanied by Systemic Lupus  Erythematosus Eun Jee Kim, Hyun Sun Park, Hyun-Sun Yoon, Soyun Cho Department of Dermatology, Seoul National University Boramae Hospital, Seoul, Korea Dear Editor: The pathologic mechanisms of systemic lupus eryth-ematosus (SLE) and psoriasis are different: psoriasis is  caused by systemic inflammatory reaction from mainly  Th1 cell activation, whereas SLE is caused by Th2 cell-re-lated abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/cf/17/ad-27-347.PMC4466299.pdf
"Tel: 82-2-829-5221, Fax: 82-2-832-3237, E-mail: dermap@hanmail.net This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.349 Infantile Scabies Masquerading as Langerhans Cell  Histiocytosis Yoon Seok Yang, Yun Sun Byun, Jin Hye Kim, Hye One Kim, Chun Wook Park Department of Dermatology, Hallym University College of Medicine, Seoul, Korea Dear Editor: Scabies is a contagious skin infestation caused by Sarcoptes  scabiei  burrowing into the epidermis.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/ad-27-349.PMC4466300.pdf
"http://dx.doi.org/10.5021/ad.2015.27.3.351 Novel Treatment Using Intradermal Radiofrequency and  Hyaluronic Acid Filler to Correct Marionette Lines Eun Jung Ko, Han Gyu Choi, Hyuk Kim1, Won-Seok Park1, Beom Joon Kim, Myeung Nam Kim Department of Dermatology, Chung-Ang University College of Medicine, Seoul, 1Aesthetic Research Team, AmorePacific Corporation  Research and Development Center, Yongin, Korea Dear Editor: Aging results in anatomical changes to the face.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/ad-27-349.PMC4466300.pdf
"http://dx.doi.org/10.5021/ad.2015.27.3.351 Novel Treatment Using Intradermal Radiofrequency and  Hyaluronic Acid Filler to Correct Marionette Lines Eun Jung Ko, Han Gyu Choi, Hyuk Kim1, Won-Seok Park1, Beom Joon Kim, Myeung Nam Kim Department of Dermatology, Chung-Ang University College of Medicine, Seoul, 1Aesthetic Research Team, AmorePacific Corporation  Research and Development Center, Yongin, Korea Dear Editor: Aging results in anatomical changes to the face.",Non-OADS,/arxiv_data1/oa_pdf/5d/f1/ad-27-351.PMC4466301.pdf
"Tel: 82-32-280- 5102, Fax: 82-32-506-9514, E-mail: hazelkimhoho@gmail.com This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:/ /  creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.http://dx.doi.org/10.5021/ad.2015.27.3.353 Phacomatosis Pigmentovascularis Type Vb  in a Three-Year Old Boy Hee Jin Jun, So Min Kim, Sang Hyun Cho, Jeong Deuk Lee, Hei Sung Kim Department of Dermatology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: We report the case of a 3-year-old boy from Russia who presented to our department with reticulated eryth- ematous brown patches involving the face and extre- mities.",Non-OADS,/arxiv_data1/oa_pdf/fa/88/ad-27-353.PMC4466302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/24/evu265.PMC4466343.pdf
"Mitochondrial Genome Sequencing The total DNAs, at a concentration of at least 100 ng/ ml, were sent to the UCDAVIS Genome Center ( http://dnatech.genoIs It an Ant or a Butterﬂy?",Non-OADS,/arxiv_data1/oa_pdf/8f/24/evu265.PMC4466343.pdf
"scabrinodis was accomplished with the CLC-BIO program: CLC Genomics Workbench v7.0.4 ( http://www.clcbio.com ,l a s t accessed December 10, 2014).",OADS,/arxiv_data1/oa_pdf/8f/24/evu265.PMC4466343.pdf
"Data Set Construction All partial or complete mtDNAs published or publically avail- able, used in this article, were downloaded from GenBank or MetAmiga ( http://amiga.cbmeg.unicamp.br/ , last accessed December 10, 2014; Feijao et al.",OADS,/arxiv_data1/oa_pdf/8f/24/evu265.PMC4466343.pdf
"( http://pacosy.informatik.uni-leip- zig.de/185-0-TreeREx.html , last accessed December 10, 2014; Bernt et al.",OADS,/arxiv_data1/oa_pdf/8f/24/evu265.PMC4466343.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/59/rjv068.PMC4466419.pdf
"http://e-jbm.org/   45Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:45-49 http://dx.doi.org/10.11005/jbm.2015.22.2.45 pISSN 2287-6375    eISSN 2287-7029 Result of Proficiency Test and Comparison of  Accuracy Using a European Spine Phantom among  the Three Bone Densitometries Ae Ja Park1, Jee-Hye Choi1, Hyun Kang2, Ki Jeong Park3, Ha Young Kim4, Seo Hwa Kim4, Deog-Yoon Kim5,   Seung-Hwan Park6, Yong-Chan Ha6 1Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul;   2Department of Anesthesiology, Chung-Ang University College of Medicine, Seoul;   3Departments of Radiology, Chung-Ang University College of Medicine, Seoul;   4Division of Endocrinology and Metabolism, Sanbon Medical Center, University of Wonkwang College of Medicine, Iksan;   5Department of Nuclear Medicine, College of Medicine, Kyung Hee University, Seoul;   6Department of Orthopedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea Background:  Although dual energy X-ray absorptiometry (DXA) is known to standard  equipment for bone mineral density (BMD) measurements.",Non-OADS,/arxiv_data1/oa_pdf/c0/34/jbm-22-45.PMC4466444.pdf
46  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.45absorptiometry (DXA).,Non-OADS,/arxiv_data1/oa_pdf/c0/34/jbm-22-45.PMC4466444.pdf
"Accuracy of Bone Densitometers http://dx.doi.org/10.11005/jbm.2015.22.2.45  http://e-jbm.org/   47and BMC of L1, L2, L3, and L1-L3 for three devices was de - scribed in Table 1.",OADS,/arxiv_data1/oa_pdf/c0/34/jbm-22-45.PMC4466444.pdf
48  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.456.2% (0.093 g/cm2) underestimation for medium (L2) and  high (L3) BMD values.,OADS,/arxiv_data1/oa_pdf/c0/34/jbm-22-45.PMC4466444.pdf
"Accuracy of Bone Densitometers http://dx.doi.org/10.11005/jbm.2015.22.2.45  http://e-jbm.org/   49ACKNOWLEDGMENT This research was supported by Ministry of Trade, Indus - try and Energy through Standard Reference Data Program.",OADS,/arxiv_data1/oa_pdf/c0/34/jbm-22-45.PMC4466444.pdf
"http://e-jbm.org/   51Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:51-56 http://dx.doi.org/10.11005/jbm.2015.22.2.51 pISSN 2287-6375 eISSN 2287-7029 A Novel Osteogenic Activity of Suberoylanilide  Hydroxamic Acid is Synergized by BMP-2 Zang Hee Lee1, Hyun-Jung Kim2, Hyun Mo Ryoo3 1Department of Cell and Developmental Biology, School of Dentistry, Seoul National University, Seoul;   2Bone Research Institute, BioRunx Co. Ltd., Seoul;   3Department of Molecular Genetics, School of Dentistry, Seoul National University, Seoul, Korea  Background:  Many histone deacetylase (HDAC) inhibitors are well recognized as poten - tial anti-cancer drugs.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
"52  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.51tion of gene expression by removing acetyl groups from ly - sine residues on histone core proteins, leading to chroma - tin condensation and transcriptio nal repression.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
"A Novel Osteogenic Activity of Suberoylanilidehydroxamic Acid http://dx.doi.org/10.11005/jbm.2015.22.2.51  http://e-jbm.org/   53kyo, Japan) according to standard formulas and nomencla - tures.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
54  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.51Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
A Novel Osteogenic Activity of Suberoylanilidehydroxamic Acid http://dx.doi.org/10.11005/jbm.2015.22.2.51  http://e-jbm.org/   55led to a significant degree of acetylation of Runx2.,Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
"56  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.51centration of SAHA in vivo  was 1 mg/kg, this may be a safe  concentration to use in future preclinical studies.",Non-OADS,/arxiv_data1/oa_pdf/ee/17/jbm-22-51.PMC4466445.pdf
"http://e-jbm.org/   57Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:57-69 http://dx.doi.org/10.11005/jbm.2015.22.2.57 pISSN 2287-6375    eISSN 2287-7029 The Effect of Eqoul, a Metabolite of Isoflavone, on  Endothelial Cell-independent Vasodilatation of  Human Uterine Artery In Vitro Jeong Yuen Kim1, Moo Yeol Lee2, Hyoung Moo Park1 1Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul;   2Department of Physiology, Chung-Ang University College of Medicine, Seoul, Korea Background:  The purpose of this study is to investigate 1) whether equol has the direct  modulation on vascular tone of endothelium-denuded human uterine artery, and 2) if  present, whether this equol-induced modulation of vascular tone is mediated by intra - cellular calcium modulation through Ca2+ & K+ channels on vascular smooth muscle cell  membrane.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
58  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57poprotein.,OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
"The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   59of cervical dysplasia, 1 case of uterine prolapse, and 1 case  of functional metrorrhagia.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
60  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57ammonium (TEA) and aminopyridine were used in study - ing the effects of equol on vasospastic response to the in - tervention of potassium channel of uterine arterial smooth  muscle.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   61Table 1.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
62  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57well as western countries.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
"The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   63equol was not a phenomenon, which was induced by the  mediation of the voltage-dependent calcium channels.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
"64  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57presented that total cholesterol, low-density lipoproteins  (LDL)-cholesterol, LDL:high-density lipoproteins (HDL)- cholesterol, non-triglyceride Lp (a) were significantly de - creased only in equol producer, thus the improvement of  blood lipids were presented as confined to equol producer.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   65cord venous endothelial cells.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
66  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57smooth muscle contraction.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   67ment factor of the cardiovascular system.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
68  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.57pendent relaxation of rabbit coronary artery by 17 beta- oestradiol in vitro.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
The Effect of Equol on Vascular Change http://dx.doi.org/10.11005/jbm.2015.22.2.57  http://e-jbm.org/   6940.,Non-OADS,/arxiv_data1/oa_pdf/82/a2/jbm-22-57.PMC4466446.pdf
"http://e-jbm.org/   71Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:71-75 http://dx.doi.org/10.11005/jbm.2015.22.2.71 pISSN 2287-6375 eISSN 2287-7029 The Reference Value of Skeletal Muscle Mass Index  for Defining the Sarcopenia of Women in Korea Hyoung-Joon Kwon1, Yong-Chan Ha2, Hyoung-Moo Park1 1Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul;   2Department of Orthopedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea Background:  Sarcopenia is considering important disease entity in elderly.",Non-OADS,/arxiv_data1/oa_pdf/7b/3d/jbm-22-71.PMC4466447.pdf
72  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.71impact on muscle strength or physical performance.,Non-OADS,/arxiv_data1/oa_pdf/7b/3d/jbm-22-71.PMC4466447.pdf
"SMI for Sarcopenia of Korean Women http://dx.doi.org/10.11005/jbm.2015.22.2.71  http://e-jbm.org/   73RESUL TS KNHANES that was performed from 2008 to 2011 involves  11,633 women aged 10 to 97 years.",Non-OADS,/arxiv_data1/oa_pdf/7b/3d/jbm-22-71.PMC4466447.pdf
74  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.71ed with SMI of 30’s and 40’s that have peak ASM.,OADS,/arxiv_data1/oa_pdf/7b/3d/jbm-22-71.PMC4466447.pdf
SMI for Sarcopenia of Korean Women http://dx.doi.org/10.11005/jbm.2015.22.2.71  http://e-jbm.org/   75Biol Sci Med Sci 2006;61:1059-64.,Non-OADS,/arxiv_data1/oa_pdf/7b/3d/jbm-22-71.PMC4466447.pdf
"http://e-jbm.org/   77Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:77-81 http://dx.doi.org/10.11005/jbm.2015.22.2.77 pISSN 2287-6375 eISSN 2287-7029 Oral Bisphosphonate and Risk of Esophageal  Cancer: A Nationwide Claim Study Gi Hyeon Seo1, Hyung Jin Choi2 1Health Insurance Review and Assessment Service, Seoul;   2Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea Background:  Epidemiology studies suggest that oral bisphosphonate may increase the  risk of esophageal cancer.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/jbm-22-77.PMC4466448.pdf
78  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.77comitant drug.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/jbm-22-77.PMC4466448.pdf
Oral Bisphosphonate and Risk of Esophageal Cancer http://dx.doi.org/10.11005/jbm.2015.22.2.77  http://e-jbm.org/   79Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/jbm-22-77.PMC4466448.pdf
"80  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.771.76, P=0.013) for comparator group 2. aHR for esophageal cancer incidence was not statistically  different between oral bisphosphonate group and com - parators (0.87; 95% CI 0.39-1.98; P=0.743 for comparator  group 1 and aHR 0.94; 95% CI 0.68-1.30; P=0.717 for com - parator group 2) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/jbm-22-77.PMC4466448.pdf
Oral Bisphosphonate and Risk of Esophageal Cancer http://dx.doi.org/10.11005/jbm.2015.22.2.77  http://e-jbm.org/   81the outcome data was based on insurance claim database  and this limitation may under- or over-estimate the esopha - geal cancer incidence.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/jbm-22-77.PMC4466448.pdf
"http://e-jbm.org/   83Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:83-86 http://dx.doi.org/10.11005/jbm.2015.22.2.83 pISSN 2287-6375 eISSN 2287-7029 A First Case of Osteomesopyknosis in Korea Bi-Na Jeoung, Jong-Min Kim, Gyoun-Eun Kang, Jang-Hwan Lim, Eui-Hyun Kim, Hyun-Ae Seo Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea Osteomesopyknosis is a rare sclerosing bone disorder of autosomal dominant inheritance.",Non-OADS,/arxiv_data1/oa_pdf/45/9d/jbm-22-83.PMC4466449.pdf
84  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.83gy and Metabolism at Daegu Fatima Hospital for evalua - tion of osteosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/45/9d/jbm-22-83.PMC4466449.pdf
A First Case of Osteomesopyknosis in Korea http://dx.doi.org/10.11005/jbm.2015.22.2.83  http://e-jbm.org/   85there was suspiciously increased uptake in vertebra.,Non-OADS,/arxiv_data1/oa_pdf/45/9d/jbm-22-83.PMC4466449.pdf
86  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.2.83combined abnormality and etc.,Non-OADS,/arxiv_data1/oa_pdf/45/9d/jbm-22-83.PMC4466449.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007043).,Non-OADS,/arxiv_data1/oa_pdf/a0/57/bmjopen-2014-007043.PMC4466600.pdf
Data analyses were performed using the R Project for Statistical Computing (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/a0/57/bmjopen-2014-007043.PMC4466600.pdf
"Three narratives wereassigned more than one secondary mechanism for assault.†Total frequency of mechanism will be greater than n=185 because some narratives were coded with more than one mechanism of near-miss or injury.EMS, Emergency Medical Services; EMT, emergency medicaltechnicians; MV, motor vehicle; NFFNMRS, National Fire Fighter Near-Miss Reporting System iThe reader is directed to the National Fire Fighter Near-Miss Reporting System (http://www.nationalnearmiss.org/) to access the full reports using the Report Numbers referenced in this study.Readers can enter the Report Number into the Google search boxﬁeld to access the applicable narrative.",OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
18The EMS community has also developed an industry-speci ﬁc training that emphasises de-escalation over self-defense or weapons (http://www.dt4ems.org).19 Struck-by Motor Vehicle and Motor Vehicle Collision were the second and third most frequently identi ﬁed mechanisms of near-miss or injury during medical calls.,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
"Emergency Medical Services Workers: Injury and Illness Data, 2012. http://www.cdc.gov/niosh/topics/ems/data2012.html 6.",OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
http://www.firefighternearmiss.com 11.,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
http://flsi13.everyonegoeshome.com/ curbside-manner.html 18.,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
http://www.dt4ems.org 20. International Association of Fire Fighters (IAFF).,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
http://www.iaff.org/hs/evsp/home.html 21.,Non-OADS,/arxiv_data1/oa_pdf/6e/eb/bmjopen-2014-007562.PMC4466601.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007866).,Non-OADS,/arxiv_data1/oa_pdf/51/18/bmjopen-2015-007866.PMC4466602.pdf
"World Health Organization (WHO) and the WHO MONICA Project investigators, 2000. http://www.ktl.fi/publications/monica/carpfish/appenda/evidence.htm 14.",Non-OADS,/arxiv_data1/oa_pdf/51/18/bmjopen-2015-007866.PMC4466602.pdf
The code lists used for this study are available from (http://www.keele.ac.uk/mrr).,Non-OADS,/arxiv_data1/oa_pdf/fa/d0/bmjopen-2014-007355.PMC4466603.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007321).,Non-OADS,/arxiv_data1/oa_pdf/0d/46/bmjopen-2014-007321.PMC4466605.pdf
"The edu-cation sessions covered the topics of Eat Well, Drink Well, Clean Well and Stay Well adapted from the Dental Health Services Victoria (DHSV) Smiles 4 Miles pro-gramme (http://www.dhsv.org.au/smiles4miles/) The sessions also included opportunities to discuss partici- pants ’own oral health beliefs, practices and strategies for managing change.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/bmjopen-2014-007321.PMC4466605.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007703).,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://esa.un.org/unpd/ wpp/unpp/panel_indicators.htm (accessed 17 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://www.unhcr.org/ pages/49e486566.html (accessed 12 Sep 2014) 14.,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://www.unhcr.org/pages/49e486566.html (accessed 18 Sep 2014) 15.,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://www.mol.gov.jo/Portals/0/qiz/qiz5 – 2011.pdf (accessed 18 Sep 2013).,OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://jordinvest.com.jo/uploads/ documents/jtel.pdf (accessed 16 Nov 2014) 19.,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://pdf.usaid.gov/pdf_docs/Pnadm793.pdf (accessed 26 Oct 2014).,OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
http://www.ilo.org/dyn/natlex/docs/ELECTRONIC/90853/105007/F-1293453209/5134-2.pdf (PDF in Arabic) (accessed 15 Apr 2015) 26.,Non-OADS,/arxiv_data1/oa_pdf/c6/09/bmjopen-2015-007703.PMC4466606.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007528).,Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
"(http://www.physiotherapy.ca/getmedia/e3f53048-d8e0-416b-9c9d-38277c0e6643/DoPEN( ﬁnal).pdf.aspx) 5 PR can therefore be active by involving physical exer- tion by the resident (eg, participating in exercise) or passive via external stimulation (eg, therapeutic modal-ities such as ultrasound or whole body vibration).",Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
(http://www.physiotherapy.ca/getmedia/e3f53048- d8e0-416b-9c9d-38277c0e6643/DoPEN( ﬁnal).pdf.aspx) 5The population of interest includes adults aged 65 years or older residing in a LTC facility.,Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
http://www.hqontario.ca/public-reporting/ long-term-care/information-about-quality-indicators/ltc-technical-report-table (accessed 20 Oct 2014).,OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
2013. http://www.health.gov.on.ca/en/pro/programs/physio/faq.aspx (accessed 19 Jun 2014).19.,Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
http://www.hc-sc.gc.ca/ hcs-sss/home-domicile/longdur/index-eng.php (accessed 8 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/35/bmjopen-2014-007528.PMC4466608.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008090).,Non-OADS,/arxiv_data1/oa_pdf/78/60/bmjopen-2015-008090.PMC4466609.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/c4/bmjopen-2014-007184.PMC4466611.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
"Malvern, PA: Centocor, 2011. http://www.remicade.com/remicade/assets/HCP_PPI.pdf (Accessed 26 Apr 2012).",OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
"Horsham, PA: Janssen Biotech, Inc., 2011. http://www.simponi.com/sites/default/files/pdf/prescribing-information.pdf (accessed 26 Apr 2012).",Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.bnf.org (accessed 14 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.pssru.ac.uk/uc/uc2010contents.htm(accessed 26 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.pssru.ac.uk/project-pages/unit-costs/2012/ (accessed 14 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.ons.gov.uk/ons/rel/lms/labour-market-statistics/december-2013/tableearn01.xls(accessed 14 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf(accessed 14 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://guidance.nice.org.uk/CG79/NICEGuidance/pdf/English (accessed 19 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
http://www.das-score.nl/das28/en/difference-between-the-das-and-das28/das-28-indepth.,Non-OADS,/arxiv_data1/oa_pdf/91/37/bmjopen-2014-006560.PMC4466612.pdf
2011 – 2015. http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2011/20110609_jc2137_global-pla 2.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.unicef.org/aids/files/ IndiaFactsheet_PMTCTFactsheet_2010.pdf (accessed 5 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.emtct-iatt.org/countries/india/ 6.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
"NACO, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India.http://aidsdatahub.org/dmdocuments/NACO_Annual_CMIS_BULLETIN_2008-09.pdf (accessed 5 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
May 2007. http://www.naco.gov.in/NACO/About_NACO/Policy__Guidelines/Policies__Guidelines1/ (accessed 5 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.who.int/gho/countries/ind/en/ 18. WHO.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.who.int/hiv/pub/mtct/programmatic_update2012/en/ 19.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.naco.gov.in/NACO/Quick_Links/Publication/Annual_ Report/NACO_Annual_Report/Annual_Report_2012-13/ 22. WHO | Map gallery.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.who.int/gho/map_gallery/en/ 23.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
http://www.hst.org.za/ publications/pmtct-guidelines-2013 27.,Non-OADS,/arxiv_data1/oa_pdf/12/2a/bmjopen-2014-006718.PMC4466614.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-007931).,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/bmjopen-2015-007931.PMC4466616.pdf
"20–23To select the most representative SNPs by capturing the majority of genetic variations, SNP genotype informationwas downloaded from the HapMap database (http:// www.hapmap.ncbi.nlm.nih.gov/) and the National Center for Biotechnology Information dbSNP database(http://www.ncbi.nlm.nih.gov/snp).",Non-OADS,/arxiv_data1/oa_pdf/d0/c8/bmjopen-2015-007931.PMC4466616.pdf
The primer design was based on published sequences 24or designed using the Primer Z software (http://genepipe.ngc.sinica.edu.tw/primerz/beginDesign.do).,OADS,/arxiv_data1/oa_pdf/d0/c8/bmjopen-2015-007931.PMC4466616.pdf
"METHODS Data sources about screening usePrevalence data about breast cancer screening (mam- mography and breast self-examination), cervical cancer screening (Pap smear), colorectal cancer screening(faecal occult blood test (FOBT), colonoscopy), and prostate cancer screening using prostate screening antigen (PSA) test were all obtained from the 2012BRFSS database http://apps.nccd.cdc.gov/brfss/.",OADS,/arxiv_data1/oa_pdf/59/d2/bmjopen-2014-006678.PMC4466617.pdf
"Google Trends (http://www.google.com/trends/explore# cmpt=q), based on Google Search, the most widely used internet search engine, offers search volume data for search terms over time since 2004 and across differentgeographical locations.",OADS,/arxiv_data1/oa_pdf/59/d2/bmjopen-2014-006678.PMC4466617.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007711).,Non-OADS,/arxiv_data1/oa_pdf/c3/5f/bmjopen-2015-007711.PMC4466618.pdf
Study was conducted in compliance with the PRISMA guidelines and registered on PROSPERO (Number: CRD42013006910 available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?,Non-OADS,/arxiv_data1/oa_pdf/c3/5f/bmjopen-2015-007711.PMC4466618.pdf
2004. http://www.joannabriggs.org/assets/docs/sumari/SUMARI-V5-User-guide.pdf (accessed 8 Oct 2014).,OADS,/arxiv_data1/oa_pdf/c3/5f/bmjopen-2015-007711.PMC4466618.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM235547.pdf (accessed 13 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/5f/bmjopen-2015-007711.PMC4466618.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007785).,Non-OADS,/arxiv_data1/oa_pdf/fa/f5/bmjopen-2015-007785.PMC4466619.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007795).,Non-OADS,/arxiv_data1/oa_pdf/c0/c3/bmjopen-2015-007795.PMC4466620.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007430).,Non-OADS,/arxiv_data1/oa_pdf/06/35/bmjopen-2014-007430.PMC4466621.pdf
doi:10.1136/bmjopen-2014- 006835 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006835).,Non-OADS,/arxiv_data1/oa_pdf/cc/e9/bmjopen-2014-006835.PMC4466623.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007070).,Non-OADS,/arxiv_data1/oa_pdf/7a/b8/bmjopen-2014-007070.PMC4466624.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007346).,Non-OADS,/arxiv_data1/oa_pdf/aa/bd/bmjopen-2014-007346.PMC4466625.pdf
KLoSA maintains a national public database(http://www.kli.re.kr/klosa/en/about/introduce.jsp).,Non-OADS,/arxiv_data1/oa_pdf/aa/bd/bmjopen-2014-007346.PMC4466625.pdf
http://survey.keis.or.kr/16.,Non-OADS,/arxiv_data1/oa_pdf/aa/bd/bmjopen-2014-007346.PMC4466625.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008446).,Non-OADS,/arxiv_data1/oa_pdf/71/37/bmjopen-2015-008446.PMC4466692.pdf
http://www.who.int/respiratory/asthma/en/ (accessed 6 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/37/bmjopen-2015-008446.PMC4466692.pdf
http://www.aberdeencity.gov.uk/nmsruntime/ saveasdialog.asp?lID=49086&sID=332 (accessed 6 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/37/bmjopen-2015-008446.PMC4466692.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008381).,Non-OADS,/arxiv_data1/oa_pdf/9c/08/bmjopen-2015-008381.PMC4466757.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/0f/bmjopen-2015-007626.PMC4466758.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007167).,Non-OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
2012. http://www.fin.gov.on.ca/en/reformcommission/chapters/report.pdf (accessed 21 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
"Organization for Economic Cooperation and Development, 2010. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=delsa/hea/wd/hwp(2010)5&doclanguage=en (accessed Oct 2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
Health Aff 2012. http://www.healthaffairs.org/healthpolicybriefs 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
http://handbook.cochrane.org/ (accessed Oct 2014).,OADS,/arxiv_data1/oa_pdf/5e/b7/bmjopen-2014-007167.PMC4466759.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ 6 El Bcheraoui C, et al.BMJ Open 2015; 5:e007801.",Non-OADS,/arxiv_data1/oa_pdf/cf/ff/bmjopen-2015-007801.PMC4466760.pdf
http://www.sama.gov.sa/sites/samaen/ ReportsStatistics/ReportsStatisticsLib/5600_R_Annual_En_49_Apx.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/ff/bmjopen-2015-007801.PMC4466760.pdf
2009. http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/BP.pdf (accessed 11 Dec 2014).12.,OADS,/arxiv_data1/oa_pdf/cf/ff/bmjopen-2015-007801.PMC4466760.pdf
2013. http://www.us-sabc.org/custom/news/details.cfm?id=1541#.VLROoivF98M 13.,Non-OADS,/arxiv_data1/oa_pdf/cf/ff/bmjopen-2015-007801.PMC4466760.pdf
http://www.moh.gov.sa/en/ HealthAwareness/Campaigns/Pages/default.aspx (accessed12 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/cf/ff/bmjopen-2015-007801.PMC4466760.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006898).,Non-OADS,/arxiv_data1/oa_pdf/50/af/bmjopen-2014-006898.PMC4466761.pdf
Available from: http://www.cisak.perpika.,Non-OADS,/arxiv_data1/oa_pdf/22/ea/PR-7-20.PMC4466764.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/19/157781 INTRODUCTION Fine‑needle aspiration (FNA) cytology has emerged as a procedure of choice for all head and neck lesions.,Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19of head and neck aspiration under ultrasound‑guidance  coupled with rapid on‑site evaluation (ROSE) assessment  by cytopathologist, in relation to the clinical context  thereby deciding on adequacy and need for additional  biopsies, further improves the diagnostic accuracy and  cost effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19was 1600 × 1200 pixels, with the NetCam‑transmitted  image having a resolution of 1600 × 1200 pixels.",Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19lymphadenitis, benign salivary gland neoplasms,  branchial cleft cysts and inflammatory processes •	 Suspicious	 or	atypical:	 Cases	with	cytologic	 features	 suspicious for malignancy or cases with atypical  cytologic features where malignant neoplasm could  not be excluded •	 Malignant:	 Cases	with	obvious	 cytologic	 features	 of malignancy.",Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19The accuracy rate of preliminary telecytopathology  and conventional on‑site microscopy diagnosis was  94.8% (54/58) and 98.3.6% (57/58), respectively [Table 4].",Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19Discrepancies between on‑site preliminary diagnosis  and final diagnosis were identified using both  telecytopathology and conventional microscopy  assessment methods and were not statistically significant.",OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
"J Pathol Inform 2015, 1:19  http://www.jpathinformatics.org/content/6/1/19aspiration of pancreatic masses.",Non-OADS,/arxiv_data1/oa_pdf/32/d7/JPI-6-19.PMC4466783.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/20/157782 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.157782 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20INTRODUCTION All chronic liver diseases are characterized by  the development of liver fibrosis, which includes  the growth of fibrous tissue around hepatocytes  (perisinusoidal fibrosis), the enlargement of  portal tracts and the development of abnormal  connections between portal or venular structures,  named bridging or septal fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20Objectives and Definitions The observed fibrosis stage by pathologist is called F  hereafter.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20of three channels red, green and blue, was decomposed  to work on the green channel only as it offers the  best contrast to visualize fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20Porto‑septal regions We measured the number of porto‑septal regions;  the mean area of porto‑septal regions (mean area of  porto‑septal fibrosis) and the average distance between  the portal tracts (mean portal distance).",OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20literature reference to distinguish F2 from F3 stages with  strict quantitative criteria; pathologists subjectively choose between a few septa (F2) and numerous septa (F3).",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20definition.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20stages were determined by a linear discriminant analysis,  providing a probability score from 0 to 1 for each F stage.",OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20stage diagnosis was, overall: 68.5% (64.0–72.3); and  per METAVIR stage: F0: 40.0%, F1: 74.7%, F2: 61.7%,  F3: 55.9%, F4: 82.0%.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20Progression The plots of morphometric significant fibrosis and  cirrhosis scores versus reference F stages showed a marked  progression thus an excellent F stage discrimination by  morphometric scores [Figure 6].",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20and cirrhosis diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20viral hepatitis C based on a histopathological  classification frequently used by pathologists.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20medicine like hepatology,[31] especially in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
"J Pathol Inform 2015, 1:20  http://www.jpathinformatics.org/content/6/1/20methodology for improving accuracy of fibrosis markers.",Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
http://rsbweb.nih.gov/ij/.,Non-OADS,/arxiv_data1/oa_pdf/77/05/JPI-6-20.PMC4466784.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/23/157789 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.157789 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23systems have functionality that can present to the  technologist images of the cultures plates not only from  a single culture but other cultures where there is perhaps  growth from other sources.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
[4] The BIOMIC V3 is also capable  of counting colonies (http://youtu.be/CT‑0rzgyk_w) and  analyzing certain ancillary tests such as Etest assays (http:// youtu.be/b2fXjs37VZI).,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23currently designed for use with mycobacteria or fungi.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23for increased time spent actually analyzing cultures, and  these changes enable technologists to be more efficient.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
Full resolution images are available  at http://goo.gl/kbbeuw or by using this QR code  Figure 3: Three captured images and one composite image  of Eikenella corrodens  are shown.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
Full resolution images are available at http://goo.gl/kbbeuw  or by using this QR code  d cb a,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23integrative analysis of microbiology testing.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
Full resolution images are  available at http://goo.gl/kbbeuw or by using this QR code,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23among the laboratory staff.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23appeared to be isolated may have time to collide with others  on the agar plate.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"J Pathol Inform 2015, 1:23  http://www.jpathinformatics.org/content/6/1/23CONCLUSION Digital plate reading is a novel tool that should be added  to the growing applications made possible by introducing  digital imaging technology into the pathology laboratory.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
Available from:  http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=  408699andlpcd=JQP .,OADS,/arxiv_data1/oa_pdf/8c/f6/JPI-6-23.PMC4466785.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comBook Review A journey through time to ancient Greek medicine with medical  historian and classical scholar Plinio Prioreschi, MD, PhD Miguel A. Faria Clinical Professor of Neurosurgery (ret.)",Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/100/158459 Copyright: © 2015 Faria MA.,Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
"Surgical Neurology International 2015, 6:100  http://www.surgicalneurologyint.com/content/6/1/100of the perceived ubiquitousness of homosexuality in the  Greek and Hellenistic world.",Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
"Surgical Neurology International 2015, 6:100  http://www.surgicalneurologyint.com/content/6/1/100school apparently based its teachings of the etiology  of diseases on the theory of perittoma  (or perissoma ), a  concept eerily similar to the Egyptian formula for the  pathophysiological basis of disease as previously discussed  in our review of Prioreschi’s A History of Medicine, Vol.",Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
"Surgical Neurology International 2015, 6:100  http://www.surgicalneurologyint.com/content/6/1/100practices; that its Pythagorean traits are coincidental; and  that the numerous [purported] violations of it by ancient  physicians were not related to its alleged Pythagorean  origin.”[9] In other words, we have no evidence to doubt  that most ancient Greek physicians followed the teaching  of the Corpus Hippocraticum.",Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
"Surgical Neurology International 2015, 6:100  http://www.surgicalneurologyint.com/content/6/1/100social standing, and notes inscriptions dedicated to them,  etc.",Non-OADS,/arxiv_data1/oa_pdf/12/50/SNI-6-100.PMC4466786.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Open surgical ligation is an effective treatment of spinal dural  arteriovenous fistula (SDAVF).",Non-OADS,/arxiv_data1/oa_pdf/6d/fb/SNI-6-99.PMC4466787.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/99/158458 Copyright: © 2015 On Tsang AC.,Non-OADS,/arxiv_data1/oa_pdf/6d/fb/SNI-6-99.PMC4466787.pdf
"Surgical Neurology International 2015, 6:99  http://www.surgicalneurologyint.com/content/6/1/99loss to all modalities between L2 and S1 dermatomes  bilaterally.",Non-OADS,/arxiv_data1/oa_pdf/6d/fb/SNI-6-99.PMC4466787.pdf
"Surgical Neurology International 2015, 6:99  http://www.surgicalneurologyint.com/content/6/1/99Microsurgical ligation, on the other hand, allows direct  visualization and ligation of the fistula without reliance  on the morphology of access vessels.",Non-OADS,/arxiv_data1/oa_pdf/6d/fb/SNI-6-99.PMC4466787.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comNeurosurgery Concepts Neurosurgery Concepts: Key perspectives on Traumatic Brain  Injury, New Treatments for Glioblastoma, Hemicraniectomy for Extensive Middle-Cerebral-Artery Stroke, Minimally Invasive Spine Surgery and Lumbar Epidural Injections for Radiculopathy Jin Mo Cho, Chaim B. Colen1, Gordon Li2, Vincent Yat Wang3, Nader Dahdaleh4, Winward Choy4,  Isaac Yang5, Zachary A. Smith4 Departments of Neurological Surgery, Ajou University School of Medicine, Suwon, South Korea, 1Beaumont Hospital, Grosse Pointe, MI, 2Stanford School of Medicine,  3University of California, San Francisco, CA, 4Feinberg School of Medicine at Northwestern University, Chicago, IL, 5David Geffen School of Medicine at University of  California Los Angeles, CA, USA  E‑mail:  Jin Mo Cho  ‑ c hojinmo@gmail.com; Chaim B. Colen  ‑ c haim.colen@gmail.com; Gordon Li  ‑gordonli@stanford.edu;    Vincent Yat Wang  ‑ wangv@neurosurg.ucsf.edu; Nader Dahdaleh  ‑ nsdahdaleh@gmail.com; Winward Choy  ‑ winward.choy@northwestern.edu;   Isaac Yang  ‑ iyang@mednet.ucla.edu; *Zachary A. Smith  ‑ zsmith@nmff.org   *Corresponding author Received: 15  December 14   Accepted: 18 December 14   Published: 08 J une 15 NEUROCOGNITION IN THE EMERGENCY  DEPARTMENT AFTER A MILD TRAUMATIC BRAIN INJURY IN YOUTH [1] Study Question: Does mild traumatic brain injury affect  neurocognitive function in youths?",Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/98/158374 Copyright: © 2015 Cho JM.,Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
"Surgical Neurology International 2015, 6:98  http://www.surgicalneurologyint.com/content/6/1/98with mTBI were suffering measurable neurocognitive  dysfunction, especially in their psychomotor speed and  reaction time, through a computerized screening battery.",Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
"Surgical Neurology International 2015, 6:98  http://www.surgicalneurologyint.com/content/6/1/98The second study NCT0088471 was also a randomized,  double‑blind, placebo‑controlled trial of adult GBM  patients treated with standard radiotherapy  (60  Gy) and  daily temozolomide.",Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
"Surgical Neurology International 2015, 6:98  http://www.surgicalneurologyint.com/content/6/1/98invasive decompression for lumbar stenosis comparable  to open decompression?",Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
"Surgical Neurology International 2015, 6:98  http://www.surgicalneurologyint.com/content/6/1/98Perspective: Lumbar epidural steroids are commonly  offered as a first‑line nonsurgical treatment for  lumbar spinal stenosis and/or radiculopathy.",Non-OADS,/arxiv_data1/oa_pdf/81/44/SNI-6-98.PMC4466788.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/22/157788 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.157788 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22INTRODUCTION The use of digital imaging technology has been increasing  in a wide variety of applications in recent years.",Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22sets presented and discussed at a multi‑head microscope  and via the digital viewing platform.",Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22and digital slides randomized from the sets above, with  the addition of run‑specific immunohistochemical  control slides.",Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22the PPA being 94.9%, and the NPA being 81.3% [Table  1].",OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22slides read by the routine glass slides and by digital whole  slide imaging (WSI) with the Philips system.",OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22These results and accompanying observations may also  argue for WSI evaluation of HER2 slides for institutions  performing their IHC in‑house.",Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
"J Pathol Inform 2015, 1:22  http://www.jpathinformatics.org/content/6/1/22consistent with the results of similar studies done in  support of FDA clearance and as research protocols.",Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf7/K071671.,Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf13/K130021.,Non-OADS,/arxiv_data1/oa_pdf/c1/be/JPI-6-22.PMC4466789.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/21/157785,Non-OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"J Pathol Inform 2015, 1:21  http://www.jpathinformatics.org/content/6/1/21Obtaining reliable ground truth data for experiments  is difficult.",Non-OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"J Pathol Inform 2015, 1:21  http://www.jpathinformatics.org/content/6/1/21settings, screen size, brightness, and contrast (using a  calibration scale).",OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"J Pathol Inform 2015, 1:21  http://www.jpathinformatics.org/content/6/1/21pathologist-scored point locations.",Non-OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"J Pathol Inform 2015, 1:21  http://www.jpathinformatics.org/content/6/1/21images.",Non-OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"J Pathol Inform 2015, 1:21  http://www.jpathinformatics.org/content/6/1/21REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/01/e7/JPI-6-21.PMC4466790.pdf
"The forum addresses an issue of increasing  importance in China and other rapidly aging middle-income countries: the diagnosis of Alzheimer’s disease •In this issue (April 2015) • A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215047  on June 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 68-69. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215047] References 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27( 2): 82-86. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 87-89. doi:  http://dx.doi.org/10.11919/j.issn.1002-0829.215043 4. van Os J.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
Am J Psychiatry   2013; 170: 695-698. doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 90-102. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215006 7.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2007; 334: 464. doi: http://dx.doi.org/10.1136/ bmj.39079.618287.0B 8.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 103-110. doi:  http://dx.doi.org/10.11919/j.issn.1002-0829.214151 10.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
doi: http://dx.doi.org/10.3969/j.issn.1006-2084.2013.17.043 12.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 111-118. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27 (2): 119-123.  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215001 14.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 124-125. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215046 15.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 126-129. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215011 16.,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
2015; 27(2): 130-135. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215044,Non-OADS,/arxiv_data1/oa_pdf/ec/ec/sap-27-02-068.PMC4466845.pdf
"•Special article • Unravelling psychosis: psychosocial epidemiology,  mechanism, and meaning Paul BEBBINGTON Division of Psychiatry, Faculty of Brain Sciences, University College London, United Kingdom correspondence: p.bebbington@ucl.ac.uk A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215027  on June 6, 2015.Summary: This paper reviews a revolution in our understanding of psychosis over the last 20 years.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"Epub 2015 Apr 2. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215027]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2 • 76 • 概述：本文回顾了过去 20年我们对精神病认识的革 命性变化。很大程度上说，这一变化主要得益于社会 心理流行病学与针对精神病的认知行为治疗（ cognitive  behavior therapy for psychosis ，CBT-p）的发展和交互促 进。而后者也促进了数据的采集和分析方法的补充策略。 这些方法包括利用与精神病相关的一系列因变量，如何分析横断面和纵向流行病学调查、 虚拟现实研究、经验抽样方法研究及治疗学临床试验中采集到的数据。研究的关键是探索各个社会心理因素的相互关系和作用。这些研究证明了外部社会在精神病性障碍的发生和发展中的作用。此外，一些产生精神病性体验的心理驱动因素也被发现。现已有可靠证据表明，社会因素明显受到非精神病性症状的影响，尤其情绪症状及其他对情感有影响的症状，如失眠。精神病性症状也可以受到归因偏移的影响，如武断下结论、顽固的信念等，但是社会因素对此如何起作用仍所知甚少。现在可以明确的是精神病的成因各异，表现形式多样。对各种类型的治疗都应考虑以下这点：应根据心理过程和社会因素影响在原始的 CBT-p方案上进行相应的 调整。目前某些特定形式的 CBT-p将个体调节因素作 为治疗目标并取得良好的效果。这反过来证实了非精神病性症状的调节作用，并证明了所描述方法的有效 性。 关键词： 流行病学；社会因素；精神病；认知行为 治疗 本文全文中文版从 2015年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215027 可供免费阅览下载解密精神病：社会心理流行病学、发病机制和疾病意义 Bebbington P References 1.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014;  171(5): 523-538.  doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 36(1): 94-103.  doi: http://dx.doi.org/10.1093/schbul/ sbp130,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 13(3): 260-261. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2003;  27(1): 95-106. doi: http://dx.doi.org/10.1023/ A:1023636021995 7.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2004;  113(4): 592-602. doi: http://dx.doi.org/10.1037/0021-843X.113.4.592 8.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2005;  12(4): 431-438. doi: http://dx.doi.org/10.1111/j.1365- 2850.2005.00858.x 9.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 46(4): 364-371. doi: http://dx.doi.org/10.1007/ s10597-010-9305-5 11.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.org/10.1155/2014/905950 12.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2015; 50 : 339-350 doi: http://dx.doi.org/10.1007/ s00127-014-z.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2007; 42(10): 771-779. doi:  http://dx.doi.org/10.1007/s00127-007-0244-6 18.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2007; 89: 101-109.  doi: http://dx.doi.org/10.1016/j.schres.2006.09.014 19.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2009; 39 (2): 179-195. doi: http://dx.doi.org/10.1017/ S0033291708003814 21.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 38: 475-485. doi: http://dx.doi.org/10.1093/schbul/ sbq09 22.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 139:  176-182. doi: http://dx.doi.org/10.1016/j.schres.2012.04.0  23.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013; 202(6): 419-427.  doi:  http://dx.doi.org/10.1192/bjp.bp.112.119032   24.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 42(6): 718-730. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 130(4): 311-317. doi:  http://dx.doi.org/10.1111/acps.12307 26. van Os J.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 71: 985-986. doi: http://dx.doi.org/10.1001/ jamapsychiatry.2014.1068 27.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 205 (3): 221-229. doi:  http://dx.doi.org/10.1192/bjp.bp.113.135467   29.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2012; 42(11): 2239-2253.  doi: http://dx.doi.org/10.1017/ S0033291711002911Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013;  46(4): 249-265. doi: http://dx.doi.org/10.1159/000342536   32.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 49: 1541-1544. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 49: 1011-1022. doi:  http://dx.doi.org/10.1007/s00127-014-0914-0 34.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2005; 193 : 501-507. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2007;  116(4): 280-289. doi: http://dx.doi.org/10.1111/j.1600-0447.2007.01011.x 39.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 12: 229. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012;  138(1): 28-76. doi: http://dx.doi.org/10.1037/a0025995   41.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2009; 8 : 221-228. doi: http://dx.doi.org/10.1017/ S1121189X00000506 44.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2006; 36: 749-759. doi: http://dx.doi.org/10.1017/ S0033291706007355 46.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 38(5): 1063-1073. doi:  http://dx.doi.org/10.1093/schbul/sbr019   47.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2005; 114: 373- 384. doi: http://dx.doi.org/10.1037/0021-843X.114.3.373 50.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 121(1): 129-139.  doi: http://dx.doi.org/10.1037/a0025297 51.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2008; 34(1): 193-199. doi:  http://dx.doi.org/10.1093/schbul/sbm069 53.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2011; 199(1): 29-37.  doi:  http://dx.doi.org/10.1192/bjp.bp.110.083642   55. van Dam DS,  van der Ven E,  Velthorst E,  Selten JP ,  Morgan  C, de Haan L. childhood  bullying  and the association  with  psychosis  in non-clinical and clinical samples:  a review  and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 42: 2463- 2474. doi: http://dx.doi.org/10.1017/S0033291712000360 56.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 12C:  17-22. doi:  http://dx.doi.org/10.1016/j.ajp.2014.09.006 58.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2001; 29(3): 257-276.  doi: http://dx.doi.org/10.1017/S1352465801003010Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2002; 41: 331-347. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.org/10.1093/schbul/sbl014 62.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2001; 58(12): 1137-1144. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2007; 27: 409-424. doi: http://dx.doi.org/10.1016/ j.cpr.2006.09.005 65.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2011; 39(1): 21- 34. doi: http://dx.doi.org/10.1017/S1352465810000457    66.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2003; 191 : 509-514.  doi: http://dx.doi.org/10.1097/01.nmd.0000082212.83842.fe 67.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.org/10.1371/ journal.pone.0062688 68.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 34: 482- 495. doi: http://dx.doi.org/10.1016/j.cpr.2014.07.002 69.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 24(1): 60-82. doi: http://dx.doi.org/10.1521/ pedi.2010.24.1.60 70.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2006; 36: 1551-1562. doi: http://dx.doi.org/10.1017/ S0033291706008579 72.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013; 39:  872-883. doi: http://dx.doi.org/10.1093/schbul/sbs186   73.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 40(2):  269-277. doi:  http://dx.doi.org/10.1093/schbul/sbt14974.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.org/10.1093/schbul/sbu103 76.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
1994; 24 (3): 707-718. doi: http://dx.doi.org/10.1017/ S0033291700027860 79.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 196 (4): 259- 265.  doi: http://dx.doi.org/10.1192/bjp.bp.109.070466 80.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2004;  109(1): 38-45. doi: http://dx.doi.org/10.1046/j.0001-690X.2003.00217.x 84.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2011;  46(12): 1203-1210. doi: http://dx.doi.org/10.1007/s00127- 010-0296-x 86.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013; 48(1): 15-24. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2012; 38(4): 661-671. doi: http://dx.doi.org/10.1093/ schbul/sbs050   88. van Winkel R,  van Nierop M,  Myin-Germeys I,  van Os J.  Childhood  trauma as a cause of  psychosis: linking genes,  psychology, and biology.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 49(7):  1011-1022. doi: http://dx.doi.org/10.1007/s00127-014- 0914-0   90.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 2: 1-17. doi: http://dx.doi.org/10.1017/ S0033291714002086 91.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 67(11): 1114-1119. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013; 39(5): 1045-1055. doi:   http://dx.doi.org/10.1093/schbul/sbs088 93.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2009; 18: 299-310. doi: http://dx.doi.org/10.1017/ S1121189X00000257 96.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2012; 47(8):  1195-1203.  doi: http://dx.doi.org/10.1007/s00127-011- 0433-1   99.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2005; 44 (Pt 2):  181-191. doi: http://dx.doi.org/10.1348/014466505X29611102.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2007; 37: 513-527. doi: http://dx.doi.org/10.1017/ S0033291706009731 103. van Nierop M, van Os J, Gunther N, van Zelst C, de Graaf R, ten Have M, et al.",OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 129(6):  467-476.  doi: http://dx.doi.org/10.1111/acps.12212   104.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014;  37(4): 475-482. doi: http://dx.doi.org/10.5665/sleep.3478 105.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2008;  34(3): 580-585. doi: http://dx.doi.org/10.1093/schbul/ sbm127 107.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 217: 202-209. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2002; 37(3): 97-104. doi:   http://dx.doi.org/10.1007/s001270200000 109.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2009; 21(4): 498-505. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2011; 50(2): 178-195. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 44: 1605-1614.  doi: http://dx.doi.org/10.1017/S0033291713002080   113.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 215: 568- 573. doi: http://dx.doi.org/10.1016/j.psychres.2013.12.033   114.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2014; 53(4):  422-432. doi: http://dx.doi.org/10.1111/bjc.12054Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2008; 192 (4): 258-263.  doi: http://dx.doi.org/10.1192/bjp.bp.107.044677 116.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2010; 119(1): 83-92.  doi: http://dx.doi.org/10.1037/a0017514 117.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 218 : 348-352. doi: http://dx.doi.org/10.1016/ j.psychres.2013.12.014 118.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014;  26(3): 841-847. doi: http://dx.doi.org/10.1037/a0036240 119.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014; 11: 1-9. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi:  http://dx.doi.org/10.1016/S2215- 0366(15)00039-5 121.,OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2002; 159(1): 5-11. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2009; 301(19): 2005-2015. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2011; 42: 330-336. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2013; 14: 214.  doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
doi: http://dx.doi.org/10.1093/schbul/sbu142 128.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
2014;  24: 930-938. doi: http://dx.doi.org/10.1016/ j.euroneuro.2014.02.005   129.,Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"2013;  123(11): 4557-4563.  doi: http://dx.doi.org/10.1172/ JCI66031   (received, 2015-02-01; accepted, 2015-02-23) Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/97/6f/sap-27-02-070.PMC4466846.pdf
"•Commentary• The transdiagnostic dimension of psychosis: implications for  psychiatric nosology and research Jim VAN OS Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht, The Netherlands King’s College London, King’s Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, United Kingdomcorrespondence: vanosj@gmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215041 on June 6, 2015.Summary: If psychosis is a transdiagnostic dimension, the expression of which is governed by a dynamic  set of contextual and emotional factors that are amenable to treatment, current approaches in psychiatric  nosology and therapeutic research may need to be revised.",Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
"2015; 27(2): 82-86. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215041]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
概述： 如果精神病是一种跨诊断的维度，精神病性症 状的出现受动态变化的情境和情感因素左右，而后者 又是可治疗的，那么目前精神科疾病的分类学和治疗研究的方法可能需要修改。迄今为止，无论在临床工作上还是在疾病概念上，占主导地位的方法是将精神病性症状置于精神分裂症的框架中。然而，终生患病率为 1%的精神分裂症只代表了部分预后不佳的精神 病谱系障碍，而后者发生更多，终生患病率为 3.5% 。 因此，精神分裂症的研究结果可能反映了预后相关的机制，而非精神病和其他症状维度之间本质上的相关性。同样，常见的非精神病性精神障碍中高达 30% 的 个体有阈下精神病性症状，他们会被归于精神病的跨诊断维度之下，这些精神症状还会影响临床严重程度和治疗有效性 。上述发现也同样提示武断区分“精神病性” 与 “非精神病性” 的做法妨碍了临床实践和研究。精神病学诊断手册可以借鉴跨诊断维度（包括精神病的跨诊断维度）的体系。引入跨诊断维度，则既能根据原则进行分类诊断（即疾病分组的特异性），又可结合个体特有的多维度综合评分（即个体特异性）。这样的益处在于促使人们思考在精神病理学中症状之间是如何动态地交互作用的，并思考社会环境是如何影响精神病理症状的。 关键词： 精神病；诊断；疾病分类学；流行病学调查； 精神分裂症；跨诊断的 本文全文中文版从 2015 年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215041 可供免费阅览下载精神病的跨诊断维度：对精神疾病的分类学与研究的意义 van Os J  References 1.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2013; 170: 695-698. doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
"doi: http://dx.doi.org/10.1371/ journal.pone.0086652 5. van Os J, Kapur S. Schizophrenia.",OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2009; 374 : 635- 645. doi: http://dx.doi.org/10.1016/S0140-6736(09)60995-8 6.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2012; 67: 130-159. doi: http://dx.doi.org/10.1037/ a0026699 8.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2015; 56(5): 558- 565. doi: http://dx.doi.org/10.1111/jcpp.12319 12.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2010; 41(6):  1-8. doi: http://dx.doi.org/10.1017/S0033291710001844 16.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2015; 42 (11): 1-13.  http://dx.doi.org/10.1017/S0033291715000380 17.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
"2012; 42: 2239-2253. doi:  http://dx.doi.org/10.1017/ S0033291711002911Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2010;  167: 1075-1082. doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2012; 47: 1195- 1203. doi: http://dx.doi.org/10.1007/s00127-011-0433-1 21.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2012; 38:  531-542. doi: http://dx.doi.org/10.1093/schbul/sbq11722.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2011; 37: 561-571. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
"doi: http://dx.doi.org/10.1371/journal.pone.0054653 25. van Os J, Delespaul P , Wigman J, Myin-Germeys I, Wichers M. Beyond DSM and ICD: introducing ""precision diagnosis"" for psychiatry using momentary assessment technology.",Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
2013; 12 :113-117. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/80/sap-27-02-082.PMC4466847.pdf
"• 87 • Institute of Mental Health, Peking University, Beijing, China correspondence: yuxin@bjmu.edu.cn A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215043  on June 6, 2015.Xin YUFinding a solution to psychosis: the emergence of a new path •Commentary• Summary : The transition from a dichotomous diagnostic classification system to the more holistic  approach to understanding mental disorders engendered by the so-called biopsychosocial model has  definite advantages, but it runs the risk of sacrificing methodological rigor to achieve all-inclusiveness.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
"2015; 27(2): 87-89. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215043]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
概述： 受所谓的生物心理社会模式的推动，对精神障 碍的认识从二分法诊断分类转向更为全面综合的方法。 虽然这种认识转变有一定的好处，但是为了顾及生物心理社会各个方面的因素，势必要冒着牺牲严谨方法的风险。本期对精神病认识的特别报道中， Bebbington 试图表明关于精神病发生的高质量心理社会流行病学研究至少可以部分克服上述认识转变的局限性。 Bebbington 强调睡眠、情绪等非精神病性症状在精神 病发生中的重要性，这为精神病的概念提供了一个新的视角。然而，上述非精神病性症状对于有效鉴别精 神分裂症或其他精神病性障碍亚类的有用性，我是心存疑虑的 。 关键词： 二分法分类；生物心理社会模式；精神病性 障碍；精神病；精神病流行病学 本文全文中文版从 2015年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215043 可供免费阅览下载寻找解答精神病的方法：一个新的答案的出现 于欣 References 1.,Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
2014; 16(11): 1-6. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
Epub 15 Nov 2014. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
"1996; 22(2): 283-303. doi:  http://dx.doi.org/10.1093/schbul/22.2.283 (received, 2015-04-07; accepted, 2015-04-13) Dr. Xin Yu is Professor of Clinical Psychiatry at the Peking University Institute of Mental Health.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/sap-27-02-087.PMC4466848.pdf
"2015; 27(1): 62-67. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215010 In the 2nd paragraph of section 2 of the paper, the parenthetical remark “(in this example, 35.5% [(19+50)/200])”  should read “(in this example, 65.5% [(66+65)/200])”.",Non-OADS,/arxiv_data1/oa_pdf/a2/e2/sap-27-02-089.PMC4466849.pdf
"2015;  27(1): 4-17. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215014 In the Forrest plot shown in Figure 2 in the printed issue the reference numbers for three of the studies listed in the figure were incorrect: 'Wang 2009[46]' should be 'Wang 2009[41]', 'Zhou 2012[50]' should be ‘Zhou 2012[47]', and 'Zhu 2012[52]' should be 'Zhu 2012[48]'.",Non-OADS,/arxiv_data1/oa_pdf/a2/e2/sap-27-02-089.PMC4466849.pdf
"• 90 • Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, United States *correspondence: Robert.Freedman46@gmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215006  on June 6, 2015.Robert FREEDMAN*, Randal G. ROSSPrenatal choline and the development of schizophrenia•Review • Background: The primary prevention of illness at the population level, the ultimate aim of medicine, seems  out of reach for schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
"2015; 27(2): 90-102. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215006]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
A parallel  search of two major Chinese-language databases (CNKI and WanFang Data) identified no phosphatidyl-choline trials and the Chinese clinical test registration center (http://www.chictr.org/cn/) had no relevant trials.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
"背景： 医学的最终目的是在人群中对疾病进行一级预 防，这对精神分裂症而言似乎是难以实现的。精神分 裂症的病因早在胎儿大脑发育时期就开始出现，远远早于病症的出现。基因因素是精神分裂症的主要病因之一，作用于烟碱型胆碱能受体上的胆碱能神经递质的传递是与此遗传风险相关的病理生理机制之一。在胎儿大脑发育过程中， 胆碱可以激活上述烟碱型受体。因而通过孕期膳食补充胆碱可能是在更早期预防精神分裂症发生发展的一种干预手段。 目的： 对有关孕期和胎儿大脑发育过程中补充胆碱或 胆碱水平与疾病关系的文献进行综述。 方法： 在Medline 上检索评估胆碱对人类胎儿发育影 响的研究，还检索了有关精神分裂症的其他产前危险因素的研究以及胆碱能神经传递对精神分裂症病理生理作用的研究。 结果： 孕期饮食中胆碱含量要高，因为膜的生物合成、 一碳单位代谢和胆碱能神经传递等都需要胆碱。高浓度胆碱能够直接作为烟碱型受体激动剂，这对正常的大脑环路发育是至关重要的。在孕中、晚期的膳食中补充磷脂酰胆碱可以增强上述胆碱的功能，更有利于胎儿的发育。有研究观察到膳食补充磷脂酰胆碱能改 善抑制性神经元功能，而该功能不足与精神分裂症和 注意缺陷障碍相关。 结论： 产前膳食补充磷脂酰胆碱，提倡食用富含胆碱 的食物 （肉类、 大豆、 鸡蛋） ， 可能会促进胎儿大脑发育，从而降低今后发生精神疾病的风险。 这种短期 （ 6个月） 干预风险低，特别适用于普通人群。这类似于以往研究发现叶酸能预防腭裂，因而建议产前补充相应的药物并改善饮食。然而，数十年内还无法获得产前补充胆碱有效性的确切证据（因为精神分裂症的发生要滞后约 20年），所以公共卫生领域的官员只能根据现有 的有限信息来决定是否提倡补充胆碱。 关键词： 精神分裂症；胎儿发育；妊娠；预防；胆碱； 受体；烟碱型 本文全文中文版从 2015 年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215006 可供免费阅览下载产前胆碱水平与精神分裂症的发生 Freedman R, Ross RG  References 1.",Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2010; 167: 261-280. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
1967; 58: 199-213. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2014; 171: 758- 767. doi: http://dx.doi.org/10.1176/appi.ajp.2014.13111452 5.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2011; 168: 1286-1294. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2008; 165(1): 66-73. doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2007; 334: 464. doi: http://dx.doi.org/10.1136/ bmj.39079.618287.0B 9.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2012; 96(6): 1465-1472. doi: http://dx.doi.org/10.3945/ ajcn.112.037184 11.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2012;  26(4): 328-335. doi: http://dx.doi.org/10.1111/j.1365- 3016.2012.01264.x 12.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2012;  26(8): 356-374. doi: http://dx.doi.org/10.1096/fj.12-207894 14.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2012; 95(5): 1060-1071. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2013; 109(5): 936-943. doi: http://dx.doi.org/10.1017/ S0007114512002103 16.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2013;  177(12): 1338-1347. doi: http://dx.doi.org/10.1093/aje/ kws395 17.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2013; 170(3): 290-298. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2006;  26: 229-250. doi: http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2011;  37(6): 1187-1199. doi: http://dx.doi.org/10.1093/schbul/ sbq027 25.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2008; 455: 232-236.  doi: http://dx.doi.org/10.1038/nature07229 29.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
1995; 38: 22-33. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
1999; 73: 1590-1597.  doi: http://dx.doi.org/10.1046/j.1471-4159.1999.0731590.x 31.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2006; 314: 1610-1613. doi: http://dx.doi.org/10.1126/ science.1134246 35.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2011; 31: 11088-11095. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
"2011; 168: 921-929. doi:  http://dx.doi.org/10.1176/appi.ajp.2011.11010052• 100 • Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2005; 112: 149-162.  doi: http://dx.doi.org/10.1007/s00702-004-0186-z 38.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
Epub 2012 Dec 20. doi: http://dx.doi.org/10.1016/ j.socscimed.2012.09.051  43.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2014; 268: 104- 110. doi: http://dx.doi.org/10.1016/j.bbr.2014.03.031  45.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2011; 37: 1200- 1208. doi: http://dx.doi.org/10.1093/schbul/sbq036 47.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2009; 195(4): 294-300. doi: http://dx.doi.org/10.1192/bjp.bp.108.062471 48.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2010; 167: 70-77. doi: http://dx.doi.org/10.1176/ appi.ajp.2009.09010133 49.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2012; 35: 585-612. doi: http://dx.doi.org/10.1016/ j.psc.2012.06.00350.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2014; 1552: 26-33. doi: http://dx.doi.org/10.1016/ j.brainres.2014.01.022  54.,OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2010; 67: 889-894. doi: http://dx.doi.org/10.1001/ archgenpsychiatry.2010.110 55.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2010; 67(2): 146-154. doi: http://dx.doi.org/10.1001/ archgenpsychiatry.2009.192  56.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2010; 65: 235-240. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
2013; 98(6): 1459-1467. doi: http://dx.doi.org/10.3945/ ajcn.113.066092 61.,Non-OADS,/arxiv_data1/oa_pdf/e2/20/sap-27-02-090.PMC4466850.pdf
"2 • 103 • •Original research article• Efficacy and safety of the Chinese herbal medicine shuganjieyu  with and without adjunctive repetitive transcranial magnetic  stimulation (rTMS) for geriatric depression: a randomized  controlled trial Minmin XIE1, Wenhai JIANG1,2*, Haibo YANG1,2 1 Daqing Campus of Harbin Medical University, Daqing, Heilongjiang Province, China 2 The Third People’s Hospital of Daqing, Daqing, Heilongjiang Province, China *correspondence: dqjwh@126.com  A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.214151  on June 6, 2015.Background: Pharmacological treatment of geriatric depression is often ineffective because patients  cannot tolerate adequate doses of antidepressant medications.",Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
2015; 27(2): 103-110. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214151],Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
2012; 12(1): 144. doi:  http://dx.doi.org/10.1186/1471-244X-12-144 3.,Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
doi: http://dx.doi.org/10.3969/ j.issn.1006-2084.2013.17.043 7.,Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
2014; 28(5): 643-655. doi:  http://dx.doi.org/10.1002/ptr.5050 9.,Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
doi: http://dx.doi.org/10.1016/j.encep.2011.08.00410.,OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
2013; 151(1): 129-135. doi: http://dx.doi.org/10.1016/ j.jad.2013.05.062 11.,OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
doi:  http://dx.doi.org/10.3969/j.issn.1674-1749.2014.02.022 14.,Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
doi: http://dx.doi.org/10.3969/ j.issn.1009-6647.2007.24.129 16.,Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
"Chinese (received, 2015-03-18; accepted, 2015-04-09)背景： 由于老年期抑郁症患者往往不能耐受足量的抗 抑郁药物，所以药物治疗老年抑郁症的疗效不佳。 目的： 探讨舒肝解郁胶囊（中国药品监督管理部门批 准用于治疗抑郁症的首个中草药）单用或联合重复 经颅磁刺激 （ repetitive transcranial magnetic stimula - tion，rTMS ）治疗老年期抑郁症的疗效和安全性。 方法： 将65例60岁以上符合 ICD-10 诊断标准的抑郁 症住院患者随机分为研究组（舒肝解郁胶囊 +rTMS ） （n =36 ）和对照组（舒肝解郁胶囊 +伪rTMS ）（ n  =29）。所有患者每日服用 4粒舒肝解郁胶囊，一共 服用 6周。 rTMS （或伪 rTMS ）治 疗 20 min/d ，每 周 5 d， 共4周。评估者在不知患者分组情况下，采用汉密尔 顿抑郁量表（ HAMD-17 ）和副反应量表评估基线和治 疗开始后 1、2、4、6周的临床疗效和安全性。在 6 周的研究过程中，研究组仅有 1人脱落，对照组仅有 2人脱落。 结果： 没有一例患者出现严重不良反应，但研究组和 对照组中分别有 40％和 50％的患者出现轻微的不良反应，均自行缓解。两组的抑郁症状在 6周内均逐步 明显改善。重复测量方差分析没有发现两组之间有显著差异。  6周后，研究组 97％的患者抑郁程度下降 幅度大于等于 25％，但只有 20％者的下降幅度大于 等于 50％；对照组中相应的患者比例分别为 96％和 19％。虽然不同的抑郁症状之间治疗起效有着轻微的、 非显著性的差异，但是治疗第二周后两组 HAMD-17 五个分量表的评分均显著改善。 结论： 中草药舒肝解郁胶囊治疗老年抑郁症是有效和 安全的，然而只有少数患者的抑郁症状在治疗 6周后 改善程度大于 50％。联合重复经颅磁刺激治疗并没有 增加舒肝解郁胶囊的总体疗效，也没有显著加快后者 的起效。 关键词： 舒肝解郁胶囊；中草药；重复经颅磁刺激； 老年期抑郁症；中国 本文全文中文版从 2015 年6月6日起在  http://dx.doi.org/10.11919/j.issn.1002-0829.214151 可供免费阅览下载中草药舒肝解郁胶囊单用或联合重复经颅磁刺激（rTMS）治疗老年期抑郁症的疗效和安全性： 一项随机对照研究 谢敏敏，姜文海，杨海波",Non-OADS,/arxiv_data1/oa_pdf/81/38/sap-27-02-103.PMC4466851.pdf
"6 Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN, United States *correspondence: XG Luo, xingguang.luo@yale.edu; CK Zhang, kangyuzhang@hotmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215031  on June 6, 2015.Background:  The organization of risk genes within signaling pathways may provide clues about the  converging neurobiological effects of risk genes for alcohol dependence.",Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
"2015; 27(2): 111-118. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215031]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
"[11,12] These  data came from the merged SAGE (Study of Addiction: Genetics and Environment) and COGA (Collaborative Study On The Genetics of Alcoholism) datasets, which are available on the database of Genotypes and Phenotypes (dbGaP)( https://www.ncbi.nlm.nih.gov/gap ).",OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gap  through dbGaP accession numbers phs000092.v1.p1  and phs000125.v1.p1.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2009; 66(7): 773-784. doi:  http://dx.doi.org/10.1001/archgenpsychiatry.2009.83 2.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2010; 34(5): 840-852. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2014; 23: 526-539. doi: http://dx.doi.org/10.1111/j.1521- 0391.2014.12147.x 7.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2013; 129: 254-264. doi: http://dx.doi.org/10.1016/ j.drugalcdep.2013.02.006 8.,OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2010; 18(1): 111-117.  doi: http://dx.doi.org/10.1038/ejhg.2009.115 10.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2009; 25(18): 2444-2446. doi: http://dx.doi.org/10.1093/ bioinformatics/btp431 11.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2012; 37(2): 557-566. doi:  http://dx.doi.org/10.1038/npp.2011.229 12.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2005; 68: 183-225.  doi: http://dx.doi.org/10.1016/S0070-2153(05)68007-6 15.,OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2008; 121(Pt 15): 2435-2444. doi: http://dx.doi.org/10.1242/jcs.018044 16.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2004; 1 (3):  261-267. doi:  http://dx.doi.org/10.2174/1567202043362388 17.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
"doi: http://dx.doi.org/10.1371/journal.pcbi.0040002Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
"2 • 117 • 背景： 信号通路中风险基因的构成可能可以解释酒精 依赖风险基因协同的神经生物学作用。 目的：识别酒精依赖的风险基因和风险基因通路。 方法： 我们采用基因富集 ( gene-set-rich ) 分析方法对酒 精依赖进行了基于通路的全基因组关联分析 ( GWAS )。 在包括 1409 名欧裔美国人 ( European-American ，EA) 酒精依赖者和 1518 名EA健康对照者的探索性样本人 群中检测了近一百万个基因标志物。此外，将 681名 非裔美国人 ( African-American , AA) 病例和 508名 AA健 康受试者作为重测样本。 结果： 我们发现了几个与酒精依赖显著相关的可 重复的全基因组风险基因和风险通路。在多重比较 Bonferroni 校正后， “细胞  - 细胞外基质相互作用 ”通 路(EA样本中 p<2.0E-4 ) 和该通路中 PXN 基因 ( 编码桩蛋白 paxillin )(EA 样本中 p=3.9E-7 ) 是最有可能的酒精依 赖的危险因素。在 EA样本 ( 0.015≤ p≤0.035 )和 AA样本 (0.025≤ p≤0.050 ) 中还有两条富含酒精依赖相关基因的 可重复的通路： “Na+/ Cl- 依赖性神经递质转运体 ”通 路和 “其他聚糖降解”通路。 结论： 一些基因和生物信号传导过程可能与酒精依赖 的风险相关，本研究的发现为此提供了新的证据。 关键词： 基于基因的全基因组关联分析；基于通路的 全基因组关联分析 ； 细胞 - 细胞外基质相互作用的通路 ；   PXN；桩蛋白；酒精依赖 本文全文中文版从 2015 年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215031 可供免费阅览下载酒精依赖的基于基因和基于通路的全基因组关联研究 Zuo L J , Zhang CK, Sayward FG, Cheung KH, Wang KS, Krystal JH, Zhao HY , Luo XG",Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2009; 19(3): 117-125. doi:  http://dx.doi.org/10.1097/YPG.0b013e32832a4f7b 21.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2009; 104 (1-2): 17-22. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2010; 11(3): 357-367. doi:  http://dx.doi.org/10.2217/pgs.09.156 32.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
doi: http://dx.doi.org/10.1093/nar/gkr1127 33.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2008; 88(1): 249-286. doi:  http://dx.doi.org/10.1152/physrev.00018.2006 34.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2011; 12(4): 342-348.  doi: http://dx.doi.org/10.1038/tpj.2011.1010 36.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2010; 30(23): 7984-7992. doi:  http://dx.doi.org/10.1523/JNEUROSCI.1244-10.2010 37.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2010; 35(3): 702-719. doi:  http://dx.doi.org/10.1038/npp.2009.178 39.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
1999; 34(2): 141-147. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
2011; 336(1): 9-16.  doi: http://dx.doi.org/10.1124/jpet.110.170928 41.,Non-OADS,/arxiv_data1/oa_pdf/38/88/sap-27-02-111.PMC4466852.pdf
"Cece YANG, Shifu XIAO* Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China  * correspondence: xiaoshifu@msn.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215001  on June 6, 2015.Summary: Alzheimer’s Disease (AD) is a leading cause of disease burden among elderly individuals that is  increasingly important in middle-income countries like China where improvements in overall health (which  increase longevity) and other factors are leading to a rapidly aging population.",Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
"2015; 27(2): 119-123. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215001]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2 • 122 • 概述： 阿尔茨海默病（ Alzheimer’s Disease ，AD）是老 年人主要疾病负担之一。在中等收入国家，如中国， 整体健康状况改善、寿命延长以及其他一些因素使得人口迅速老龄化， AD所致的负担日益加重。近来 AD 诊断标准的修订，则反映了过去三十年中对该病认识的新进展。不同国际组织提出不同的 AD诊断标准， 这些标准都将 AD疾病谱细分为若干阶段，所分的阶 段彼此有些重叠。某些情况下，诊断标准要求同时存在记忆受损的表现以及特定的生物标记物。然而，这些修订的标准有几大不足：需要有训练有素的临床医生才能明确区分不同的阶段；诊断标准提及的生物标记物在 AD的发生和发展中的作用仍然不明确；需要 由训练有素的技术人员使用昂贵的高科技设备来评估这些生物标记物。上述问题限制了这些诊断标准的临床应用，资源匮乏的地方受限更甚，因为那里负责诊断和治疗 AD患者的临床医生获得的培训有限，并且 还缺少设备来确定上述生物标记物。 关键词： 阿尔茨海默病；诊断标准；中低收入国家 本文全文中文版从 2015 年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215001 可供免费阅览下载修订的阿尔茨海默病诊断标准适用于中低收入国家吗？ 杨策策，肖世富 References 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2007; 6(8): 734-746. doi:  http://dx.doi.org/10.1016/S1474-4422(07)70178-3,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2010;  9(11): 1118-1127. doi: http://dx.doi.org/10.1016/S1474- 4422(10)70223-4 6.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2011; 7 (3): 263-269. doi: http://dx.doi.org/10.1016/ j.jalz.2011.03.005 7.,OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2011; 7(3): 270-279. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2011; 7(3): 257-262. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2011; 7 (3): 280-292. doi: http://dx.doi.org/10.1016/ j.jalz.2011.03.003 10.,OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2014; 13(6): 614-629. doi: http://dx.doi.org/10.1016/S1474- 4422(14)70090-0 12.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
1999; 66: 184-188.  doi: http://dx.doi.org/10.1136/jnnp.66.2.184 13.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2012; 367(9):  795-804. doi: http://dx.doi.org/10.1056/NEJMoa1202753 19.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2004; 3: 246-248. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2014;  275(3): 204-213. doi: http://dx.doi.org/10.1111/joim.12199 21.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
doi: http://dx.doi.org/10.1016/ j.neurobiolaging.2011.02.018 22.,OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2012; 71(6): 765-775. doi:  http://dx.doi.org/10.1002/ana.22628 23.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2014; 13(6): 541. doi:  http://dx.doi.org/10.1016/S1474-4422(14)70106-1 24.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2009; 461: 916-922. doi: http://dx.doi.org/10.1038/ nature08538 25.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2012; 314(1-2): 48-56. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
2011; 12(5): 372-376. doi: http://dx.doi.org/10.1016/ j.jamda.2010.03.004 28.,OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
"2012; 83(9): 917- 922. doi: http://dx.doi.org/10.1136/jnnp-2011-301628 (received, 2015-01-09; accepted, 2015-02-24)Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/3f/d7/sap-27-02-119.PMC4466853.pdf
"•Forum• New diagnostic criteria for Alzheimer’s disease Clinical and research value of the new diagnostic criteria  for Alzheimer’s disease Wei CHEN Psychiatric Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang Province, China correspondence: srrcw@zju.edu.cn A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215046  on June 6, 2015.Summary: The use of biomarkers in the diagnosis of Alzheimer’s disease (AD) has been increasingly  emphasized, but the feasibility and value of using biomarkers in clinical practice remain limited.",Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
"2015; 27(2): 124-125. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215046]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
"概述： 在阿尔茨海默氏病（ Alzheimer’s disease, AD ）的 诊断中采用生物标志物已日益得到重视，但在临床实 践中使用生物标志物的可行性和价值仍然是有限的。然而， AD临床和制药研究中生物标志物的使用也许可 以证明对明确 AD的病理基础是非常有用的，并有助 于提高在有效预防和治疗措施下的早期识别。此外，新诊断标准的广泛采用将提高不同研究结果之间的可比性，并为使用 meta 分析方法合并和比较不同研究 的结果创造了可能性 —— 这种分析能够明确回答关于 AD的病因、病程、预防和治疗等基本问题。 关键词 :阿尔茨海默氏病；诊断标准；生物标记物 本文全文中文版从 2015 年6月6日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215046 可供免费阅览下载阿尔茨海默病新诊断标准的临床研究价值 陈炜 References 1.",Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
2003; 289(16): 2094-2103. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
doi: http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
2008;  300(19): 2253-2262. doi: http://dx.doi.org/10.1001/ jama.2008.683 6.,Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
"2014; 59(3): 607-612. doi:  http://dx.doi.org/10.1016/j.archger.2014.07.010 (recieved, 2015-04-08; accepted, 2015-04-15) Dr. Wei Chen is the Director of the Department of Psychiatry at the Sir Run Run Shaw Hospital, Zhejiang  University School of Medicine in Hangzhou, China.",Non-OADS,/arxiv_data1/oa_pdf/82/b2/sap-27-02-124.PMC4466854.pdf
"•Case report• Case report of visual hallucinations in anxiety Ankur SACHDEVA*, Ankit SAXENA, Manish KANDPAL Post Graduate Institute of Medical Education and Research, Dr. Ram Manohar Lohia Hospital, Park Street, New Delhi, India *correspondence: drankur.rml@gmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215011  on June 6, 2015.Summary:  Hallucinations rarely occur in individuals with anxiety disorders.",Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
"2015; 27(2): 126-129. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215011]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
"概述： 焦虑障碍患者很少出现幻视。本病例报告描述 了一位男性患者， 36岁，患有社交恐惧症和伴惊恐发 作的广场恐惧症。该患者幻视明显，令其深受困扰、 功能受损。用舍曲林 200 mg/d 、氯硝西泮 1mg/d 和普 萘洛尔 20 mg/d 治疗一个月后， 患者的焦虑和幻视缓解， 能继续工作， 恢复社会生活。 本报告强调这样一个事实，即幻视并不一定预示着精神病性障碍，很多精神障碍都可能出现视幻觉。如果非精神病性障碍患者出现幻视，那么治疗这些非精神病性障碍通常也能同时缓解相关的幻视，而无需使用抗精神病药物。详细分析此类罕见病例有助于加深对精神病样症状的病理机制的认识。 关键词 :幻视；焦虑障碍；病例报告；印度 本文全文中文版从 2015 年6月6日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215011 可供免费阅览下载病例报告：焦虑障碍出现幻视一例 Sachdeva A, Saxena A, Kandpal M References 1.",Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
doi: http://dx.doi.org/10.1093/schbul/sbu036 6.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
1997; 62: 16-21. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2005; 4: 605-610. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2000; 97: 153-164. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2011; 4: 12.  doi: http://dx.doi.org/10.1186/1755-7682-4-12 14.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2011; 37(4): 811-821.  doi: http://dx.doi.org/10.1093/schbul/sbp148 15.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2001;  21: 1125-1141.  doi: http://dx.doi.org/10.1016/S0272-7358(01)00103-9,OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
2008; 39: 1-17. doi: http://dx.doi.org/10.1017/ S003329170800381417.,Non-OADS,/arxiv_data1/oa_pdf/d1/8a/sap-27-02-126.PMC4466855.pdf
"•Biostatistics in psychiatry (26) • Decision tree methods: applications for classification  and prediction Yan-yan SONG1,2*, Ying LU2,3 1 Department of Pharmacology and Biostatistics, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2 Division of Biostatistics, Department of Health Research and Policy, Stanford University, Stanford, CA, USA 3 Veterans Affairs Cooperative Studies Program Palo Alto Coordinating Center, the VA Palo Alto Health Care System, Palo Alto, CA, USA *correspondence: yanyansong@sjtu.edu.cn A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215044  on June 6, 2015.Summary: Decision tree methodology is a commonly used data mining method for establishing classification  systems based on multiple covariates or for developing prediction algorithms for a target variable.",Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
"2015; 27(2): 130-135. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215044]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
"概述： 决策树是一种常用的数据挖掘方法，用于多 变量分析时建立分类系统或制定预测结果变量的算 法。此方法将一个数据群分割成分枝状节段，构造 出包括根节点、内部节点和叶节点的倒置形树状模 型。该算法运用非参数方法，不需要套用任何复杂的参数模型就能有效地处理大型复杂的数据库。当样本足够大时，可将研究数据分为训练数据集和验 证数据集。使用训练数据集构建决策树模型，使用验证数据集来决定树的适合大小， 以获得最优模型。 本文介绍了构建决策树的常用算法（包括 CART ， C4.5，CHAID 和QUEST ），并描述了 SPSS 和SAS软 件中将树结构可视化的程序。 关键词： 决策树；数据挖掘；分类；预测 本文全文中文版从 2015 年06月06日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215044 可供免费阅览下载用于分类与预测的决策树分析 Song YY , Lu Y References 1.",Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
Available from: http://rulequest.com/see5-comparison.html 16.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
2009;  9: 75. doi: http://dx.doi.org/10.1186/1471-244X-9-75 18.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
Int Stat Rev .2014; 82(3): 329-348 .doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
2014; 82(3): 349-352. doi:  http://dx.doi.org/10.1111/insr.1205920.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
2004; 24(6): 670-680. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
2004; 24(4): 386-398. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
2008; 28(6): 909-916. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
"2012;  19(12): 1529-1536. doi: http://dx.doi.org/ 10.1016/ j.acra.2012.09.007 (received, 2015-04-01; accepted, 2015-04-09) Dr. Yan-yan Song is a Lecturer in the Department of Biostatics at the Shanghai Jiao Tong University  School of Medicine who is currently a visiting scholar in the Division of Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/00/eb/sap-27-02-130.PMC4466856.pdf
https://http://www.osha.gov/pls/oshaweb/ owadisp.show_document?p_table=UNIFIED_AGENDA&p_id=4481.,Non-OADS,/arxiv_data1/oa_pdf/ae/f9/indhealth-53-206.PMC4466874.pdf
"For all analyses, we used the software package R (version  2.11.1) by the R Foundation for Statistical Computing (Vienna, Austria) (http://www.r-project.org/foundation/).",OADS,/arxiv_data1/oa_pdf/7d/be/indhealth-53-271.PMC4466878.pdf
http://www.stats.gov.cn/.,OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.stats.gov.cn/.,OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://niohp.chinacdc.cn/.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.chinasafety.gov.cn/.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.moh.gov.cn/jkj/s5898 b/201312/3abbd667050849d19b3bf6439a48b775.shtml.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://niohp.chinacdc.cn/.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://niohp.chinacdc.cn/.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.chinasafety.gov.cn/misc/diaochayanjiu.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.chinasafety.gov.cn/newpage/Contents/Channel_20712/2012/0114/162939/ content_162939.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.gov.cn/gongbao/content/2003/ content_62571.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.gov.cn/gzdt/2009– 09/11/content_1415323.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
http://www.scopsr.gov.cn/once/gzdt/201010/t20101019_15188.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/33/indhealth-53-300.PMC4466881.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/50/dddt-9-2553.PMC4466888.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2553–2563Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2553Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8153 9aging-related rotenone-induced neurochemical  and behavioral deficits: role of SIRT2 and redox  imbalance, and neuroprotection by aK-7 Xijin Wang1 Qiang guan2 Meihua Wang1 liu Yang1 Jie Bai1 Zhiqiang Yan3 Yuhong Zhang4 Zhenguo liu1 1Department of Neurology, Xinhua  Hospital Affiliated to Shanghai Jiao  T ong University School of Medicine,   2Department of Neurology, Tongji  hospital, T ongji University, 3shanghai  laboratory animal center, chinese  Academy of Sciences, 4Department  of Neurology, Shanghai T enth People’s  hospital, T ongji University, shanghai,   People’s Republic of ChinaAbstract:  Aging is one of the strongest risk factors for Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/9c/50/dddt-9-2553.PMC4466888.pdf
"With the development of molecular biology and further understanding of PD,  increasing importance is being attached to the search for aging-related molecules  involved in PD neurodegeneration and to develop effective therapeutic strategies for  PD through the use of aging animals.1–3correspondence: Xijin Wang;  Zhenguo liu Department of Neurology, Xinhua  Hospital Affiliated to Shanghai Jiao  Tong University School of Medicine,  1665 Kongjiang road, shanghai 200092,  People’s Republic of China Tel +86 137 7426 1539 email ychwjs2004@163.co m;  zhenguoliu2011@aliyun.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Role of SIRT2 and AK-7 in Parkinson’s disease DOI: http://dx.doi.org/10.2147/DDDT.S81539",Non-OADS,/arxiv_data1/oa_pdf/9c/50/dddt-9-2553.PMC4466888.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9c/50/dddt-9-2553.PMC4466888.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/50/dddt-9-2553.PMC4466888.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d4/e7/10.1177_2325967115585783.PMC4467027.pdf
2006. http://www.fda.gov/OHRMS/ DOCKETS/98fr/06d-0344-gdl0001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/01/cpdd0004-0155.PMC4467237.pdf
American Academy of Child and Adolescent Psychia- try published practice parameters for child andadolescent anxiety disorders in 2007: http://download.journals.elsevierhealth.com/pdfs/journals/0890-8567/PIIS0890856709618384.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
The Academy havealso published parameters for two speciﬁc anxiety dis-orders in children including obsessive-compulsive dis-order (OCD) http://download.journals.elsevierhealth.com/pdfs/journals/0890-8567/PIIS0890856711008823.pdf; and post-traumatic stress disorder (PTSD)http://download.journals.elsevierhealth.com/pdfs/journals/0890-8567/PIIS0890856710000821.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"There areguidelines for the treatment of OCD, PTSD, and socialphobia that include information for the treatment ofboth adults and children: OCD (http://www.nice.org.uk/nicemedia/live/10976/29947/29947.pdf), PTSD(http://www.nice.org.uk/nicemedia/live/10966/29769/29769.pdf), and social phobia (http://www.nice.org.uk/nicemedia/live/14168/63868/63868.pdf).",Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"(https://accessmq.com.au/node/117) b. Rapee, R. M., Lyneham, H. J., Schniering, C. A., Wuthrich, V ., Abbott, M. A., Hudson J. L., &Wignall, A.",OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
(For 7–12 year olds see https://accessmq.com.au/node/119; 13–18 year olds see https://accessmq.com.au/node/130).,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"Also available inTurkish, Swedish, Icelandic, Korean, and Danish(see http://centreforemotionalhealth.com.au/pages/international-cool-kids.aspx).",Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"For 3–6 yearolds, see the Cool Little Kids programme (http://accessmq.com.au/node/128).",Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
(see https://accessmq.com.au/node/115) 2.,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
This is a CDrom self-help programme for adolescents with anxiety (see https://accessmq.com.au/node/134) 2.,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
(http://www.oup.com).,Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"See http://www.psychiatry.pitt.edu/research/tools-research/assessment-instruments)Birmaher, B.,Khetarpal, S., Brent, D.A., Cully, M., Balach, L.,Kaufman, J., & Neer, S. M. (1997).",Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
"See http://www.childﬁrst.ucla.edu/Resources.html)Chorpita, B. F., L. M., Mofﬁtt, C. E.,Umemoto, L. A., & Francis, S. E. (2000).",Non-OADS,/arxiv_data1/oa_pdf/67/02/cp0018-0052.PMC4467238.pdf
Available from URL: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm124718.htmPYM Woo et al.,Non-OADS,/arxiv_data1/oa_pdf/62/e5/ash0019-0002.PMC4467242.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0).,Non-OADS,/arxiv_data1/oa_pdf/34/2f/icrp-2-043.PMC4467246.pdf
"http://informahealthcare.com/crp ISSN: 2332-0885 (electronic) Cas Rep Plast Surg Hand Surg, 2015; 2(2): 43 –45 DOI: 10.3109/23320885.2015.1026348",Non-OADS,/arxiv_data1/oa_pdf/34/2f/icrp-2-043.PMC4467246.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?curl ¼pages/medicines/human/re- ferrals/Motilium/human_referral_000090.jsp&mid ¼WC0- b01ac05805c516f Accessed 23 April 2013.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/cpdd0004-0041.PMC4467253.pdf
Available at: http://www.fda.gov/downl oads/Drugs/GuidanceCom- plianceRegulatoryInfor mation/Guidances/UCM074963.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/cpdd0004-0041.PMC4467253.pdf
ICH guidance for industry: E14 Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiar- rhythmicdrugs.May2005.Availableat:http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129357.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/cpdd0004-0041.PMC4467253.pdf
Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf Accessed 21 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/cpdd0004-0041.PMC4467253.pdf
Available at: http://seer.cancer.gov/csr/1975_2011/results_merged/sect_22_pancreas.,Non-OADS,/arxiv_data1/oa_pdf/43/93/mpa-44-686.PMC4467583.pdf
Available at: http://seer.cancer.gov/faststats/.,Non-OADS,/arxiv_data1/oa_pdf/43/93/mpa-44-686.PMC4467583.pdf
"Familial PC emerged as a theme to be presented separately and is entitledScreening in Familial Pancreatic Cancer, which is presented inan addendum to this article (Supplemental Digital Content 1, http://links.lww.com/MP A/A372).",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"Subjects with a strong family history of PC have been of-fered screening for early PC using noninvasive and invasive imaging tests, which is discussed in an addendum to this article entitled Screening in Familial Pancreatic Cancer (SupplementalDigital Content 1, http://links.lww.com/MP A/A372).",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"Applications of Imaging for PC Detection —High-Risk Populations While it remains cost-prohibitive and difficult with current technology to screen the general population for PC, models dem- onstrate screening of individuals younger than 70 years and who have a lifetime risk of PC greater than or equal to 16% is cost- effective.96In this regard, it is important to note that despite its high mortality, the overall incidence of PC is relatively low; the overall lifetime risk is 1 in 80 (http://seer.cancer.gov/).",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
Listings of current FPCregistries are provided by the Pancreatic Cancer Action Network at http://www.pancan.org/section-facing-pancreatic-cancer/learn- about-pan-cancer/risk-factors/risk-f actors-family-registries/ and by Pancreatica at http://pancreatica.org/faq/pancreatic-cancer-registries/.The FPC registries generally identify families in which there are 2 or more FDRs with PC and/or family members who develop PC prior to age 50 years or in some cases have known syndromes that are associated with a higher incidence of PC.,Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
One such effort is the Pancreatic Cancer Collabora- tive Registry (PCCR; http://pccr.unmc.edu/).,Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"The Ronald S. Hirshberg Translational Pancreatic Cancer Research Labora- tory houses a current program project grant (Guido Eibl, PI,Targeting Diet Induced Promotion of Kras-Initiated PancreaticAdenocarcinoma; http://dietandpancreaticcancer.com).",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"In addi- tion, the UCLA Center for Excellence in Pancreatic Diseases (http://www.pancreaticdiseasecenter.org/), under the leadershipof Vay Liang W .",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"The Southern California Research Center for Alco-holic Liver and Pancreatic Disease is a National Institute onAlcohol Abuse and Alcoholism –funded Alcohol Research Cen- ter, which is the first Los Angeles city –wide Center for Excellence devoted to Studies on Alcoholic Liver and Pancreatic Injury (http://www.usc.edu/schools/medicine/research/alcohol_center/).The center was created through the consolidation of existing col-laborative and interactive programs among the established inves- tigators at the University of Southern California (USC) and UCLA.",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"The NIDDK Digestive Disease Core Center (CURE) (http://www.cure.med.ucla.edu/) is a digestive diseases research center composed of a cohesive group of physicians and basic scien- tists with strong independent, grant-supported research programs inthe biology of the gut and pancreas.",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"This compares poorly to the National Institutes of Health report that the 5-year relative survival rate for breast cancer is 90%, colorectal canceris 67%, and prostate cancer is nearing 100% (http://seer.cancer.",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"An addendum containinginformation related to Screening in Familial Pancreatic Canceris included with this article (Supplemental Digital Content 1, http://links.lww.com/MPA/A372).",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
"REFERENCES References are available online at: http://links.lww.com/MPA/A374.Chari et al Pancreas Volume 44, Number 5, July 2015 712 www.pancreasjournal.com © 2015 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/36/64/mpa-44-693.PMC4467589.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/31/ott-8-1387.PMC4467640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1387–1398OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1387Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4888 3extracellular matrix as target for antitumor  therapy Revekka Harisi Andras Jeney 1st institute of Pathology and  experimental Cancer Research,   Faculty of Medicine, Semmelweis  University, Budapest, HungaryAbstract:  The aim of the present review is to survey the accumulated knowledge on the  extracellular matrix (ECM) of tumors referring to its putative utility as therapeutic target.",Non-OADS,/arxiv_data1/oa_pdf/8b/31/ott-8-1387.PMC4467640.pdf
"The metabolic reprogramming ability of ECM can be regarded as  an active contributor to the malignant processes.3,4 ECM in tumor progression ECM has multiple effects on the biological behaviors of tumors.5,6 It was concluded  from our previous study that the localization of the tumor in the host organism could  modify the malignant phenotype of the same tumor.5 Examination of gene expression of ECM components demonstrated that breast  carcinomas could be classified to four subtypes with different clinical outcomes.7  Correspondence: Andras Jeney 1st institute of Pathology and  experimental Cancer Research, Faculty  of Medicine, Semmelweis University,  H-1085, 26 Üllői út, Budapest,   H-1085, Hungary Tel +36 1 317 1070 Fax +36 1 317 1070 email ajeney@korb1.sote.h u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Harisi and Jeney Running head recto: Extracellular matrix and antitumor therapy DOI: http://dx.doi.org/10.2147/OTT.S48883",Non-OADS,/arxiv_data1/oa_pdf/8b/31/ott-8-1387.PMC4467640.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/31/ott-8-1387.PMC4467640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/31/ott-8-1387.PMC4467640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/ott-8-1351.PMC4467641.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1351–1354OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1351Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7892 5an active treatment of lung adenocarcinoma  cancer with brain metastases: icotinib Ying Zhang Huaping Tang Jun Li Meng Li Department of respiration Medicine,   Municipal Hospital, Qingdao, people’s  republic of ChinaAbstract:  Lung cancer has the highest mortality rate of all cancers world wide.",Non-OADS,/arxiv_data1/oa_pdf/97/e3/ott-8-1351.PMC4467641.pdf
"Abdominal Correspondence: Ying Zhang 5 Donghai Middle road, Qingdao,  shandong, people’s republic of China Tel +86 135 8920 0795 email zhangyoufang163@163.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: Treatment of lung adenocarcinoma cancer with brain metastases DOI: http://dx.doi.org/10.2147/OTT.S78925",Non-OADS,/arxiv_data1/oa_pdf/97/e3/ott-8-1351.PMC4467641.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/97/e3/ott-8-1351.PMC4467641.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/e3/ott-8-1351.PMC4467641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1363–1373OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1363Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8330 2axitinib versus sorafenib as a second-line  therapy in asian patients with metastatic renal  cell carcinoma: results from a randomized  registrational study shukui Qin,1 Feng Bi,2 Jie  Jin,3 Ying cheng,4 Jun guo,5  Xiubao ren,6 Yiran huang,7  Jamal Tarazi,8 Jie Tang,9  connie chen,9 sinil Kim,8  Dingwei Ye10 1Department of Medical Oncology,   Pla cancer center, nanjing Bayi  hospital, nanjing, Jiangsu, People’s  republic of china; 2Department  of Medical Oncology, West china  hospital of sichuan University,   chengdu, sichuan Province, People’s  republic of china; 3Department  of Urology, Peking University First  hospital, Beijing, People’s republic  of china; 4Department of Oncology,   Jilin Provincial cancer hospital,   changchun, Jilin Province, People’s  republic of china; 5Department  of renal cancer and Melanoma,   Peking University cancer hospital/ institute, Beijing, People’s republic  of china; 6Department of Biology  Treatment, Tianjin Oncology hospital,   Tianjin, People’s republic of china;   7Department of Urology, renji  hospital, shanghai Jiao T ong University  school of Medicine, shanghai,   People’s republic of china; 8clinical  Development, Pfizer Oncology, san  Diego, ca, Usa; 9global Outcomes  research, Pfizer inc., new Y ork, nY,   Usa; 10Department of Urology, Fudan  University shanghai cancer center,   shanghai, People’s republic of chinaBackground:  This registrational trial evaluated the efficacy, safety, and patient-reported  outcomes of axitinib versus sorafenib as a second-line treatment in Asian patients with clear- cell metastatic renal cell carcinoma (mRCC).",Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
"Keywords:  axitinib, renal cell carcinoma, sorafenib, vascular endothelial growth factor receptor  inhibitor Introduction In 2012, kidney cancer was diagnosed in more than 66,000 people in China and resulted  in more than 25,000 deaths, a twofold increase in the number of deaths from 2008.1,2  Renal cell carcinoma (RCC) accounts for ~90% of kidney cancers, of which clear-cell  carcinoma is the predominant histological subtype, accounting for 85% of RCC.3 In many countries, the management of metastatic RCC (mRCC) has changed  dramatically with the introduction of molecularly targeted agents such as sunitinib,4–7  pazopanib,8–10 sorafenib,11–14 temsirolimus,15 and everolimus.16 However, according to  the resource-stratified guidelines developed at the 2012 Asian Oncology Summit,17  interferon α is still commonly used in Japan and considered the most cost-effective correspondence: Dingwei Ye Department of Urology, Fudan  University shanghai cancer center,  270 Dong an road, shanghai 200032,  People’s republic of china Tel +86 137 0166 3571 Fax +86 21 6443 8640 email dwyeli@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Qin et al Running head recto: Axitinib versus sorafenib in Asian patients with mRCC DOI: http://dx.doi.org/10.2147/OTT.S83302",Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
"Available from: http://globocan.iarc.f r. Accessed January 28,  2015.",Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls / PDF/kidney.pd f. Accessed January 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/bc/ott-8-1363.PMC4467642.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/01/ott-8-1355.PMC4467643.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1355–1362OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1355Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8217 4Decreased pretreatment lymphocyte/monocyte  ratio is associated with poor prognosis in stage  ib1–iia cervical cancer patients who undergo  radical surgery liang chen1,2 Fang Zhang3 Xiu-gui sheng2 shi-qian Zhang1 1Department of Obstetrics and  gynecology, Qilu hospital of  shandong University, Jinan, People’s  republic of china; 2Department of  gynecological Oncology, shandong  cancer hospital and institute,   Jinan, People’s republic of china;   3Department of radiology, Provincial  hospital affiliated with shandong  University, Jinan, People’s republic of  chinaBackground:  Recently, pretreatment monocyte counts and the lymphocyte/monocyte ratio  (LMR) have been proven to be significantly associated with the clinical outcomes of several  types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/f7/01/ott-8-1355.PMC4467643.pdf
"However, the use of biomarkers is currently limited primar - ily to clinicopathological prognostic factors, including the histological grade, the  pathological type, the number of metastatic lymph nodes, and venous and lymphatic, correspondence: shi-qian Zhang Department of Obstetrics and  gynecology, Qilu hospital of shandong  University, Wenhuaxi road 107, Jinan  250012, People’s republic of china Tel/fax +86 531 6762 6546 email chchliang9898@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: LMR predicts clinical outcome in patients with cervical cancer DOI: http://dx.doi.org/10.2147/OTT.S82174",Non-OADS,/arxiv_data1/oa_pdf/f7/01/ott-8-1355.PMC4467643.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f7/01/ott-8-1355.PMC4467643.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/01/ott-8-1355.PMC4467643.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/ca/cia-10-931.PMC4467644.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 931–937Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  931RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5081 9Zonisamide in the management of epilepsy  in the elderly Andrea Romigi1,2 eti A Femia3 Cinzia Fattore4 Giuseppe vitrani1 Giancarlo Di Gennaro1 valentina Franco4 1Istituto Neurologico Mediterraneo,   IRCCS Neuromed, Pozzilli (IS), Italy;   2Neurophysiopathology Department,   University of Rome T or vergata,   Rome, Italy; 3Dipartimento di Scienze  della Salute, Università degli Studi  di Milano, Milano, Italy; 4Clinical  Trial Centre & Antiepileptic Drugs,   C. Mondino National Neurological  Institute, Pavia,  ItalyAbstract:  Zonisamide (ZNS), a second-generation antiepileptic drug, indicated as add-on  treatment of focal epilepsy, has been recently approved as monotherapy for the treatment of  partial seizures in adults affected by newly diagnosed epilepsy in Europe.",Non-OADS,/arxiv_data1/oa_pdf/df/ca/cia-10-931.PMC4467644.pdf
"This agent is also approved in Europe and USA as adjunctive  therapy of focal seizures with or without secondary generalization with a proven  safety and tolerability profile.13,14 A recent pooled analysis of clinical studies, where  patients with epilepsy aged $65 years treated with ZNS were enrolled, showed a  favorable safety/tolerability profile.4 This, in combination with the negligible expected  drug interactions, and the advantage of once-daily dosing,15 has led to an increasing Correspondence: Andrea Romigi Neurophysiopathology Department,  University of Rome Tor vergata, viale  Oxford 81, 00133 Rome, Italy Tel +39 06 2090 2107 Fax +39 06 9765 5221 email a_romigi@inwind.i tJournal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Romigi et al Running head recto: Zonisamide in the elderly with epilepsy DOI: http://dx.doi.org/10.2147/CIA.S50819",Non-OADS,/arxiv_data1/oa_pdf/df/ca/cia-10-931.PMC4467644.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/df/ca/cia-10-931.PMC4467644.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/df/ca/cia-10-931.PMC4467644.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/56/ott-8-1291.PMC4467645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1291–1313OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1291Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7392 4Computed tomography versus magnetic  resonance imaging for diagnosing cervical lymph  node metastasis of head and neck cancer:  a systematic review and meta-analysis J Sun1 B Li2 CJ Li1 Y Li1 F Su3 QH Gao4 FL wu4 T  Yu5 L wu6 LJ Li1 1Department of Head and Neck  Oncology, west China Hospital of  Stomatology, State Key Laboratory  of Oral Diseases, Sichuan University,  Chengdu, People’s Republic of China;  2west China School of Stomatology,  State Key Laboratory of Oral Diseases,  Sichuan University, Chengdu, People’s  Republic of China; 3Department of  stomatology, Tianjin University of  Traditional Chinese Medicine, Tianjin,  People’s Republic of China; 4Department  of Oral and Maxillofacial Surgery, State  Key Laboratory of Oral Diseases,  west China Hospital of Stomatology,  Sichuan University, Chengdu, People’s  Republic of China; 5Department of Head  and Neck Oncology Surgery, Sichuan  Cancer Hospital, Chengdu, People’s  Republic of China; 6Center for Clinical  and Translational Science, Mayo Clinic,  Rochester, MN, USAAbstract:  Computed tomography (CT) and magnetic resonance imaging (MRI) are common  imaging methods to detect cervical lymph node metastasis of head and neck cancer.",Non-OADS,/arxiv_data1/oa_pdf/f7/56/ott-8-1291.PMC4467645.pdf
"Keywords:  computed tomography, magnetic resonance imaging, metastasis, head and neck  cancer, meta-analysis Introduction The occurrence of cervical lymph node metastasis in patients with head and neck  cancers are very common.¹ The presence of cervical lymph node metastasis may affect  the optimal treatment choice as well as prognosis in patients.² Management of patients  presenting with cervical lymph node metastasis includes selective or radical neck dis - section, followed by radiotherapy and/or chemotherapy depending on the pathological  findings of the nodes.3–5 Besides, the detection of cervical lymph node metastasis is  very important for predicting prognosis in patients with head and neck cancers.6–8 Many imaging techniques exist for identifying cervical lymph node metastasis in  patients with head and neck cancers.9–12 Among them, computed tomography (CT)  and magnetic resonance imaging (MRI) are the most widely used tools.13 Both of  them have improved accuracy of nodal staging over clinical palpation and the nodes  which are clinically occulted can be visualized through these techniques.14 Usually the Correspondence: CJ Li; LJ Li Department of Head and Neck  Oncology, west China Hospital  of Stomatology, State Key Laboratory  of Oral Diseases, Sichuan University,  14# sec 3, South Renmin Road, Chengdu,  610041, People’s Republic of China Tel +86 28 8550 1428 email lichunjie07@qq.co m;  muzili63@163.co mJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Sun et al Running head recto: Computerized tomography versus magnetic resonance imaging DOI: http://dx.doi.org/10.2147/OTT.S73924",Non-OADS,/arxiv_data1/oa_pdf/f7/56/ott-8-1291.PMC4467645.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f7/56/ott-8-1291.PMC4467645.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/56/ott-8-1291.PMC4467645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/4a/opth-9-1017.PMC4467646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1017–1028Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1017Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6039 4Current aspects on the management of viral  uveitis in immunocompetent individuals Uwe Pleyer1 Soon-Phaik Chee1–5 1Augenklinik, Charité–  Universitätsmedizin Berlin,   Campus virchow-Klinikum, Berlin,   Germany; 2Ocular inflammation  and immunology Service, Singapore  National eye Centre, 3Singapore eye  Research institute, 4Department of  Ophthalmology, Y ong Loo Lin School  of Medicine, National University  of Singapore, 5Duke-NUS Graduate  Medical School Singapore, SingaporeAbstract:  Viruses are a fundamental etiology of ocular inflammation, which may affect all  structures of the organ.",Non-OADS,/arxiv_data1/oa_pdf/ce/4a/opth-9-1017.PMC4467646.pdf
"Both virus-induced cytopathology and the subsequent inflammatory response are  responsible for ocular damage.Correspondence: Uwe Pleyer Department of Ophthalmology, Charité –  Universitätsmedizin Berlin, Campus  virchow-Klinikum, Augustenburger  Platz 1, 13353 Berlin, Germany Tel +49 30 4 5065 4131 Fax +49 30 4 5055 4900 email uwe.pleyer@charite.d eJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Pleyer and Chee Running head recto: Management of viral uveitis DOI: http://dx.doi.org/10.2147/OPTH.S60394",Non-OADS,/arxiv_data1/oa_pdf/ce/4a/opth-9-1017.PMC4467646.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ce/4a/opth-9-1017.PMC4467646.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/4a/opth-9-1017.PMC4467646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/83/ceg-8-169.PMC4467647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 169–174Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  169OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S6990 5Differential response to microbial antigens by age  of diagnosis in patients with Crohn’s disease sandra M Quezada ankur rustgi Guruprasad D Jambaulikar raymond K Cross Department of Medicine, Division   of Gastroenterology and hepatology,   University of Maryland school of  Medicine, Baltimore, MD, Usa Correspondence: sandra M Quezada   100 north Greene street, lower level,  Baltimore, MD 21201, Usa   Tel +1 410 706 3387   Fax +1 410 706 4330   Email squezada@medicine.umaryland.ed uPurpose:  Fifteen percent of incident Crohn’ s disease (CD) cases are diagnosed at older ages and  demonstrate colonic location and inflammatory behavior.",Non-OADS,/arxiv_data1/oa_pdf/1e/83/ceg-8-169.PMC4467647.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/1e/83/ceg-8-169.PMC4467647.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/83/ceg-8-169.PMC4467647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/5d/ceg-8-159.PMC4467648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 159–167Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  159REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S6723 1Profile of rifaximin and its potential in the  treatment of irri table bowel syndrome Natalya iorio Zubair Malik Ron Schey Section of Gastroenterology,   Department of Medicine, Temple  University Hospital, Philadelphia, PA,   USA Correspondence: Ron Schey   Section of Gastroenterology, Department  of Medicine, Temple University Hospital,  3401 North Broad Street, Philadelphia  19140, PA, USA   Tel +1 215 707 9900   Fax +1 215 707 2684   Email r on.schey@tuhs.temple.ed uAbstract:  Irritable  bowel syndrome (IBS) is a chronic functional gastrointestinal disorder  characterized by recurrent abdominal pain and abnormal bowel patterns.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/ceg-8-159.PMC4467648.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/bb/5d/ceg-8-159.PMC4467648.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/5d/ceg-8-159.PMC4467648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph p ClinicoEconomics and Outcomes Research 2015:7 325–336 ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  325ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8013 0Relative cost-effectiveness of an extensively  hydrolyzed casein formula containing   the probiotic Lactobacillus rhamnosus  gg   in managing infants with cow’s milk allergy in italy Julian F guest1,2 Monica Panca1 Olga Ovcinnikova1 Rita nocerino3 1CaTalYsT health Economics  Consultants, northwood, Middlesex,  UK; 2Faculty of life sciences and  Medicine, King’s College, london,  UK; 3Department of Translational  Medical science, Pediatric section,  University of naples ‘Federico ii’,  naples, italy Correspondence: Julian F guest   CaTalYsT health Economics  Consultants, 34B high street,  northwood, Middlesex, UK   Tel +44 1923 450045   Fax +44 1923 450046   Email julian.guest@catalyst-health.co.u kObjective:  To estimate the cost-effectiveness of using an extensively hydrolyzed casein formula  (eHCF) containing the probiotic Lactobacillus rhamnosus  GG, (eHCF + LGG; Nutramigen LGG)  as first-line management for cow’ s milk allergy (CMA) compared with eHCF alone, soy-based  formulae (SBF), hydrolyzed rice formulae (HRF), and amino acid formulae (AAF) in Italy, from  the perspective of the Italian National Health Service (INHS) and parents.",Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
Available from:  http://www.worldallergy.org/publications/WAO_DRACMA_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
Available  from: http://www.nice.org.uk/guidance/cg116/resources/cg116-food- allergy-in-children-and-young-people-full-guideline 3.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
Available from: http://www.salute.gov.it/portale/temi/p2_6.jsp?l ingua =italiano&id =1767&are a=programmazioneSanitariaLea&menu =lea.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
Available from: http://demo.istat.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/b3/ceor-7-325.PMC4467649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 279–286Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  279PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S8100 7Radium-223 dichloride: illustrating the benefits  of a multidisciplinary approach for patients with  metastatic castration-resistant prostate cancer Joseph F renzulli ii Jennifer collins Anthony Mega Genitourinary Multidisciplinary   clinic, the Miriam Hospital,   Providence, ri, UsA correspondence: Joseph F renzulli ii   Genitourinary Multidisciplinary clinic,   the Miriam Hospital, 195 collyer street,  suite 201, Providence, ri 02904, UsA   tel +1 401 272 7799   Fax +1 401 453 9078   email jrenzulli@lifespan.or gabstract:  Improving options for patients with metastatic castration-resistant prostate cancer  (mCRPC) provide latitude in designing treatment plans that meet patients’ medical needs and  personal goals.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/f_guidelines_nojava.as p. Accessed October 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
"Available  from: http://www.auanet.org/common/pdf/education/clinical- guidance / Castration-Resistant-Prostate-Cancer.pd f. Accessed October 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
Available from: http://www.esmo.,Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/85/jmdh-8-279.PMC4467650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 939–949Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  939RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7432 2Bladder cancer in the elderly patient: challenges  and solutions elizabeth A Guancial1 Breton Roussel2 Derek P Bergsma3 Kevin C Bylund3 Deepak Sahasrabudhe1 edward Messing4 Supriya G Mohile1 Chunkit Fung1 1Division of Hematology/Oncology,   Department of Medicine, wilmot  Cancer Institute, University of  Rochester Medical Center School of  Medicine and Dentistry, Rochester,   NY, 2Robert wood Johnson Medical  School, Rutgers University, New  Brunswick, NJ, 3Department of  Radiation Oncology, wilmot Cancer  Institute, University of Rochester,   Rochester, NY, 4Department of  Urology, University of Rochester,   Rochester, NY, USAAbstract:  Bladder cancer (BC) is an age-associated malignancy with increased prevalence in the  elderly population.",Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
rochester.ed u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Guancial et al Running head recto: Bladder cancer in the elderly patient DOI: http://dx.doi.org/10.2147/CIA.S74322,Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
"Available from: http://seer.cancer.gov/ statfacts/html/urinb.htm l. Accessed April 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/70/22/cia-10-939.PMC4467651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/ba/copd-10-1061.PMC4467652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1061–1073International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1061OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8129 5a randomized controlled trial evaluating the   effectiveness of a web-based, computer-tailored  self-management intervention for people with  or at risk for COPD Correspondence: huibert Tange Maastricht University, PO Box 616,  6200MD, Maastricht, netherlands Tel +31 43 388 2230 Fax +31 43 361 9344 email h.tange@maastrichtuniversity.n l Viola Voncken-Brewster1 huibert Tange1 hein de Vries2 Zsolt nagykaldi3 Bjorn Winkens4 Trudy van der Weijden1 1Department of Family Medicine,  2Department of health Promotion,  school for Public health and  Primary Care (C aPhrI), Maastricht  University Medical Center, Maastricht,  netherlands; 3Department of Family  and Preventive Medicine, University  of Oklahoma health sciences Center,  Oklahoma City, OK, Usa; 4Department  of Methodology and statistics, C aPhrI,  Maastricht University Medical Center,  Maastricht, netherlandsIntroduction:  COPD is a leading cause of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/91/ba/copd-10-1061.PMC4467652.pdf
"Keywords:  smoking cessation, physical activity, Internet intervention, tailoring, COPD Background COPD is one of the leading causes of morbidity and mortality worldwide.1 COPD  patients suffer from airflow limitation that is typically progressive and not reversible.2  Adequate patient self-management and behavior modification, such as smoking ces - sation and increasing the level of physical activity, are recommended to decelerate  disease progression.3,4 A relatively small number of studies on the effectiveness of COPD self-management  interventions have been conducted, and the evidence on effectiveness remains  inconclusive.5 Self-management interventions have mainly focused on educating COPD  patients using standardized information, but are now increasingly offering personalized  information to patients through counseling with a health care provider.5Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Voncken-Brewster et al Running head recto: Effectiveness of a computer-tailored COPD self-management intervention DOI: http://dx.doi.org/10.2147/COPD.S81295",Non-OADS,/arxiv_data1/oa_pdf/91/ba/copd-10-1061.PMC4467652.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/91/ba/copd-10-1061.PMC4467652.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/ba/copd-10-1061.PMC4467652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/ott-8-1399.PMC4467653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1399–1406OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8028 8The effect of ataxia-telangiectasia mutated kinase- dependent hyperphosphorylation of checkpoint  kinase-2 on oligodeoxynucleotide 7909 containing  cpg motifs-enhanced sensitivity to X-rays  in human lung adenocarcinoma a549 cells Xiaoqun liu1,* Xiangdong liu2,* Tiankui Qiao1 Wei chen1 sujuan Yuan1 1Department of Oncology,   2Department of Ophthalmology,   affiliated Jinshan hospital, Fudan  University, shanghai, People’s republic  of china *These authors contributed equally  to this workObjective:  The aim of the study reported here was to further investigate the potential effect  of ataxia-telangiectasia mutated (ATM) kinase-dependent hyperphosphorylation of checkpoint  kinase-2 (Chk2) on radiosensitivity enhanced by oligodeoxynucleotide 7909 containing CpG  motifs (CpG ODN7909) in human lung adenocarcinoma A549 cells.",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/ott-8-1399.PMC4467653.pdf
"Keywords:  ATM kinase, ODN, signal pathway, cell cycle, apoptosis, radiosensitivity Background Worldwide, non-small cell lung cancer (NSCLC) is one of the leading cancers respon - sible for death in both men and women, and is still an incurable disease.1 One of the correspondence: Tiankui Qiao Department of Oncology, Affiliated  Jinshan hospital, Fudan University,  longhang road 1508, Jinshan District,  shanghai, People’s republic of china Tel +86 189 3077 8786 email 18019206896@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: CpG ODN7909 potentiation of A549 cell radiosensitivity DOI: http://dx.doi.org/10.2147/OTT.S80288",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/ott-8-1399.PMC4467653.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/ff/ott-8-1399.PMC4467653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/ff/ott-8-1399.PMC4467653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1001–1015Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1001Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7495 9Management of neovascular age-related macular  degeneration: current state-of-the-art care  for optimizing visual outcomes and therapies  in development Aniruddha Agarwal william R Rhoades Mostafa Hanout Mohamed Kamel Soliman Salman Sarwar Mohammad Ali Sadiq Yasir Jamal Sepah Diana v Do Quan Dong Nguyen Stanley M Truhlsen eye institute,   University of Nebraska Medical  Center, Omaha, N e, USAAbstract:  Contemporary management of neovascular age-related macular degeneration (AMD)  has evolved significantly over the last few years.",Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
"Evidence from large multicenter clinical trials in the last decade has brought about a  paradigm shift with neovascular AMD.8 Increasing knowledge of the pathogenic mecha - nisms responsible for neovascular growth and complications in AMD has resulted in  translational research targeting specific pathways that were previously unexplored.9 Treat - ments targeting vascular endothelial growth factor (VEGF) have been shown to improve  vision in patients with neovascular AMD and now constitute the mainstay of therapy.10  Results from research on newer therapeutic strategies including gene therapy suggest that  novel treatment options may be on the horizon.11 The fast pace of clinical research has Correspondence: Quan Dong Nguyen Stanley M Truhlsen eye institute,  University of Nebraska Medical Center,  985540 Nebraska Medical Center,  Omaha, Ne 68198-5540, USA Tel +1 402 559 4276 Fax +1 402 559 5514 email quan.nguyen@unmc.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Agarwal et al Running head recto: State-of-the-art management of AMD DOI: http://dx.doi.org/10.2147/OPTH.S74959",Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
"Available  at: http://www.aao.org/Assets/db935a77-1997-4d60-b850-71 - b7602f46e2/635582143853270000/age-related-macular-degeneration- ppp-pd f. Accessed May 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT0143686 4.,Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/0b/opth-9-1001.PMC4467654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/45/dddt-9-2927.PMC4467655.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2927–2940Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2927Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7736 9Cissus quadrangularis  inhibits il-1 β induced  inflammatory responses on chondrocytes and  alleviates bone deterioration in osteotomized  rats via p38 MaPK signaling Jagat r Kanwar1 rasika M samarasinghe1 Kuldeep Kumar2 ramesh arya2 sanjeev sharma2 shu-Feng Zhou3 sreenivasan sasidharan4 rupinder K Kanwar1 1nanomedicine-laboratory  of immunology and Molecular  Biomedical research (nliMBr),   school of Medicine (soM), Molecular  and Medical research (MM r)  strategic research centre, Faculty  of health, geelong Technology Precinct  (gTP), Deakin University, Waurn Ponds,  Vic, australia; 2ayurvedic college,   Paprola, Kangra, himachal Pradesh,   india; 3Department of Pharmaceutical  sciences, college of Pharmacy,   University of south Florida, Tampa,   Fl, Usa; 4institute for research in  Molecular Medicine (in FOrMM),   Universiti sains Malaysia, Penang,   MalaysiaIntroduction:  Inflammatory mediators are key players in the pathogenesis of osteoarthritis  (OA) and bone destruction.",Non-OADS,/arxiv_data1/oa_pdf/20/45/dddt-9-2927.PMC4467655.pdf
"These mediators consequentially induce a destructive cascade of events that lead to  a positive stimulatory loop of the cytokines as well as the synthesis of matrix metal - loproteinase (MMP) and prostaglandins.4–6 Current therapeutics such as nonsteroidal correspondence: Jagat r Kanwar nanomedicine-laboratory of immunology  and Molecular Biomedical research  (nliMBr), school of Medicine (soM),  Molecular and Medical research (MMr)  strategic research centre, Faculty  of health, geelong Technology Precinct  (gTP), Deakin University, Pigdons road,  Waurn Ponds, Vic 3216, australia Tel +61 3 52271148 Fax +61 3 52273402 email jagat.kanwar@deakin.edu.a u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kanwar et al Running head recto: Cissus quadrangularis  induces chondroprotection and osteogenesis DOI: http://dx.doi.org/10.2147/DDDT.S77369",Non-OADS,/arxiv_data1/oa_pdf/20/45/dddt-9-2927.PMC4467655.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/20/45/dddt-9-2927.PMC4467655.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/45/dddt-9-2927.PMC4467655.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 297–306Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  297ExpErt OpInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CCID.S7230 1IncobotulinumtoxinA in aesthetics: russian   multidisciplinary expert consensus  recommendations Yana Yutskovskaya1 Elena Gubanova2 Irina Khrustaleva3 Vasiliy Atamanov4 Anastasiya Saybel5 Elena parsagashvili6 Irina Dmitrieva7 Elena Sanchez8 natalia Lapatina9 tatiana Korolkova10 Alena Saromytskaya11 Elena Goltsova12 Elmira Satardinova13 1Department of Dermatovenereology  and Cosmetology, pacific State Medical  University, Vladivostock,  2Department of  Skin and Venereal Diseases, postgraduate  Medical Institute, Moscow national  University of Food production, Moscow,   3Department of plastic Surgery, I p pavlov  Medical State University, St petersburg,   4Department of reconstructive and  plastic Surgery, S n Fedorova, Federal  State Institution, novosibirsk,  5Clinic  Ideal, Laser technologies Center,   Moscow,  6Aestima-clinic,  7Clinic  “Academy”, St petersburg,  8Eklan Medical  Center of Cosmetological Correction,   9Clinic of Aesthetic Medicine and  plastic Surgery, Moscow,  10Department  of Cosmetology, II Mechnikov north- Western State Medical University,    St petersburg,  11plastic Surgery Clinic,   Center of Aesthetic Medicine and  Beauty Cosmetology,  12“neo-Clinic,”  tyumen,  13Botulinum toxin therapy  Department, Diagnostic Center of  the Irkutsk State Medical Academy of  postgraduate Education, Irkutsk, russia Correspondence: Yana Yutskovskaya   Budennogo Avenue 26, Building 1,  Moscow, 105118, russia   tel +7 985 388 0077  Email yutsk@mail.r uBackground:  Although there are various international consensus recommendations on the use  of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or  Russian  guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within  specific aesthetic indications.",Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
Available  from: http://www.lantox.ru.,Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
Available from: http://www.1nep.ru/en/articles/177070 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
"Available from: http://www.awmf.org/ uploads/tx_szleitlinien/013-077l_S1_%C3%84sthetische_Botulinum - toxin_Therapie_2012-11.pd f. Accessed March 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
Available from:  https://wcd.coe.int/ViewDoc.jsp?id=84665 5.,OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
"Available from: http://www.surgery.org/media/statistic s. Accessed  February  10, 2014.",OADS,/arxiv_data1/oa_pdf/e3/ae/ccid-8-297.PMC4467658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/d8/mder-8-265.PMC4467659.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 265–278Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  265REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S7063 0Emerging clinical applications of computed  tomography Carlo Liguori1 Giulia Frauenfelder2 Carlo Massaroni3 Paola Saccomandi3 Francesco Giurazza4 Francesca Pitocco4 Riccardo Marano5 Emiliano Schena3 1Radiology Unit, AORN A Cardarelli,   2Radiology Unit, AOU Federico ii,   Naples, 3Measurement and Biomedical  instrumentation Unit, 4Radiology Unit,   Università Campus Bio-Medico di  Roma, 5Department of Radiological  Sciences, institute of Radiology,   Catholic University of Rome,    A Gemelli University Hospital,    Rome, italy Correspondence: Emiliano Schena   Measurement and Biomedical  instrumentation Unit, Università Campus  Bio-Medico di Roma, via Álvaro del  Portillo 21, 00128 Rome, italy   Tel +39 06 22541 9650   Email e.schena@unicampus.i tAbstract:  X-ray computed tomography (CT) has recently been experiencing remarkable growth  as a result of technological advances and new clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/mder-8-265.PMC4467659.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/mder-8-265.PMC4467659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 191–196HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  191ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S7884 5Prevalence of anemia and nutritional status among  HIV-positive children receiving antiretroviral  therapy in Harar, eastern ethiopa Zelalem T eklemariam1 Habtamu Mitiku1 Firehiwot Mesfin2 1Department of Medical laboratory  Sciences, College of Health and  Medical Sciences, Haramaya  University, Harar, ethiopia;  2School  of nursing and Midwifery, College  of Health and Medical Sciences,  Haramaya University, Harar, ethiopia Correspondence: Zelalem Teklemariam   Department of Medical laboratory   Sciences, College of Health and Medical   Sciences, Haramaya University,   PO Box  331, Harar, ethiopia   email zelalemtmariam@yahoo.co mPurpose:  Anemia and growth retardation are common manifestations of HIV -positive children,  which threaten their lives.",Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
"Available from:  http://www.who.int/nutrition/topics/Paper%20Number%204%20-%20 Growth%20failure.pd f. Accessed June 25, 2010.",Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/66914/1/ WHO_NHD_01.3.pd f. Accessed May 7, 2015.",OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
"Available from: http://www.cdc.gov/mmwr/PDF/rr/rr4312.pd f. Accessed  May 23, 2012.",OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
Available from: http://www.who.int/childgrowth/standards/ Technical_report.pdf?ua= 1.,Non-OADS,/arxiv_data1/oa_pdf/03/40/hiv-7-191.PMC4467660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 147–162Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  147Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S5441 4Profile of neratinib and its potential in the  treatment of breast cancer Katharina Feldinger1 Anthony Kong2 1Department of Oncology, The  Weatherall Institute of Molecular  Medicine, University of Oxford,   Oxford, 2The Robert Aitkin Institute,   School of Cancer Sciences, University  of Birmingham, Birmingham, UK Correspondence: Anthony Kong   The Robert Aitkin Institute, School  of Cancer Sciences, University of  Birmingham, Birmingham B15 2TT, UK   Tel +44 121 414 9294   Fax +44 121 414 8046   email a.h.kong@bham.ac.u kAbstract:  The HER (ErbB) receptor tyrosine kinase receptors are implicated in many cancers  and several anti-HER treatments are now approved.",Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
Available from: https://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
"Available from: http://www.pumabiotechnol - ogy.com/pr20140407.htm l. Accessed March 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
"Available from: http://www.pumabiotechnol - ogy.com/pr2014072202.htm l. Accessed March 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
"Available from: http://investor.pumabiotechnol - ogy.com/press-release/puma-biotechnology-expands-cohort-phase- ii-trial-pb272-neratinib-her2-mutation-positi v. Accessed March 28,  2015.",Non-OADS,/arxiv_data1/oa_pdf/67/77/bctt-7-147.PMC4467661.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/4e/ceor-7-337.PMC4467662.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 337–345ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  337ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7697 2Medical costs associated with cardiovascular  events among high-risk patients with  hyperlipidemia Machaon M Bonafede1 Barbara h Johnson1 akshara Richhariya2 shravanthi R gandra2 1Outcomes Research, Truven health  analytics, Cambridge, M a, Usa;   2global health Economics, amgen,   Thousand Oaks, C a, Usa Correspondence: Machaon M Bonafede   Outcomes Research, Truven health  analytics, 77 Rowell Road, Brentwood,   nh 03833, Usa   Tel +1 603 580 5587   Fax +1 617 492 9365   Email machaon.bonafede@truvenhealth.",Non-OADS,/arxiv_data1/oa_pdf/da/4e/ceor-7-337.PMC4467662.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/da/4e/ceor-7-337.PMC4467662.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/4e/ceor-7-337.PMC4467662.pdf
Available from: http://www.bls.gov/news.release/archives/ cpi_01162014.pd f.  10.,Non-OADS,/arxiv_data1/oa_pdf/da/4e/ceor-7-337.PMC4467662.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/b5/ott-8-1407.PMC4467663.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1407–1418OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1407Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8208 7effect of radiotherapy on survival of women  with locally excised ductal carcinoma in situ of  the breast: a surveillance, epidemiology, and end  results population-based analysis guo-Wei Qian1,* Xiao-Jian ni1,* Zheng Wang2 Yi-Zhou Jiang1 Ke-Da Yu1 Zhi-Ming shao1 1Department of Breast surgery,   2Department of radiation Oncology,   shanghai cancer center and cancer  institute, Fudan University, shanghai,   People’s republic of china *These authors contributed equally  to this workBackground:  Although it has been previously reported that radiotherapy (RT) effectively  reduced the incidence of local recurrence of ductal carcinoma in situ (DCIS) following breast- conserving surgery (BCS), little is known about the effect of RT on survival of patients with  locally excised DCIS.",Non-OADS,/arxiv_data1/oa_pdf/ab/b5/ott-8-1407.PMC4467663.pdf
"Currently, BCS has become the most common surgery  for DCIS, constituting 74% of treated cases according to a query of the Surveillance,  Epidemiology, and End Results (SEER) database.2 In addition, radiotherapy (RT) has  become one of the main types of adjuvant therapy for DCIS.3correspondence: Zhi-Ming shao Department of Breast surgery, shanghai  cancer center and cancer institute,  Fudan University, 270 Dong-an road,  shanghai 200032, People’s republic  of china Tel +86 21 6417 5590 ext 82341 Fax +86 21 6443 4556 email zhiming_shao@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Qian et al Running head recto: Radiotherapy for locally excised DCIS DOI: http://dx.doi.org/10.2147/OTT.S82087",Non-OADS,/arxiv_data1/oa_pdf/ab/b5/ott-8-1407.PMC4467663.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/b5/ott-8-1407.PMC4467663.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/b5/ott-8-1407.PMC4467663.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/ca/amep-6-439.PMC4467664.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 439–445Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  439PErsPEctivEsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S7918 2Acquiring experience in pathology predominantly  from what you see, not from what you read:   the HiPON e-learning platform Olga riccioni1,2 charalambos vrasidas3 Luka Brcic4 Goce Armenski5 sven seiwerth4 Annemieke smeets6 J Han JM van Krieken6 Andreas c Lazaris1 11st Department of Pathology, school of  Medicine, the National and Kapodistrian  University of Athens, Athens, Greece;   2school of Medicine, La sapienza  University of rome, rome, italy;  3centre  for the Advancement of research and  Development in Educational technology  LtD, Nicosia, cyprus;  4institute of  Pathology, school of Medicine, University  of Zagreb, Zagreb, croatia;  5Faculty  of computer science and Engineering,  saints cyril and Methodius University,  skopje, FYrOM/ republic of Macedonia;   6Department of Pathology, radboud  University Nijmegen Medical center,  Nijmegen, the Netherlands correspondence: Olga riccioni   school of Medicine, La sapienza University of  rome, Piazzale Aldo Moro  5, 00185, rome,  italy  tel +39 33 1934 3242  Email olga.riccioni@outlook.co mAbstract:  It is indisputable that nowadays one of the hardest and most important tasks in  medicine  and especially in medical education, is the conversion of the extensive amount of available data,  into medical experience, after a proper analysis.",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/amep-6-439.PMC4467664.pdf
Or use: http://dvpr.es/1cupRd A,Non-OADS,/arxiv_data1/oa_pdf/2f/ca/amep-6-439.PMC4467664.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/amep-6-439.PMC4467664.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/ca/amep-6-439.PMC4467664.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/ed/opth-9-1029.PMC4467733.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1029–1031Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1029ShO rt repO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S8617 3prolonged increase in tear meniscus height  by 3% diquafosol ophthalmic solution in eyes  with contact lenses Yukiko Nagahara1 Shizuka Koh1 Kohji Nishida1 hitoshi Watanabe1,2 1Department of Ophthalmology,   Osaka University Graduate School  of Medicine, Suita, Osaka, 2Kansai  rosai hospital, Amagasaki, hyogo,   JapanPurpose:  This study aimed to evaluate the increase in tear meniscus height (TMH) induced  by 3% diquafosol ophthalmic solution in eyes with contact lens (CL).",Non-OADS,/arxiv_data1/oa_pdf/97/ed/opth-9-1029.PMC4467733.pdf
"These actions  have been reported to improve tear film stability and provide therapeutic relief for  dry eye symptoms in various types of dry eyes.4–9 Therefore, we speculate that eyes  with a remarkable reduction in TMH due to high-water-content CL wear might benefit Correspondence: hitoshi Watanabe Department of Ophthalmology, Osaka  University Graduate School of Medicine,  room e7, 2-2 Yamadaoka, Suita, Osaka  565-0871, Japan tel +81 6 6879 3456 Fax +81 6 6879 3458 email wat@kanrou.ne t Journal name: Clinical Ophthalmology Article Designation: Short Report Y ear: 2015 Volume: 9 Running head verso: Nagahara et al Running head recto: Effect of diquafosol ophthalmic solution in eyes with contact lenses DOI: http://dx.doi.org/10.2147/OPTH.S86173",Non-OADS,/arxiv_data1/oa_pdf/97/ed/opth-9-1029.PMC4467733.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/97/ed/opth-9-1029.PMC4467733.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/ed/opth-9-1029.PMC4467733.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijnrd-8-059.PMC4467734.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 59–64International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  59ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S6863 9changes in skeletal muscle microcirculation   after a hemodialysis session correlates   with adequacy of dialysis chrysoula Pipili1 eirini grapsa1 elli-sophia Tripodaki1 sophia Ioannidou2 christos Manetos1 Maria Parisi1 serafim Nanas1 1First critical care Department,   2laboratory of Biochemistry,   evangelismos general hospital,   National and Kapodistrian University  of athens, athens, greece correspondence: chrysoula Pipili   First critical care Department,  evangelismos general hospital, National  and Kapodistrian University of athens,  Ypsilantou 45-47, 10675, athens, greece   Fax +30 21 3204 3385   email chrysapi2001@gmail.co mBackground:  Monitoring of the microcirculation may add additional information in terms of  improving the adequacy of hemodialysis (HD) for patients.",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijnrd-8-059.PMC4467734.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijnrd-8-059.PMC4467734.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/60/ijnrd-8-059.PMC4467734.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/35/ppa-9-753.PMC4467735.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 753–758Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  753OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8172 4A technology-enabled adherence enhancement  system for people with bipolar disorder: results  from a feasibility and patient acceptance analysis Martha sajatovic1 Michael s Davis2 Kristin A cassidy3 Joseph nestor2 Johnny sams3 edna Fuentes-casiano3 1Department of Psychiatry and  neurological and Behavioral  Outcomes center, case Western  reserve University school of Medicine  and University hospitals case  Medical center, cleveland, Oh, UsA;   2Medica safe, new Y ork, n Y, UsA;   3Department of Psychiatry, case  Western reserve University school  of Medicine, University hospitals  case Medical center, cleveland,   Oh, UsAObjective:  As poor medication adherence is common in bipolar disorder (BD), technology- assisted approaches may help to monitor and enhance adherence.",Non-OADS,/arxiv_data1/oa_pdf/23/35/ppa-9-753.PMC4467735.pdf
"Keywords:  adherence, compliance, bipolar disorder, manic depressive disorder, mood  stabilizers Introduction Bipolar disorder (BD) is a chronic mental illness associated with reduced individual  quality of life, devastating effects on families and children, and enormous costs to  society.1–3 A cornerstone of treatment uniformly recommended by guidelines on ill - ness management for BD patients is mood-stabilizing medication such as lithium,  anticonvulsants, or atypical antipsychotic drugs.1,4–6 Y et, approximately one in two  individuals with BD are poorly adherent with prescribed medication treatments,7–10  resulting in a variety of negative consequences, including relapse, rehospitalization,  suicide, and significantly increased costs of care.3,11–17 Although evidence-based interventions to change health behavior exist, their high  costs and resource-intensive nature make them impractical for many BD patients.18–20 correspondence: Martha sajatovic Department of Psychiatry, University  hospitals case Medical center, 10524  euclid Avenue, seventh Floor, cleveland, Oh 44106, UsA Tel +1 21 6844 2808 Fax +1 44 0423 1863 email martha.sajatovic@uhhospitals.or g Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sajatovic et al Running head recto: Technology-enabled adherence in BD DOI: http://dx.doi.org/10.2147/PPA.S81724",Non-OADS,/arxiv_data1/oa_pdf/23/35/ppa-9-753.PMC4467735.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/23/35/ppa-9-753.PMC4467735.pdf
Available from:  http://documents.apec.umn.edu/DKarlanT&DSemSp08.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/23/35/ppa-9-753.PMC4467735.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/4e/ijwh-7-581.PMC4467736.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 581–585International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  581OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8455 9low-birth-weight babies among hospital deliveries  in nepal: a hospital-based study arun K Koirala1 Dharma n Bhatta2,3 1administrative Department,   Helping Hands community Hospital,   chabahil, Kathmandu, 2Department  of Public Health, n obel college,   Pokhara University, Kathmandu,   nepal; 3epidemiology Unit, Faculty of  Medicine, Prince of songkla University,   songkhla, ThailandBackground:  Birth weight is an important indicator of a population’s health and is associated  with numerous interrelated factors in the infant, mother, and physical environment.",Non-OADS,/arxiv_data1/oa_pdf/1d/4e/ijwh-7-581.PMC4467736.pdf
"Box 25791, Kathmandu, nepal Tel +977 98 4926 4178 email arunkoirala4@yahoo.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Koirala and Bhatta Running head recto: Low-birth-weight babies among hospital deliveries in Nepal DOI: http://dx.doi.org/10.2147/IJWH.S84559",Non-OADS,/arxiv_data1/oa_pdf/1d/4e/ijwh-7-581.PMC4467736.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1d/4e/ijwh-7-581.PMC4467736.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/4e/ijwh-7-581.PMC4467736.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/tcrm-11-915.PMC4467737.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 915–923Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  915Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6843 9Neurogenic orthostatic hypotension –  management update and role of droxidopa Joy vijayan1 vijay K Sharma1,2 1Department of Medicine, Division  of Neurology, National University  Health System, 2Yong Loo Lin School  of Medicine, National University  of Singapore, SingaporeAbstract:  Orthostatic hypotension (OH) is defined as a significant decrease in blood pres - sure (BP) during the first 3 minutes of standing or a head up on a tilt table.",Non-OADS,/arxiv_data1/oa_pdf/55/8e/tcrm-11-915.PMC4467737.pdf
"Correspondence: vijay K Sharma Department of Medicine, Division  of Neurology, National University Health  System, Level 10, Tower Block, 1e Kent  Ridge Road, Singapore 119228, Singapore Tel +65 6772 2516 Fax +65 6872 3566 email drvijay@singnet.com.s g Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Vijayan and Sharma Running head recto: Management of orthostatic hypotension DOI: http://dx.doi.org/10.2147/TCRM.S68439",Non-OADS,/arxiv_data1/oa_pdf/55/8e/tcrm-11-915.PMC4467737.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/55/8e/tcrm-11-915.PMC4467737.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/8e/tcrm-11-915.PMC4467737.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/88/ijn-10-3887.PMC4467738.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3887–3896International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3887OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7599 9T uning the surface microstructure of titanate  coatings on titanium implants for enhancing  bioactivity of implants hui Wang1,2 Yue-Kun lai1 ru-Yue Zheng1 Ye Bian1 Ke-Qin Zhang1 chang-Jian lin2 1National engineering laboratory  for Modern silk, college of Textile  and clothing engineering, soochow  University, suzhou, 2state Key  laboratory for Physical chemistry  of solid surfaces, Department of  chemistry, college of  chemistry  and chemical engineering, Xiamen  University, Xiamen, People’s  republic  of chinaAbstract:  Biological performance of artificial implant materials is closely related to their  surface characteristics, such as microtopography, and composition.",Non-OADS,/arxiv_data1/oa_pdf/6a/88/ijn-10-3887.PMC4467738.pdf
"Hopefully, the surface modification of titanium and its alloys can  optimize the biological performance of Ti-based biomaterials, and at the same time  retain their favorable mechanical properties.4–10 When implanted into a living body,  the surface physicochemical properties of the biomaterials determine the interactions  between them and the surrounding biological environment.10–12 Recent efforts in this  field have highlighted the importance of modifying the surface topography and com - position of materials to achieve good biological performance of implants.13–15 In the  past decade, design and fabrication of nanostructured titania and titanate layers on  titanium have attracted much attention because of the improved biological perfor - mance of titanium and its widespread application in bone implants.14–18 Generally, correspondence: hui Wang National engineering laboratory  for Modern silk, college of Textile  and clothing engineering, soochow  University, suzhou 215123,  People’s republic of china Tel +86 512 6706 1169 Fax +86 512 6706 1129 email whui@suda.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Tuning the surface microstructure of titanate coatings DOI: http://dx.doi.org/10.2147/IJN.S75999",Non-OADS,/arxiv_data1/oa_pdf/6a/88/ijn-10-3887.PMC4467738.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6a/88/ijn-10-3887.PMC4467738.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/88/ijn-10-3887.PMC4467738.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/9a/ijn-10-3897.PMC4467739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3897–3909International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3897OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8370 5chitosan–tripolyphosphate nanoparticles as  Arrabidaea chica  standardized extract carrier:  synthesis, characterization, biocompatibility,  and antiulcerogenic activity leila servat-Medina1,2 alvaro gonzález-gómez2,3 Felisa reyes-Ortega2 Ilza Maria Oliveira sousa1 Nubia de cássia almeida  Queiroz1 Patricia Maria Wiziack  Zago1 Michelle Pedrosa Jorge1 Karin Maia Monteiro1,4 João ernesto de carvalho1 Julio san román2,3 Mary ann Foglio1 1chemical, Biological and agricultural  Pluridisciplinary research center- state University of campinas  (cPQB a-UNIcaMP), campinas-sP ,   Brazil; 2Biomaterials group, Polymer  science and T echnology Institute- spanish National research council  (IcTP-csIc), 3cIBer-BBN, centro  de Investigación Biomédica en red,   Madrid, spain; 4Department of Medical  clinics, Faculty of Medical sciences,   University of campinas, campinas-sP ,   BrazilAbstract:  Natural products using plants have received considerable attention because of their  potential to treat various diseases.",Non-OADS,/arxiv_data1/oa_pdf/fe/9a/ijn-10-3897.PMC4467739.pdf
"B. Verlot (Bignoniaceae), popularly known  as Crajiru, is a native tropical American vine employed in folk medicine for wound  healing, inflammation, and gastrointestinal colic.2 Previous studies with A. chica   demonstrated in vitro and in vivo healing properties,3 also increasing collagen content correspondence: Mary ann Foglio chemical, Biological and  agricultural Pluridisciplinary  research center, state University  of campinas (cPQBa-UNIcaMP),  avenida alexandre cazelatto 999,  13148-218, campinas-sP, Brazil Tel +55 192 139 2861 Fax +55 192 139 2850 email foglioma@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Servat-Medina et al Running head recto: Chitosan-tripolyphosphate NPs DOI: http://dx.doi.org/10.2147/IJN.S83705",Non-OADS,/arxiv_data1/oa_pdf/fe/9a/ijn-10-3897.PMC4467739.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/9a/ijn-10-3897.PMC4467739.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/9a/ijn-10-3897.PMC4467739.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1345–1349OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1345Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7523 2adjuvant treatment in patients at high risk  of recurrence of thymoma: efficacy and safety  of a three-dimensional conformal radiation  therapy regimen Francesco Perri1 salvatore Pisconti1 Manuel conson2,3 roberto Pacelli2,3 giuseppina Della Vittoria  scarpati2 antonio gnoni1 carmine D’aniello1 carla cavaliere1 antonella licchetta1 laura cella2,3 Mario giuliano4,5 concetta schiavone7 sara Falivene7 giuseppe Di lorenzo4 carlo Buonerba6 Vincenzo ravo7 Paolo Muto7 1Medical Oncology Unit, PO c s  annunziata, Taranto, 2Department of  advanced Biomedical sciences, University  of naples Federico ii, naples, 3institute  of Biostructures and Bioimaging,  national council of research, naples,  4Department of clinical Medicine and  surgery, University of naples Federico  ii, naples, italy; 5lester and sue smith  Breast center, Baylor college of  Medicine, houston, TX, Usa; 6Division  of Oncology, centro di riferimento  Oncologico di Basilicata, irccs  rionero  in Vulture, Potenza, 7Department of  radiotherapy, istituto nazionale per la  cura dei T umori-Fondazione g. Pascale.",Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
"correspondence: Francesco Perri Medical Oncology Unit, POc s annunziata,  Taranto, italy Tel +39 099 458 5813 Fax +39 099 458 5813 email francesco.perri80@alice.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Perri et al Running head recto: Adjuvant treatment to prevent recurrence of thymoma DOI: http://dx.doi.org/10.2147/OTT.S75232",Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/be/79/ott-8-1345.PMC4467740.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/dc/jpr-8-277.PMC4467741.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 277–288Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  277ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8256 6Identification of a potential fibromyalgia   diagnosis using random forest modeling   applied to electronic medical records Birol emir1 Elizabeth T Masters1 Jack Mardekian1 andrew clair1 Max Kuhn2 stuart l silverman3 1Pfizer inc., new York, nY, 2Pfizer inc.,  groton, cT, 3Cedars-Sinai Medical  Center, Los Angeles, CA, USA correspondence: Birol emir   Pfizer Inc.,  235 east  42nd street,   new York, nY  10017-5755, USA   Tel +1 212 733 8581  Fax +1 212 351 1008  email birol.emir@pfizer.co mBackground:  Diagnosis of fibromyalgia (FM), a chronic musculoskeletal condition charac - terized by widespread pain and a constellation of symptoms, remains challenging and is often  delayed.",Non-OADS,/arxiv_data1/oa_pdf/ee/dc/jpr-8-277.PMC4467741.pdf
Available from: http://www.humedica.com/ solutions/research /.,OADS,/arxiv_data1/oa_pdf/ee/dc/jpr-8-277.PMC4467741.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/ee/dc/jpr-8-277.PMC4467741.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/dc/jpr-8-277.PMC4467741.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/4f/ppa-9-745.PMC4467742.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 745–751Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  745OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7511 0cognitive dysfunction and poor health literacy  are common in veterans presenting with  acute coronary syndrome: insights from the  MeDic ATiOn study lucas n Marzec1 evan P carey1 Anne c lambert-Kerzner1 eric J Del giacco2 stephanie D Melnyk3 chris l Bryson4 ibrahim e Fahdi2 hayden B Bosworth3 Fran Fiocchi5 P Michael ho1 1Division of cardiology, Denver VA  Medical center, Denver, cO, UsA;   2Department of Medicine, little  rock VA Medical center, little rock,   Ar, UsA; 3Department of Medicine,   Durham VA Medical center, Durham,   nc, UsA; 4Department of Medicine,   Puget sound VA Medical center,   seattle, WA, UsA; 5American college  of cardiology, Washington, Dc , UsABackground:  Patient nonadherence to cardiac medications following acute coronary syndrome  (ACS) is associated with increased risk of recurrent events.",Non-OADS,/arxiv_data1/oa_pdf/83/4f/ppa-9-745.PMC4467742.pdf
"Keyword:  medication adherence Introduction Mild cognitive dysfunction is present in 15% of those over the age of 70,1 affecting an  estimated 5.4 million people in the United States.2 Cognitive dysfunction may have  implications following acute coronary syndrome (ACS) as its presence may impact  patients’ ability to understand and adhere to secondary prevention medication regimens  that potentially consist of several new medicines with differing dosing schedules.3  Up to 12% of patients with ACS have cognitive dysfunction;4 however, the relationship correspondence: lucas n Marzec Academic Office 1, Room #7104, 12631  e 17th Avenue, campus Box B-130,  Aurora, cO 80045, UsA Tel +1 303 724 2105 Fax +1 303 724 2094 email lucas.marzec@ucdenver.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Marzec et al Running head recto: Cognitive dysfunction and poor health literacy in the MEDICATION study DOI: http://dx.doi.org/10.2147/PPA.S75110",Non-OADS,/arxiv_data1/oa_pdf/83/4f/ppa-9-745.PMC4467742.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/83/4f/ppa-9-745.PMC4467742.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 161–169Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  161ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S8064 2sleep problems in anxious and depressive   older adults Marie-France leblanc1 sophie Desjardins1 alain Desgagné2 1Department of Psychology,  Université du Québec à Trois- Rivières, Trois-Rivières, 2Department  of Mathematics, Université du  Québec à Montréal, Montréal, Q c,  canada correspondence: sophie Desjardins   Département de psychologie, Université  du Québec à Trois-Rivières, cP  500,  Trois-Rivières, Qc g9a 5h7, canada   Tel +1 819 376  5011  Fax +1 819 376  5195  email sophie.desjardins@uqtr.c aPurpose:  The objective of this study was to identify the sleep problems most often encountered  by the elderly according to the presence or absence of anxiety and mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
Available from: http://doxa.u-pec.fr/ theses/th0243099.pd f. French.,Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
Available from: http://www.stat.gouv.qc.ca/statistiques/ sante/etat-sante/mentale/troubles-mentaux-toxicomanie.pd f. French.,Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
Available from: http://www.douglas.,Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
"Available from: http://www.dsm5.or g. Accessed  January 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/17/74/prbm-8-161.PMC4467743.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/f6/prom-6-157.PMC4467744.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 157–165Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  157ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S8136 1Performance of the measures of processes   of care for adults and service providers   in rehabilitation settings elena l Bamm1 Peter Rosenbaum1,2 seanne Wilkins1 Paul stratford1 1school of Rehabilitation science,   2canchild centre for childhood  Disability Research, McMaster  University, hamilton, On , canada correspondence: elena Bamm   McMaster University, 1400 Main street  West – iahs  402, hamilton, On,   canada l8s  1c7  Tel +1 905 525 9140 ext  26410  Fax +1 905 524 0069  email ebamm@cogeco.c aIntroduction:  In recent years, client-centered care has been embraced as a new philosophy  of care by many organizations around the world.",Non-OADS,/arxiv_data1/oa_pdf/77/f6/prom-6-157.PMC4467744.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/77/f6/prom-6-157.PMC4467744.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/77/f6/prom-6-157.PMC4467744.pdf
"Available from: http://canchild.ca/en/childrenfamilies/ fcs_sheet.as p. Accessed February  10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/77/f6/prom-6-157.PMC4467744.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/0a/tcrm-11-905.PMC4467745.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 905–914Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  905Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5593 0Comprehensive overview: efficacy, tolerability,   and cost-effectiveness of clobazam in   Lennox–Gastaut syndrome Michele A Faulkner1,2 1Department of Pharmacy  Practice, Creighton University  School of Pharmacy, 2Department  of Neurology, Creighton University  School of Medicine, Omaha, NE, USAAbstract:  Clobazam is the newest medication approved by the US Food and Drug Administration  (FDA) for the treatment of Lennox–Gastaut syndrome (LGS) in patients at least 2 years of age,  although the medication has been available in countries around the world to treat epilepsy and  anxiety disorders for many years.",Non-OADS,/arxiv_data1/oa_pdf/d6/0a/tcrm-11-905.PMC4467745.pdf
"It is estimated that between 1% and 10% of childhood epilepsies are a  result of this syndrome.6 Previous data have suggested that only approximately 10% of  LGS patients have seizures that are fully controlled with medication therapy.7 Seizure  types vary from patient to patient, but the most commonly observed include tonic,  atypical absence, and atonic (drop seizures [DS]), the latter of which is responsible  for the elevated rate of injury noted in patients with this diagnosis.7 The mortality rate Correspondence: Michele A Faulkner Department of Pharmacy Practice,  Creighton University School of  Pharmacy, 2500 California Plaza,  Omaha, NE 69178, USA Tel +1 402 280 3145 Fax +1 402 280 3320 email faulkner@creighton.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Faulkner Running head recto: Clobazam use in Lennox–Gastaut syndrome DOI: http://dx.doi.org/10.2147/TCRM.S55930",Non-OADS,/arxiv_data1/oa_pdf/d6/0a/tcrm-11-905.PMC4467745.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d6/0a/tcrm-11-905.PMC4467745.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/0a/tcrm-11-905.PMC4467745.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/90/rru-7-085.PMC4467746.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 85–99Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  85Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S2964 4Neurogenic bladder in spinal cord injury patients waleed Al Taweel Raouf Seyam Department of Urology, King Faisal  Specialist Hospital and Research  Center, Riyadh, Saudi Arabia Correspondence: waleed Al Taweel   Department of Urology, King Faisal  Specialist Hospital and Research Centre,  PO Box  3354, Riyadh  11211, Saudi Arabia   Tel +966 11 442 4300   Fax +966 11 442 4301   email drwt1@hotmail.co mAbstract:  Neurogenic bladder dysfunction due to spinal cord injury poses a significant threat  to the well-being of patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/90/rru-7-085.PMC4467746.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/90/rru-7-085.PMC4467746.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/90/rru-7-085.PMC4467746.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/18/dddt-9-2941.PMC4467747.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2941–2946Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2941EDiT orialopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8639 6Inflammation, cytokines, the IL-17/IL-6/STAT3/ NF-κB axis, and tumorigenesis Xiao-Wu Chen1 Shu-Feng Zhou2 1Department of General Surgery,   The First People’s Hospital of  Shunde, Southern Medical University,   Shunde, Foshan, Guangdong, People’s  Republic of China; 2Department  of Pharmaceutical Sciences, College of  Pharmacy, University of South Florida,   Tampa, FL, USAIn the recently published paper by Xie et al1 in the journal of  Drug Design, Development  and Therapy , the authors have evaluated interleukin (IL)-17–driven inflammatory  responses in 17 cases of human colon adenocarcinomas, 16 cases of human normal  colon tissues adjacent to the resected colon adenocarcinomas, ten cases of human  ulcerative colitis tissues from biopsies, and eight cases of human benign colon pol - yps.",Non-OADS,/arxiv_data1/oa_pdf/fe/18/dddt-9-2941.PMC4467747.pdf
"Phosphorylation of STAT3, the downstream signal of IL-6 and IL-21, is a key  process in the differentiation of Th17 cells in the presence of transforming growth  factor (TGF)- β1.4 Correspondence: Xiao-Wu Chen Department of General Surgery,  The First People’s Hospital of Shunde,  Southern Medical University,   1 Penglai Road, Shunde, Foshan 528300,  Guangdong, People’s Republic of China Tel +86 757 2231 8555 Fax +86 757 2222 3899 Email drchenxiaowu@163.com   Shu-Feng Zhou Department of Pharmaceutical Sciences,  College of Pharmacy, University of   South Florida, 12901 Bruce B Downs  Boulevard, Tampa, FL 33612, USA Tel +1 813 974 6276 Fax +1 813 974 9885 Email szhou@health.usf.edu  Journal name: Drug Design, Development and Therapy Article Designation: Editorial Y ear: 2015 Volume: 9 Running head verso: Chen and Zhou Running head recto: Inflammation, cytokines, and tumorigenesis DOI: http://dx.doi.org/10.2147/DDDT.S86396",Non-OADS,/arxiv_data1/oa_pdf/fe/18/dddt-9-2941.PMC4467747.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fe/18/dddt-9-2941.PMC4467747.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/18/dddt-9-2941.PMC4467747.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/bf/ndt-11-1413.PMC4467748.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1413–1420Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1413Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6587 4Psychiatric symptoms in glioma patients:  from diagnosis to management Florien w Boele1 Alasdair G Rooney2 Robin Grant2 Martin Klein1 1Department of Medical Psychology,   vU University Medical Center,   Amsterdam, the Netherlands;   2Department of Clinical  Neurosciences, western General  Hospital, edinburgh, UKAbstract:  Patients with primary intrinsic brain tumors can experience neurological, cognitive,  and psychiatric symptoms that greatly affect daily life.",Non-OADS,/arxiv_data1/oa_pdf/b8/bf/ndt-11-1413.PMC4467748.pdf
"In this review, we will therefore focus on these neurobehavioral Correspondence:  Florien w Boele Department of Medical Psychology,  D-345, vU University Medical Center,  van der Boechorststraat 7, PO Box 7057,  1081 BT Amsterdam, the Netherlands Tel +31 20 444 6099 Fax +31 20 444 8230 email f.boele@vumc.n l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Boele et al Running head recto: Psychiatric symptoms of glioma patients DOI: http://dx.doi.org/10.2147/NDT.S65874",Non-OADS,/arxiv_data1/oa_pdf/b8/bf/ndt-11-1413.PMC4467748.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b8/bf/ndt-11-1413.PMC4467748.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/bf/ndt-11-1413.PMC4467748.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/ad/vhrm-11-311.PMC4467749.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 311–316Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  311ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S8283 9Blood pressure control to prevent   decline in cognition after stroke Hege ihle-Hansen1 Bente Thommessen2 Morten W Fagerland3 anne R Øksengård4 T orgeir B Wyller5 Knut engedal6 Brynjar Fure7 1Department of internal Medicine,  Vestre Viken Hospital Trust,  Bærum Hospital, Bærum, norway;   2Department of neurology,  akershus University Hospital,  lørenskog, norway;  3Oslo centre  for Biostatistics and epidemiology,  Research support services, Oslo  University Hospital, norway ;  4Department of internal medicine,  Vestre Viken Hospital Trust,  Bærum Hospital, Bærum, norway;   5Department of geriatric Medicine,  Oslo University Hospital, Oslo,  norway;  6norwegian centre for  Dementia Research, Oslo University  Hospital, Oslo, norway;  7norwegian  Knowledge centre for the Health  services, Oslo, norway correspondence: Hege ihle-Hansen   Department of internal Medicine,   Vestre Viken Hospital Trust, Bærum   Hospital,  3004 Drammen, norway   Tel +47 4144 3866  email hege.ihle-hansen@vestreviken.n oBackground:  Treatment of hypertension post-stroke preserves cognition through prevention  of recurrent stroke, but it is not clear whether it prevents cognitive decline through other   mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/88/ad/vhrm-11-311.PMC4467749.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/88/ad/vhrm-11-311.PMC4467749.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/ad/vhrm-11-311.PMC4467749.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/3c/ott-8-1419.PMC4467750.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1419–1426OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1419Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8371 0Daily rhythm variations of the clock gene PER1  and cancer-related genes during various stages  of carcinogenesis in a golden hamster model  of buccal mucosa carcinoma hua Ye Kai Yang Xue-Mei Tan Xiao-Juan Fu han-Xue li Department of Oral and Maxillofacial  surgery, The First affiliated hospital  of chongqing Medical University,   chongqing, People’s republic of chinaBackground:  Recent studies have demonstrated that the clock gene PER1  regulates various  tumor-related genes.",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/ott-8-1419.PMC4467750.pdf
"Keywords:  circadian rhythm, clock gene, PER1 , tumor, carcinogenesis Introduction “Circadian” is a Latin word that means “about a day”.1 Living organisms on earth  have evolved with an endogenous timing system, specifically the circadian clock.1–3  Current research has demonstrated that numerous vital physiological processes  that occur in mammals  in vivo, such as sleeping and waking, hormone secretion,  and immune activity, exhibit a circadian fluctuation of approximately 24 hours.1,4–7 correspondence: Kai Yang Department of Oral and Maxillofacial  Surgery, The First Affiliated Hospital  of chongqing Medical University, no 1,  Youyi road, Yuzhong District, chongqing  400016, People’s republic of china Tel +86 23 8901 2569 Fax +86 23 8901 2569 email cqfyyk@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Y e et al Running head recto: Daily rhythm of PER1 , VEGF , KI67 , C-MYC , and P53 in canceration DOI: http://dx.doi.org/10.2147/OTT.S83710",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/ott-8-1419.PMC4467750.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/3c/ott-8-1419.PMC4467750.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/3c/ott-8-1419.PMC4467750.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/86/jmdh-8-287.PMC4467751.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 287–290Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  287SHort reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S7771 4Application of integrative information system  improves the quality and effectiveness   of cancer case management pei-Yi Lee1,2 tsue-rung Chang1 1Department of Nursing, MacKay  Memorial Hospital, taipei, taiwan;   2Department of Nursing, MacKay  Medical College, taipei, taiwan Correspondence: pei-Yi Lee   Department of Nursing, MacKay  Memorial Hospital,  45, Minsheng road,  tamsui District, New taipei City, taiwan   email cheryl3507@gmail.co mAbstract:  Cancer case management provides consecutive care during the entire process through  diagnosis to treatment and follow-up.",Non-OADS,/arxiv_data1/oa_pdf/03/86/jmdh-8-287.PMC4467751.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/03/86/jmdh-8-287.PMC4467751.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/2e/opth-9-985.PMC4467752.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 985–994Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  985Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5982 8Risk definition and management strategies   in retinoblastoma: current perspectives Fariba Ghassemi Alireza Khodabande eye Research Center, Farabi eye  Hospital, Tehran University of Medical  Sciences, T ehran, T ehran Province,   islamic Republic of iranAbstract:  This manuscript focuses on high-risk factors of metastatic disease in retinoblastoma  and evaluation of the current treatments of retinoblastoma.",Non-OADS,/arxiv_data1/oa_pdf/47/2e/opth-9-985.PMC4467752.pdf
"These workups enable the pos - sibility of preimplantation genetic diagnosis, an option that is likely to be considered  by affected individuals.9 Invasive retinoblastoma with higher recurrence rate, termed “high-risk” factors,  ranges from 0% to 81% of all retinoblastoma tumors in the literature.10–15 There have  been numerous retrospective studies attempting to identify which patients are at highest  risk for metastatic disease after enucleation.16–21 Considering the high-risk factors, the  benefit of adjuvant therapy in preventing relapses after enucleation is addressed in the  literature, although there are no prospective, randomized studies.Correspondence: Fariba Ghassemi eye Research Center, Farabi eye  Hospital, Qazvin Square, Tehran  1336616351, Tehran Province, islamic  Republic of iran Tel +98 21 5542 1006/ +98 21 5540 0014 Fax +98 21 5541 6134 email ghasemi_f@sina.tums.ac.i r Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Ghassemi and Khodabande Running head recto: Retinoblastoma: risk definition and management strategies DOI: http://dx.doi.org/10.2147/OPTH.S59828",Non-OADS,/arxiv_data1/oa_pdf/47/2e/opth-9-985.PMC4467752.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/47/2e/opth-9-985.PMC4467752.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/2e/opth-9-985.PMC4467752.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/1f/dmso-8-255.PMC4467753.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 255–262Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  255Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5065 9Assessing the obese diabetic patient for bariatric  surgery: which candidate do i choose?",Non-OADS,/arxiv_data1/oa_pdf/35/1f/dmso-8-255.PMC4467753.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/35/1f/dmso-8-255.PMC4467753.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/1f/dmso-8-255.PMC4467753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/2d/dddt-9-2887.PMC4467754.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2887–2910Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2887Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8272 4small-molecule Bh3 mimetic and pan-Bcl-2  inhibitor AT -101 enhances the antitumor efficacy  of cisplatin through inhibition of aPe1 repair  and redox activity in non-small-cell lung cancer correspondence: Dong Wang 10 changjiang Zhi road, Yuzhong District,  cancer center, Daping hospital and  research institute of surgery, Third Military  Medical University, chongqing 400042,  People’s republic of china Tel +86 23 6875 7151 Fax +86 23 6889 4062 email dongwang64@hotmail.co m  shu-Feng Zhou 12901 Bruce B Downs Boulevard, Department  of Pharmaceutical sciences, college of  Pharmacy, University of south Florida,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Tao ren,1–3,* Jinlu shan,1,*  Mengxia li,1 Yi Qing,1  chengyuan Qian,4 guangjie  Wang,5 Qing li,1,3 guoshou  lu,1 chongyi li,1 Yu Peng,1  hao luo,1 shiheng Zhang,1  Yuxing Yang,1 Yi cheng,1  Dong Wang,1 shu-Feng  Zhou3 1cancer center, Daping hospital and  research institute of surgery, Third Military  Medical University, chongqing, 2Department  of Oncology, The affiliated hospital,   north sichuan Medical college, sichuan,   People’s republic of china; 3Department  of Pharmaceutical sciences, college of  Pharmacy, University of south Florida,   Tampa, Fl, Usa; 4Department of Oncology,   The 97 hospital of P la, Jiangsu, 5cancer  Diagnosis and Treatment center, Military  District general hospital of chengdu  Military region, sichuan, People’s republic  of china *These authors contributed equally to this  workAbstract:  AT-101 is a BH3 mimetic and pan-Bcl-2 inhibitor that has shown potent anticancer  activity in non-small-cell lung cancer (NSCLC) in murine models, but failed to show clinical  efficacy when used in combination with docetaxel in NSCLC patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/2d/dddt-9-2887.PMC4467754.pdf
"In 2010,  about  605,946 patients were diagnosed with lung cancer, including  416,333 men   and 189,613 women, with a crude incidence rate of 46.08 per 100,000 accounting Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ren et al Running head recto: AT-101 and cisplatin promote apoptosis and antiangiogenesis by inhibiting APE1 DOI: http://dx.doi.org/10.2147/DDDT.S82724",Non-OADS,/arxiv_data1/oa_pdf/cb/2d/dddt-9-2887.PMC4467754.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cb/2d/dddt-9-2887.PMC4467754.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/2d/dddt-9-2887.PMC4467754.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/b1/opth-9-1033.PMC4467755.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1033–1040Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1033Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8256 2sterile endophthalmitis rates and particle size  analyses of different formulations of triamcinolone  acetonide David g Dodwell1 Darrel a Krimmel1 Christopher M de Fiebre2 1illinois retina Center, springfield, il,   Usa; 2CMdeF Consulting, Upper saint  Clair, P a, UsaPurpose:  To evaluate the rate of sterile endophthalmitis (SE) following intravitreal injection  of three different formulations of triamcinolone acetonide (TA) in a single physician practice  and also to assess the mean diameter and concentration of particles of the two TA formulations  currently available commercially in the USA.",Non-OADS,/arxiv_data1/oa_pdf/04/b1/opth-9-1033.PMC4467755.pdf
"It typically develops within 1 day following Correspondence: David g Dodwell illinois retina Center, 1230 Centre West  Drive, Springfield, IL 62704, USA Tel +1 217 321 2020 Fax +1 217 321 2026 email ddodwell@illinoisretinacenter.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Dodwell et al Running head recto: Sterile endophthalmitis rates and particle size analyses of TA DOI: http://dx.doi.org/10.2147/OPTH.S82562",Non-OADS,/arxiv_data1/oa_pdf/04/b1/opth-9-1033.PMC4467755.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/04/b1/opth-9-1033.PMC4467755.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/b1/opth-9-1033.PMC4467755.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/a9/opth-9-995.PMC4467756.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 995–1000Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  995Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8279 6Ocular neovascularization in eyes with a central  retinal artery occlusion or a branch retinal  artery occlusion John O Mason iii1,2 shyam a Patel1 richard M Feist1,2 Michael a albert Jr1,2 Carrie huisingh1 gerald Mcgwin Jr1,3 Martin l Thomley1,2 1Department of Ophthalmology,   University of alabama school of  Medicine, Birmingham, al, Usa;   2retina Consultants of alabama,   Callahan eye Foundation hospital,   Birmingham, al, Usa; 3Department of  epidemiology, school of Public health,   University of alabama at Birmingham,   Birmingham, al, UsaPurpose:  To investigate the ocular neovascularization (ONV) rate in eyes with a branch retinal  artery occlusion (BRAO) or a central retinal artery occlusion (CRAO), and to study factors that  may influence the ONV rate secondary to CRAO.",Non-OADS,/arxiv_data1/oa_pdf/d4/a9/opth-9-995.PMC4467756.pdf
"The occurrence rate of ONV in eyes with a CRAO varies from 3.0% to 18.8% in studies  conducted during the past 35 years.2,4–10 Furthermore, the detection of ONV following  CRAO has ranged from as early as the day of presentation to 2 years after the CRAO  diagnosis.4,8 With frequent visits, many cases of ONV can be managed early with Correspondence: John O Mason iii retina Consultants of alabama, Callahan  eye Foundation hospital, 700 south  18th street, suite 707, Birmingham,  al 35233, Usa Tel +1 205 918 0047 email masonallmason@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Mason III et al Running head recto: Neovascularization after a CRAO or a BRAO DOI: http://dx.doi.org/10.2147/OPTH.S82796",Non-OADS,/arxiv_data1/oa_pdf/d4/a9/opth-9-995.PMC4467756.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d4/a9/opth-9-995.PMC4467756.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/a9/opth-9-995.PMC4467756.pdf
The database is periodically updated (last update 18 March 2014) and is available at  http://bfw.ac.at/200/2043.html .,OADS,/arxiv_data1/oa_pdf/02/a9/apps.1400085.PMC4467757.pdf
Technical publication downloaded from  http://www.idtdna.com/pages/support/technical-vault/reading-room/technical-reports  [accessed 3 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/02/a9/apps.1400085.PMC4467757.pdf
Available  at  http://evolve.zoo.ox.ac.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/02/a9/apps.1400085.PMC4467757.pdf
"The barcode/sample  keyﬁ le and all pipeline XML conﬁ  guration ﬁ  les are archived at the Dryad  Digital Repository (http://dx.doi.org/10.5061/dryad.16pj5;  Beck and Semple, 2015 ).",OADS,/arxiv_data1/oa_pdf/16/a6/apps.1500014.PMC4467758.pdf
"Original read data (FASTQ)  have been deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) under BioProject ID PRJNA284163, and ﬁ  l- tered subsection-speciﬁ  c HapMap matrices are archived at the  Dryad Digital Repository (http://dx.doi.org/10.5061/dryad.16pj5;  Beck and Semple, 2015 ).",OADS,/arxiv_data1/oa_pdf/16/a6/apps.1500014.PMC4467758.pdf
Website  http://www.iucnredlist.org/  [accessed 25 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/0c/5e/apps.1500020.PMC4467760.pdf
Website  https://www.env.go.jp/press/15619.html  [accessed 26 March 2015] (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/0c/5e/apps.1500020.PMC4467760.pdf
Phobos Version 3.3.11.  http://www.ruhr-uni-bochum .de/spezzoo/cm/cm_phobos.htm  [accessed 21 May 2015  ].,Non-OADS,/arxiv_data1/oa_pdf/77/e0/apps.1500027.PMC4467761.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/b8/main.PMC4467834.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44461 .2.,OADS,/arxiv_data1/oa_pdf/37/b8/main.PMC4467834.pdf
http://dx.doi.org/10.1016/j.gdata.2015.05.007 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/b8/main.PMC4467834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/b8/main.PMC4467834.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/37/b8/main.PMC4467834.pdf
(Cell Mol Gastro- enterol Hepatol 2015;1:267 –274; http://dx.doi.org/ 10.1016/j.jcmgh.2015.04.001 ) Keywords: Cholestasis; Adaptive Immunity; Neonatal Autoimmunity.,Non-OADS,/arxiv_data1/oa_pdf/02/33/main.PMC4467898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/33/main.PMC4467898.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.04.001,OADS,/arxiv_data1/oa_pdf/02/33/main.PMC4467898.pdf
(Cell Mol Gastroenterol Hepatol 2015;1:275 –284; http://dx.doi.org/10.1016/j.jcmgh.2015.04.003 ) Keywords: Dysbiosis; Leaky Gut; Alcoholic Liver Disease; NASH; NAFLD; Cirrhosis; Microbiome; PAMPs.,Non-OADS,/arxiv_data1/oa_pdf/3c/da/main.PMC4467911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/da/main.PMC4467911.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.04.003,OADS,/arxiv_data1/oa_pdf/3c/da/main.PMC4467911.pdf
Lichman M. UCI Machine Learning Repository [http://archive.ics.,OADS,/arxiv_data1/oa_pdf/a4/7d/JRMS-20-214.PMC4468223.pdf
Available  from:  http://www.gests.org/ 56.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/JRMS-20-214.PMC4468223.pdf
Available from:  http://www.mathworks.com/matlabcentral/fileexchange/29043- neuro-fuzzy-classifier.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/JRMS-20-214.PMC4468223.pdf
Available  from: http://www.who.int/tb/publications/global_report/2011/ gtbr11_full.pdf.,OADS,/arxiv_data1/oa_pdf/34/88/JRMS-20-224.PMC4468224.pdf
TAF Prev Med Bull 2013;12:615-8.  http://www.scopemed.org/?mno=25026 or doi:10.5455/pmb.1- 1345995269 [Last cited on 2014 Apr 16].,OADS,/arxiv_data1/oa_pdf/34/88/JRMS-20-224.PMC4468224.pdf
Available from: http://www.usrds.org.,Non-OADS,/arxiv_data1/oa_pdf/3a/bd/JRMS-20-244.PMC4468228.pdf
Available from: http://www.msn.org.my/nrr.,Non-OADS,/arxiv_data1/oa_pdf/3a/bd/JRMS-20-244.PMC4468228.pdf
http://esa.un.org/unpd/wpp/unpp/ panel_population.htm [Last accessed on 2011 May 10].,Non-OADS,/arxiv_data1/oa_pdf/96/e7/JRMS-20-250.PMC4468229.pdf
Available on http://www.un.org/en/development/ desa/population/publications/pdf/policy/WPP2003/Publication_ highlights.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/e7/JRMS-20-250.PMC4468229.pdf
Available from: http://www.tumj.ir/pdf/globalresearchreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from:  http://www.healthmetricsandevaluation.org/gbd/publications/ policy-report/global-burden-disease-middle-east-north-africa.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.idf.org/diabetesatlas/5e.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.thomsonreuters.com/ products_services/science/science_products/a-z/web_of_science/.,OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.scopus.com.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/.,OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from:  http://www.worldatlas.com/webimage/countrys/asia/lgcolor/ middleeastmap.htm.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.hbi.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.vosviewer.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
http://www.scimagojr.com/ compare.php?c1=IR&c2=TR&c3=IL&c4=&area=2700&category=2 712&in=it.,OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available  from: http://www.data.worldbank.org/indicator.,OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
Available from: http://www.viz.,Non-OADS,/arxiv_data1/oa_pdf/17/ef/JRMS-20-253.PMC4468230.pdf
"p.Ser1613Gly, p.Ser1040Asn, p.Pro871Leu, and  p.Glu1038Gly) were predicted to have an impact on protein  structure (Align‑GVGD, http: www.//agvgd.iarc.fr/) and  SIFT (http://www.sift.bii.a‑star.edu.sg/).",OADS,/arxiv_data1/oa_pdf/e5/e1/JRMS-20-284.PMC4468235.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs103/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/dc/JRMS-20-318.PMC4468240.pdf
Available from: http://www.who.int/csr/disease/ Ebola/Ebola-6-months/west-africa/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/dc/JRMS-20-318.PMC4468240.pdf
Available from: http://www.who.int/csr/disease/Ebola/ Ebola-6-months/sierra-leone/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/dc/JRMS-20-318.PMC4468240.pdf
Available from: http://www.who.int/ features/2014/liberia-Ebola-survivors/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/dc/JRMS-20-318.PMC4468240.pdf
Available from:  http://www.who.int/features/2014/ebola-community-care/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/dc/JRMS-20-318.PMC4468240.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/main.PMC4468352.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.04.0022213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/main.PMC4468352.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/8f/main.PMC4468352.pdf
"This is an open access a r t i c l eu n d e rt h eC CB Y - N C - N Dl i c e n s e (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: α-Synuclein Lewy bodyParkinson's diseasePig Synphilin-1Meta Gene 5 (2015) 32 –42 Abbreviations: ORF, open reading frame; LB, Lewy body; SNCAIP, α-synuclein interacting protein ☆The sequence of the porcine SNCAIP cDNA, encoding the synphilin-1 protein and the three splice variants of synphilin-1, synphilin-1tv1, synphilin-1tv2, and synphilin-1tv3 have been submitted to GenBank under the accession numbers, GenBank ID: NM_001105053, GenBank ID: NM_001105054, GenBank ID: EF154192, and GenBank ID: NM_001098601, respectively.",Non-OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
"Madsen), Leila.Farajzadeh@mbg.au.dk (L. Farajzadeh), Christian.Bendixen@mbg.au.dk (C. Bendixen) http://dx.doi.org/10.1016/j.mgene.2015.04.005 2214-5400/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
Characterization of porcine SNCAIP genomic sequence To determine the intron –exon structure of the porcine SNCAIP gene we performed a blast search in the Pig Genome v.10 sequence database (http://www.animalgenome.org/blast/blast.php?bdb=pig10 ) using the por- cine SNCAIP cDNA sequence (GenBank ID: EF1654190).,OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
The nucleo- tide sequence of the genomic DNA 369 bp upstream from the transcription start site (TSS) of the porcine SNCAIP gene was analyzed for transcription factor binding sites using the computer-based MatInspector and TFSEARCH program ( http://molsun1.cbrc.aist.go.jp/htbin/nph-tfsearch ) and using the transfac database.,OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
Identi ﬁcation of a potential miRNA recognition site in the 3 ′UTR of SNCAIP Using the Target Scan ( http://www.targetscan.org ) a recognition site sequence for miR24/24ab/24-3p was identi ﬁed in the 3 ′UTR of the human SNCAIP gene.,OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.mgene.2015.04.005 .,OADS,/arxiv_data1/oa_pdf/c6/f9/main.PMC4468357.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/bc/main.PMC4468365.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2015.04.001,OADS,/arxiv_data1/oa_pdf/8c/bc/main.PMC4468365.pdf
©2015TheAuthors.PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/63/main.PMC4468367.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.04.007 2213-2244/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/63/main.PMC4468367.pdf
This is an open access article under the CC B Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).International Journal for Parasitology: Parasites and Wildlife 4 (2015) 256–263 Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw,Non-OADS,/arxiv_data1/oa_pdf/93/63/main.PMC4468367.pdf
©2015TheAuthors.PublishedbyElsevierLtdonbehalfofAustralianSocietyforParasitology.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/7a/main.PMC4468368.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.04.003 2213-2244/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/28/7a/main.PMC4468368.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/b9/main.PMC4468369.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2015.04.002,Non-OADS,/arxiv_data1/oa_pdf/16/b9/main.PMC4468369.pdf
Supplementary Materials Supplementary data to this article can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/b9/main.PMC4468369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/83/main.PMC4468370.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.04.006,OADS,/arxiv_data1/oa_pdf/2d/83/main.PMC4468370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/32/main.PMC4468371.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.04.003,OADS,/arxiv_data1/oa_pdf/3d/32/main.PMC4468371.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/dc/main.PMC4468372.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.04.005,OADS,/arxiv_data1/oa_pdf/d7/dc/main.PMC4468372.pdf
Experimental Procedure miRNA Target Predictions STAT1 sequences were obtained from the National Center for Biotechnology Information Nucleotide database ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/d7/dc/main.PMC4468372.pdf
Sequences of mature human miRNAs were obtained from the miRNA Registry at miRBase ( http://www.mirbase.org ).,OADS,/arxiv_data1/oa_pdf/d7/dc/main.PMC4468372.pdf
"STAT1 (Cell Signaling Technology, Danvers, MA) and Bcl2, p21, p27, or actin (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies.Western blot quantification was performed by using the Java-basedimage processing program ImageJ ( http://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/d7/dc/main.PMC4468372.pdf
Available from: http://www.cpresearch.org.au/pdfs/2013_ACPR- Report_Web.pdf.,OADS,/arxiv_data1/oa_pdf/df/75/JRMS-20-321.PMC4468444.pdf
Available  from: http://www.ipcc.ch/publications_and_ data/ar4/wg2/en/ contents.html [Last accessed on 2014 Jun15].,OADS,/arxiv_data1/oa_pdf/84/92/JRMS-20-397.PMC4468458.pdf
Available from: http://www.candyfavorites.com/shop/education.,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.madehow.com/Volume-1/Chewing- Gum.html [Last accessed on 2013 July 15].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.gumassociation.org.,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.chewinggumfacts.com/chewing-gum- benefits/chewing-gum-negative-effects/ [Last accessed on 2013 July  15].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.dupont.com/products-and-services/ plastics-polymers-resins/elastomers/articles [Last accessed on 2013  Aug 24].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from : http://www.alsiano.com/Food/container/ container/Food/Confectionery/Chewing-gum.aspx [Last accessed  on 2013 Aug 24].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://fertin.com/expertise/gum/ [Last accessed  on 2013 Aug 25].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://mathworld.wolfram.com/LatinSquare.html  [Last accessed on 2013 Sept 1].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: https://www.nde-ed.org/EducationResources/ CommunityCollege/Materials/Mechanical/Tensile.htm [Last  accessed on 2013 Sept 12].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.wrigley.com/global/about-us/how- gum-made.aspx [Last accessed on 2013 Sept 22].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from: http://www.business-review-webinars.com/ webinar/Pharma/Medicated_chewing_gum_formulation_and_ production-pQ1rK3ZM [Last accessed on 2013 Oct 10].,Non-OADS,/arxiv_data1/oa_pdf/ea/33/JRMS-20-403.PMC4468459.pdf
Available from:  http://ceqg-rcqe.ccme.ca/en/index.html.,OADS,/arxiv_data1/oa_pdf/8b/f0/JRMS-20-420.PMC4468462.pdf
"Available from: http://www.nursingworld.org/ ojin/ [8] Barclay L. Nurses should play grater role in health policy planning, management.",Non-OADS,/arxiv_data1/oa_pdf/45/2a/TONURSJ-9-15.PMC4468584.pdf
Available from: http://www.worldbank.org/en/country/iran/overview [14] Iran Demographics Profile.,Non-OADS,/arxiv_data1/oa_pdf/45/2a/TONURSJ-9-15.PMC4468584.pdf
Available from: http://www.indexmundi.com/iran/demographi cs_profile.html [15] National view to health.,Non-OADS,/arxiv_data1/oa_pdf/45/2a/TONURSJ-9-15.PMC4468584.pdf
"Available from: http://salamatnews.blogsk y.com/1390/09/27/post-6/ [16] Zarea K, Negarandeh R, Dehghan-Nayery N, Rezaei- Adaryani M. Nurs and Health Sciences 2012: 19(4) 464-478.",Non-OADS,/arxiv_data1/oa_pdf/45/2a/TONURSJ-9-15.PMC4468584.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/2a/TONURSJ-9-15.PMC4468584.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/e4/TOOPHTJ-9-113.PMC4468585.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/97/TORMJ-9-67.PMC4468588.pdf
"2015;3(2):88-93.             http://abjs.mums.ac.ir the online version of this article  abjs.mums.ac.ir Valentin Neuhaus, MD; Dimitrios C. Christoforou, MD; Amir Reza Kachooei, MD; Jesse B. Jupiter, MD; David C. Ring, MD, PhD; Chaitanya S. Mudgal, MD Research performed at Massachusetts General Hospital, Harvard Medical School, Boston, USA IntroductionRadial head arthroplasty is commonly performed when managing unreconstructible comminuted radial head fractures or less often in the treatment  of chronic post-traumatic complications.",Non-OADS,/arxiv_data1/oa_pdf/0a/9f/ABJS-3-88.PMC4468614.pdf
"2015;3(2):141-143.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Hamid Farhangi, MD; Mahdi Farzadnia, MD; Ali Alamdaran, MD Research performed at Dr. Sheikh Pediatric Hospital, Mashhad University of Medical Siences, Mashhad, Iran IntroductionOsteosarcoma (OS) is one the most frequent  malignant tumors that is derived from mesenchymal cells with bone formation capacity (1).",Non-OADS,/arxiv_data1/oa_pdf/94/bb/ABJS-3-141.PMC4468615.pdf
"2015;3(2):137-140.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Sohrab Keyhani, MD; Arash Sharafat Vaziri, MD; Hossein shafiei, MD; Mohsen Mardani-Kivi, MD Research performed at Akhtar Hospital, Tehran, Iran IntroductionAnterior cruciate ligament (ACL) reconstruction is  the sixth most commonly performed orthopedic procedure with more than 100,000 surgeries  performed annually in the United States (1-5).",Non-OADS,/arxiv_data1/oa_pdf/b5/75/ABJS-3-137.PMC4468616.pdf
"2015;3(2):71.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Ali Moradi MD Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Technology has affected all aspects of our lives, but  it seems that it does not penetrate to clinical research  centers as much as other fields.",Non-OADS,/arxiv_data1/oa_pdf/16/9c/ABJS-3-71.PMC4468617.pdf
"2015;3(2):72-81.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Alisina Shahi, MD; Javad Parvizi MD, FRCS Research performed at the Rothman Institute of Orthopaedics at Thomas Jefferson University, Philadelphia, PA IntroductionTotal joint arthroplasty (TJA) is the ultimate  treatment for degenerative joint disease.",Non-OADS,/arxiv_data1/oa_pdf/d0/a1/ABJS-3-72.PMC4468618.pdf
Available from: http://www.aaos.org/research/guidelines/PUDP/PUDP_guideline.pdf 97.,Non-OADS,/arxiv_data1/oa_pdf/d0/a1/ABJS-3-72.PMC4468618.pdf
"2015;3(2):99-103.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Amir M Navali, MD; Mohammad Asghari Jafarabadi, PhD Research performed at Department of Orthopedic Surgery, Shahid Gazi Hospital, Tabriz University of Medical Sciences, Tabriz, Iran IntroductionBone-patellar tendon-bone (BTB or BPTB) graft is  considered the “gold standard” for anterior cruciate ligament (ACL) reconstruction by many surgeons  and has been used for years with a longstanding track record of good-to-excellent clinical outcomes (1).",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/ABJS-3-99.PMC4468619.pdf
"2015;3(2):130-133.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Prakash Jayakumar, MRCS; David Ring, MD Research performed at Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard, USA IntroductionDistal humerus fractures (DHFs) are relatively  uncommon injuries that are usually treated operatively (1,2).",Non-OADS,/arxiv_data1/oa_pdf/db/80/ABJS-3-130.PMC4468620.pdf
"2015;3(2):114-118.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Masoud ShayestehAzar, MD; Mohammad H Kariminasab, MD; Majid Sajjadi Saravi, MD; Mahmoud Abedini, MD; Mehran Fazli, MD; Seyyed Abbas Hashemi, MD; Pedram Abdizadeh, MD Research performed at Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran IntroductionMultiple sclerosis (MS) is a chronic immune- mediated disease of the central nervous system that causes long-term physical disability (1).",Non-OADS,/arxiv_data1/oa_pdf/3a/0a/ABJS-3-114.PMC4468621.pdf
"2015;3(2):82-87.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Shayan Abdollah Zadegan, MD; Masoumeh Firouzi, PhD; Mohammad Hossein Nabian, MD;  Leila Oriady Zanjani, MD; Ahmad Mohebbi Ashtiani, MD; Reza Shahryar Kamrani, MD Research performed at Research Center for Neural Repair (RCNR), University of Tehran, Tehran, Iran and Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran IntroductionPeripheral nerve injury (PNI) in the upper limb  is a significant cause of disability.",Non-OADS,/arxiv_data1/oa_pdf/b6/37/ABJS-3-82.PMC4468622.pdf
"2015;3(2):119-123.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Anil Gupta, MS; Rashid Anjum, MS; Navdeep Singh, MS; Shafiq Hackla, MS Research performed at Government Medical College Jammu, Jammu, India IntroductionFracture of the distal tibia accounts for 7 to 9% of  lower extremity fractures, with the fibula fractured in about 85% of these cases (1-4).",Non-OADS,/arxiv_data1/oa_pdf/f0/13/ABJS-3-119.PMC4468623.pdf
"2015;3(2):124-129.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Arvind von Keudell, MD; Marjan Alimi, MD; Harry Gebhard, MD; Roger Härtl, MD Research performed at Cornell University, New York, USA IntroductionAdult degenerative scoliosis is prevalent in 68% of  the asymptomatic population, who are over 60 (1).",Non-OADS,/arxiv_data1/oa_pdf/ca/5b/ABJS-3-124.PMC4468624.pdf
"2015;3(2):109-113.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Hasan Ghandehari, MD; Maryam Ameri Mahabadi, MD; Seyed Mani Mahdavi, MD;  Ali Shahsavaripour, MD; Seyed Hossein Vahid Tari, MD; Farshad Safdari, MSc Research performed at Shafa Yahyaian Hospital, Tehran, Iran IntroductionIdiopathic scoliosis (IS) is a complex three-dimensional  deformity of the spinal column being the most common type of spinal curvature (1).",Non-OADS,/arxiv_data1/oa_pdf/62/56/ABJS-3-109.PMC4468625.pdf
Available at: http://www.srs.org/professionals/education/ adolescent/idiopathic/.,Non-OADS,/arxiv_data1/oa_pdf/62/56/ABJS-3-109.PMC4468625.pdf
"2015;3(2):144-147.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Mohamad H. Ebrahimzadeh, MD; Meysam Fathi Choghadeh, MD; Ali Moradi, MD; Hamid Hejrati Kalati, MD; Amir Hossein Jafarian, MD Research performed at Orthopedic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran IntroductionOsteoid osteoma was first described by Jaffe in 1935  as a benign osteoblastic tumor which produces severe pain (1).",Non-OADS,/arxiv_data1/oa_pdf/70/2d/ABJS-3-144.PMC4468626.pdf
"2015;3(2):94-98.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir Deep Sharma, MD; Pooja Dhiman, MD; Jagdish Menon, MD; Komuravalli Varun Krishna, MD Research performed at Jawaharlal Institute of Post Graduate Medical Education & Research(JIPMER), Puducherry, India IntroductionAbnormalities of the sternocostoclavicular joint  (SCCJ) although common, is still the most underdiagnosed entity in Orthopaedics.",Non-OADS,/arxiv_data1/oa_pdf/6b/37/ABJS-3-94.PMC4468627.pdf
2015;3(2):134-136.             http://abjs.mums.ac.irthe online version of this article  abjs.mums.ac.ir T .V.,Non-OADS,/arxiv_data1/oa_pdf/ae/76/ABJS-3-134.PMC4468628.pdf
"Accepted:  2015-03-02 doi:10.4103/1673-5374.156944         http://www.nrronline.org/ Favero M, Cangiano A, Busetto G (2015) Lesson from the neuromus - cular junction: role of pattern and timing of nerve activity in synaptic  developme nt.",Non-OADS,/arxiv_data1/oa_pdf/9c/9c/NRR-10-686.PMC4468748.pdf
"Accepted:  2015-03-16 doi:10.4103/1673-5374.156946         http://www.nrronline.org/ Takeda YS, Xu Q (2015) Synthetic and nature-derived lipid nanopar - ticles for neural regeneration.",OADS,/arxiv_data1/oa_pdf/da/9c/NRR-10-689.PMC4468749.pdf
Accepted:  2015-04-03 doi:10.4103/1673-5374.156947         http://www.nrronline.org/ Chen C (2015) Homeostatic regulation of brain functions by endo - cannabinoid signaling.,Non-OADS,/arxiv_data1/oa_pdf/82/8f/NRR-10-691.PMC4468750.pdf
Accepted:  2015-04-12 doi:10.4103/1673-5374.156950         http://www.nrronline.org/ Baloyannis SJ (2015) Staining neurons with Golgi techniques in de - generative diseases of the brain.,Non-OADS,/arxiv_data1/oa_pdf/49/a6/NRR-10-693.PMC4468751.pdf
"Accepted:  2015-04-22 doi:10.4103/1673-5374.156954         http://www.nrronline.org/ Bobkova N, Vorobyov V (2015) The brain compensatory mechanisms  and Alzheimer’s disease progression: a new protective strategy.",Non-OADS,/arxiv_data1/oa_pdf/d1/2e/NRR-10-696.PMC4468752.pdf
Accepted:  2015-04-21 doi:10.4103/1673-5374.156953         http://www.nrronline.org/Turgeman G (2015) The therapeutic potential of mesenchymal stem  cells in Alzheimer’s disease: converging mechanisms.,Non-OADS,/arxiv_data1/oa_pdf/bf/51/NRR-10-698.PMC4468753.pdf
Accepted: 2015-03-13 doi:10.4103/1673-5374.156955         http://www.nrronline.org/ Bate C (2015) Enhanced neuronal degradation of amyloid- β oligomers  allows synapse regeneration.,OADS,/arxiv_data1/oa_pdf/dd/da/NRR-10-700.PMC4468754.pdf
"Accepted: 2015-03-11 doi:10.4103/1673-5374.156957         http://www.nrronline.org/ Mallio CA, Zobel BB, Quattrocchi CC (2015) Evaluating rehabili - tation interventions in Parkinson’s disease with functional MRI: a  promising neuroprotective strategy.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/NRR-10-702.PMC4468755.pdf
"Accepted:  2015-02-26 doi:10.4103/1673-5374.156958         http://www.nrronline.org/ Schlachetzki JC, Winkler J (2015) The innate immune system in Par - kinson’s disease: a novel target promoting endogenous neuroregenera - tion.",Non-OADS,/arxiv_data1/oa_pdf/4c/83/NRR-10-704.PMC4468756.pdf
"Accepted:  2015-02-28 doi:10.4103/1673-5374.156962         http://www.nrronline.org/ Ronchi G, Raimondo S, Geuna S, Gambarotta G (2015) New  insights on the standardization of peripheral nerve regeneration  quantitative analysis.",Non-OADS,/arxiv_data1/oa_pdf/43/7b/NRR-10-707.PMC4468757.pdf
"Accepted:  2015-04-15 doi:10.4103/1673-5374.156963         http://www.nrronline.org/ Rask-Andersen H, Liu W (2015) Auditory nerve preservation and re - generation in man: relevance for cochlear implantation.",OADS,/arxiv_data1/oa_pdf/75/1c/NRR-10-710.PMC4468758.pdf
"Accepted:  2015-03-31 doi:10.4103/1673-5374.156961         http://www.nrronline.org/ Mladinic M, Nistri A (2015) Dynamic expression of ATF3 as a  novel tool to study activation and migration of endogenous spi - nal stem cells and their role in neural repair.",OADS,/arxiv_data1/oa_pdf/5c/99/NRR-10-713.PMC4468759.pdf
"The Global Burden of Disease: 2004 Update  (WHO, 2008).http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf Y amamoto S, Y amamoto N, Kitamura T, Nakamura K, Nakafuku M  (2001) Proliferation of parenchymal neural progenitors in response to  injury in the adult rat spinal cord.",OADS,/arxiv_data1/oa_pdf/5c/99/NRR-10-713.PMC4468759.pdf
Accepted:  2015-04-01 doi:10.4103/1673-5374.156960           http://www.nrronline.org/ Zhang M (2015) Aromatic L-amino acid decarboxylase cells in the  spinal cord: a potential origin of monoamines.,Non-OADS,/arxiv_data1/oa_pdf/86/92/NRR-10-715.PMC4468760.pdf
"Accepted:  2015-03-19 doi:10.4103/1673-5374.156964         http://www.nrronline.org/ Isaiah A, Hartley DEH (2015) Can training extend current guidelines  for cochlear implant candidacy?",Non-OADS,/arxiv_data1/oa_pdf/ea/82/NRR-10-718.PMC4468761.pdf
From: http://tuszynskilab.ucsd.edu/ rosenz.php Copyright © and courtesy of Dr. Ephron Rosenzweig (2006).,Non-OADS,/arxiv_data1/oa_pdf/90/25/NRR-10-726.PMC4468763.pdf
"Image preprocessing was performed with the Data  Processing Assistant for Resting-State fMRI (DPARSF) V1.0  software package (http://restfmri.net/forum/DPARSF; Y an  and Zang, 2010), which is a convenient software plug-in  based on SPM (http://www.fil.ion.ucl.ac.uk/spm), and the  Resting-State fMRI Data Analysis T oolkit (http://www.rest - fmri.net).",OADS,/arxiv_data1/oa_pdf/9b/86/NRR-10-760.PMC4468767.pdf
"Data analysis Data were analyzed using SPSS 17.0 software (SPSS, Chicago,  IL, USA) and SPM software (http://www.fil.ion.ucl.ac.",OADS,/arxiv_data1/oa_pdf/9b/86/NRR-10-760.PMC4468767.pdf
Primers were de - signed and synthesized by Invitrogen in accordance with the  sequences of DMT1  and FPN1  genes in GenBank (DMT1:  http://www.ncbi.nlm.nih.gov/gene/18174; FPN1: http:// www.ncbi.nlm.nih.gov/gene/53945).,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/NRR-10-778.PMC4468770.pdf
"Accepted:  2015-04-10 doi:10.4103/1673-5374.156990         http://www.nrronline.org/ Seo YS, Jang SH (2015) Recovery of a degenerated corticospinal tract  after injury in a patient with intracerebral hemorrhage: confirmed by  diffusion tensor tractography imaging.",Non-OADS,/arxiv_data1/oa_pdf/c9/03/NRR-10-829.PMC4468779.pdf
"Conﬂict of interests The authors declare that they have no conﬂict of interest.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3c/69/10549_2015_Article_3448.PMC4468806.pdf
J NatlCancer Inst 105(13):978–988 15.http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ breast/survival/breast-cancer-survival-statistics .,Non-OADS,/arxiv_data1/oa_pdf/3c/69/10549_2015_Article_3448.PMC4468806.pdf
Carbohydrate-Active enZYmes  Database http://www.cazy.org/.,Non-OADS,/arxiv_data1/oa_pdf/d4/a0/CMC-22-1757.PMC4468916.pdf
http://www.who.int/malaria/publications/atoz/in- terim˙position˙statement˙larviciding˙sub˙saharan˙africa.pdf (accessed April 2012).,Non-OADS,/arxiv_data1/oa_pdf/e2/b1/CD008090-0001.PMC4468924.pdf
http://www.who.int/mediacentre/factsheets/fs094/en/ December 2014 (Accessed 15 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/71/CD010458.PMC4468925.pdf
http://www.who.int/topics/cholera/publications/ cholera outbreak/en/ 2004. WHO 2009a World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
"31, 2009, 84, 309-24. http://www.who.int/wer/2009/wer8431.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
Cholera in Zimbabwe: update 4. http://www.who.int/csr/don/2009 0609/en/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
http://www.who.int/ csr/don/2013 1028/en/.,OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
"Characteristics of studies awaiting assessment [ordered by study ID] Chatchai 1994 Methods Unknown Participants Unknown Interventions Doxycycline 300 mg, single dose T etracyline 500 mg four times per day Outcomes Unknown Notes This reference came up in the search conducted in The Cochrane Library : http://www.mrw.interscience.wiley.com/cochrane/clcentral/a rticles/179/CN-00617179/frame.html There are no UK holdings for the journal.",OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
Optimal Information Size Calculations: Continuous outcomes Outcome Hypothesis Power αerror Mean in control groupMean in inter- vention groupStandard devia- tionTotal sample size required Diarrhoea durationSuperiority 80% 5% 30115 10 14 30122 10 50 130165 40 12 130198 40 50 Duration of pathogen ex- cretionSuperiority 80% 5% 321.5 1 20 322.25 1 76 623 2 20 624.5 2 76 Calculations performed with http://www.sealedenvelope.co m. 1The mean duration of diarrhoea in the control groups ranged fr om 29.3 to 127.2 hours ( Analysis 1.1 ).,Non-OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
Optimal Information Size Calculations: Dichotomou s outcomes (Continued) 12% 9%43272 Bacteriological failureSuperiority 80% 5% 75% 37.5%348 75% 56.25%4194 20% 10%3394 20% 15%41806 Calculations performed with http://www.sealedenvelope.co m. 1The overall proportion of clinical failures in people randomi zed to placebo or no treatment was 61% ( Analysis 1.4 ).,Non-OADS,/arxiv_data1/oa_pdf/ab/52/CD008625.PMC4468928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1103–1109International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1103OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6857 0Comprehensive analysis of gene-expression  profile in chronic obstructive pulmonary disease lei Wei1,* Dong Xu2,* Yechang Qian1 guoyi huang1 Wei Ma1 Fangying liu1 Yanhua shen1 Zhongfu Wang1 li li1 shanfang Zhang1 Yafang Chen1 1Department of respiratory Disease,   Baoshan District hospital of  Integrated Traditional Chinese and  Western Medicine, shanghai, 2Medical  College of soochow University,   Suzhou, People’s Republic of China *These authors contributed equally to  this work Correspondence: Yechang Qian   Department of respiratory Disease,  Baoshan District hospital of Integrated  Traditional Chinese and Western  Medicine, no 181 Youyi road, shanghai  201900, People’s Republic of China   Tel +86 21 6591 8108   Fax +86 21 3607 0892   email qian_yel@163.co m    guoyi huang   Department of respiratory Disease,  Baoshan District hospital of Integrated  Traditional Chinese and Western  Medicine, no 181 Youyi road, shanghai  201900, People’s Republic of China   Tel +86 21 5660 1100   Fax +86 21 3607 0892   email guoyiyellow@163.co mObjective:  To investigate the gene-expression profile of chronic obstructive pulmonary  disease (COPD) patients and explore the possible therapeutic targets.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
"Materials and methods affymetrix® microarray data One transcription profile of GSE291339 that included six  samples of alveolar epithelial type II cells from the lung  tissues of three COPD and three non-COPD patients was  obtained from a public functional genomics data repository,  the Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/ geo/).",OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
"gene-ontology and pathway-enrichment  analyses Gene-ontology (GO) terms and Kyoto Encyclopedia of Genes  and Genomes (KEGG) pathways were enriched for DEGs  by the Functional Annotation Clustering Tool in the Da ta- base for Annotation, Visualization and Integrated Discovery  (DA VID; v 6.7, http://david.abcc.ncifcrf.go v).12 The major  GO terms associated with biological processes and cellular  components were manually summarized based on gene-term  enrichment buttons provided for each functional group at a  P-value of ,0.1. regulatory elements analysis DEGs were divided into up- and downregulated genes.",OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/8f/copd-10-1103.PMC4468932.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/43/57/copd-10-1075.PMC4468933.pdf
"Potentially pathogenic microorganisms (PPMs) have  been identified at stable state in bronchoalveolar lavage fluid1,2 and sputum.3 The most  commonly identified species are Haemophilus influenzae and Moraxella catarrhalis.1,2  Although often assumed to reflect colonization, previous work has shown that a single  positive sputum culture for a PPM is associated with increased neutrophilic airway  inflammation,4,5 worsened health status,6 increased exacerbations,7 and an increased Correspondence: Mona Bafadhel Respiratory Medicine Unit, NDM  Research Building, Nuffield Department  of Clinical Medicine, University  of Oxford, Old Road Campus, Oxford,  OX3 7FZ, UK Tel +44 18 65 61 2898 email mona.bafadhel@ndm.ox.ac.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bafadhel et al Running head recto: Airway bacteria in stable COPD using qPCR and culture DOI: http://dx.doi.org/10.2147/COPD.S80091",Non-OADS,/arxiv_data1/oa_pdf/43/57/copd-10-1075.PMC4468933.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/43/57/copd-10-1075.PMC4468933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/57/copd-10-1075.PMC4468933.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/67/dddt-9-2983.PMC4468934.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2983–2992Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2983Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8097 9Protective effect of galangin in concanavalin a-  induced hepatitis in mice Qingqiong luo1,* liping Zhu1,* Jieying Ding1 Xing Zhuang1 lili Xu2 Fuxiang chen1 1Department of clinical immunology,   shanghai ninth People’s hospital,   shanghai JiaoT ong University  school of Medicine, 2Division of  gastroenterology, Zhongshan  hospital, Fudan University, shanghai,   People’s republic of china *These authors contributed equally  to this workAbstract:  Galangin is an active pharmacological ingredient from propolis and Alpinia  officinarum Hance , and has been reported to have anti-inflammatory and antioxidative prop - erties.",Non-OADS,/arxiv_data1/oa_pdf/16/67/dddt-9-2983.PMC4468934.pdf
"Galangin (3,5,7-trihydroxyflavone; Figure 1A) is a naturally active flavonoid  extracted from propolis and the root of Alpinia officinarum Hance , a plant that has been  used as a spice and as a herbal medicine for various ailments in Asia for centuries.6  The biological activity of galangin includes antimutagenic, anticlastogenic, antioxi - dative, radical scavenging, metabolic enzyme-modulating, bactericidal, antifibrotic, correspondence: lili Xu Division of gastroenterology, Zhongshan  hospital, Fudan University, no 180,  Fenglin road, shanghai 200032,  People’s republic of china email xu.lili3@zs-hospital.sh.c n  Fuxiang chen Department of clinical immunology,  shanghai ninth People’s hospital,  shanghai JiaoTong University school  of Medicine, no 639, Zhizaoju road,  shanghai 200011, People’s republic   of china email chenfx@sjtu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Luo et al Running head recto: Protective effect of galangin in CIH DOI: http://dx.doi.org/10.2147/DDDT.S80979",Non-OADS,/arxiv_data1/oa_pdf/16/67/dddt-9-2983.PMC4468934.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/67/dddt-9-2983.PMC4468934.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/67/dddt-9-2983.PMC4468934.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/b3/copd-10-1085.PMC4468935.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1085–1091International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1085OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8143 9screening of COPD patients for abdominal aortic  aneurysm Ingo h Flessenkaemper1 robert loddenkemper2 stephanie roll3 Kathrin enke-Melzer1 henrik Wurps2 T orsten T Bauer2 1Department for Vascular Medicine,   2Department of Pneumology,   helios Klinikum emil von Behring,   Berlin, germany; 3Institute for  social Medicine, epidemiology  and health economics, Charité –  Universitätsmedizin Berlin, Berlin,   germanyPurpose:  Screening for abdominal aortic aneurysm (AAA) in “men aged over 65 years who  have ever smoked” is a recommended policy.",Non-OADS,/arxiv_data1/oa_pdf/9c/b3/copd-10-1085.PMC4468935.pdf
"The main group to screen includes “men  aged over 65 years who ever smoked”.13,14 It seems meaningful to look for additional Correspondence: Ingo h Flessenkaemper Department for Vascular Medicine,  helios Klinikum emil von Behring,  Walterhöferstraße, 11, 14165 Berlin,  germany Tel/fax +49 30 8102 2200 email ingo.flessenkaemper@helios- kliniken.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Flessenkaemper et al Running head recto: COPD and AAA screening DOI: http://dx.doi.org/10.2147/COPD.S81439",Non-OADS,/arxiv_data1/oa_pdf/9c/b3/copd-10-1085.PMC4468935.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9c/b3/copd-10-1085.PMC4468935.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/b3/copd-10-1085.PMC4468935.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/c9/dddt-9-2993.PMC4468936.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2993–2999Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8130 3assessment of hydroxychloroquine maculopathy  after cessation of treatment: an optical coherence  tomography and multifocal electroretinography study Marilita M Moschos1 eirini nitoda1 irini P chatziralli1 Zisis gatzioufas2 chryssanthi Koutsandrea1 george Kitsos3 1First Department of Ophthalmology,   Medical school, national  and Kapodistrian University  of athens, athens, greece; 2swiss  eye research Foundation, Orasis  eye clinic, reinach, switzerland;   3Department of Ophthalmology,   Medical school, University  of ioannina, ioannina, greeceObjective:  This study was conducted to evaluate the macular status of patients treated with  hydroxychloroquine before and after cessation of treatment.",Non-OADS,/arxiv_data1/oa_pdf/cc/c9/dddt-9-2993.PMC4468936.pdf
"Keywords:  hydroxychloroquine, toxic retinopathy, visual acuity, multifocal electroretinography,  optical coherence tomography Introduction Chloroquine and hydroxychloroquine are the most common antimalarials used for the  treatment of autoimmune and connective tissue diseases, including systemic lupus ery - thematosus, rheumatoid arthritis, psoriatic arthritis, palindromic rheumatism, dermato - myositis, Sjögren’s syndrome, and juvenile chronic arthritis.1 Although chloroquine and  hydroxychloroquine are chemically similar 4-aminoquinolines, differing only by an  ethyl group, the latter exhibits almost half the efficacy and toxicity as compared with the  former.1 Modification of the cellular microenvironment induces changes in inflammatory  mediators and receptor activity, as well as changes in production of proteins and autoan - tibodies.1 The most common side effects of antimalarials include gastrointestinal cramps  and nausea, skin lesions, and central nervous system symptoms that are usually reversible.1  Hydroxychloroquine has been also implicated in cardiomyopathy, vacuolar myopathy,  and hypoglycemia observed in patients with type 2 diabetes mellitus, while massive correspondence: Marilita M Moschos First Department of Ophthalmology,  Medical school, national and Kapodistrian  University of athens, 154 Mesogion  street, athens 11527, greece email moschosmarilita@yahoo.f r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Moschos et al Running head recto: Hydroxychloroquine maculopathy after cessation of treatment DOI: http://dx.doi.org/10.2147/DDDT.S81303",Non-OADS,/arxiv_data1/oa_pdf/cc/c9/dddt-9-2993.PMC4468936.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cc/c9/dddt-9-2993.PMC4468936.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/c9/dddt-9-2993.PMC4468936.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/7c/dddt-9-2975.PMC4468937.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2975–2982Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2975Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8226 3Oxidant/antioxidant status, paraoxonase activity,  and lipid profile in plasma of ovariectomized  rats under the influence of estrogen, estrogen  combined with progesterone, and genistein Elif Agacayak1 serdar Basaranoglu2 senem Yaman T unc1 Mehmet sait icen1 Fatih Mehmet Findik1 ibrahim Kaplan3 Osman evliyaoglu3 Talip gul1 1Department of Obstetrics and  gynecology, Dicle University school  of Medicine, Diyarbakir, T urkey;   2Department of Obstetrics and  Gynecology, Idil State Hospital, Sirnak,   T urkey; 3Department of Biochemistry,   Dicle University School of Medicine,   Diyarbakir, T urkeyIntroduction:  The aim of this study was to investigate whether estradiol (E2), E2 combined  with progesterone (Prog) (E2/Prog), and genistein (Gen) treatment had antioxidative and anti - hyperlipidemic effects in the plasma of ovariectomized (OVX) rats.",Non-OADS,/arxiv_data1/oa_pdf/28/7c/dddt-9-2975.PMC4468937.pdf
"The highest amounts of isoflavones are present in soy, and the most abundant  isoflavone in soy is Gen. Gen is also abundant in red clover.2Correspondence: Elif Agacayak Department of Obstetrics and  gynecology, Dicle University school  of Medicine, 21280, Diyarbakir, Turkey Tel +90 505 943 3449 Fax +90 412 248 8523 email drelifagacayak@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Agacayak et al Running head recto: Plasma changes in ovariectomized rats under the influence of genistein DOI: http://dx.doi.org/10.2147/DDDT.S82263",Non-OADS,/arxiv_data1/oa_pdf/28/7c/dddt-9-2975.PMC4468937.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/28/7c/dddt-9-2975.PMC4468937.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/7c/dddt-9-2975.PMC4468937.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 317–332Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  317ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7906 5Direct oral anticoagulants: key considerations for  use to prevent stroke in patients with nonvalvular  atrial fibrillation Jerome Ment Department of Cardiology,   Birmingham Heartlands Hospital,   Birmingham, UK Correspondence: Jerome Ment   Department of Cardiology, Birmingham  Heartlands Hospital, Bordesley Green  east, Bordesley Green, Birmingham,  west Midlands B9 5SS, UK   Tel +44 121 424 0744   Fax +44 121 424 1074   email jerome.ment@heartofengland.nhs .",Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000829/WC500041059.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://dsi.com/prescribing- information-portlet/getPIContent?productName =Savaysa&inline =true.,OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://dx.doi.org/10.1002/14651858.CD000024.pub 3.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0216486 4.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0222072 5.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0220772 5.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT0210494 7.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/9d/vhrm-11-317.PMC4468938.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2947–2959Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2947Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7947 5A novel bispecific immunotoxin delivered by  human bone marrow-derived mesenchymal stem  cells to target blood vessels and vasculogenic  mimicry of malignant gliomas Y onghong Zhang1,2 Xinlin sun1 Min huang1 Yiquan Ke1 Jihui Wang1 Xiao liu1 1national Key clinic specialty,   neurosurgery institute of  guangdong Province, guangdong  Provincial Key laboratory on Brain  Function repair and regeneration,   Department of neurosurgery,   Zhujiang hospital, southern Medical  University, guangzhou, 2Department  of neurosurgery, First hospital  of lanzhou University, lanzhou,   People’s republic of chinaBackground:  In previous years, immunotoxins have been shown to be a greatly promising  therapeutic tool for brain malignancies, such as gliomas.",Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
"In this study, we hypothesized that immunotoxin targeting correspondence: Yiquan Ke Department of neurosurgery, Zhujiang  hospital, southern Medical University,  253 gongye road, guangzhou,  guangdong 510282, People’s republic  of china Tel/fax +86 20 6164 3266 email zjkeyiquan@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: A novel bispecific immunotoxin for human malignant gliomas DOI: http://dx.doi.org/10.2147/DDDT.S79475",Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
Available from: http://www.nap.edu/openbook.php?record_ id=5140&page=R1.,Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/2e/dddt-9-2947.PMC4468939.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1093–1102International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1093RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7285 8LAMA/LABA vs ICS/LABA in the treatment of  COPD in Japan based on the disease phenotypes Nobuyuki Hizawa Department of Pulmonary Medicine,   Faculty of Medicine, University  of Tsukuba, Ibaraki, JapanAbstract:  In the combined use of bronchodilators of different classes, ie, long-acting β2-agonists  (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both  directly, through LABA-mediated stimulation of β2-adrenergic receptors, and indirectly, through  LAMA-mediated inhibition of acetylcholine action at muscarinic receptors.",Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
"Long-acting  bronchodilators, such as tiotropium, formoterol, and salmeterol, are proven to provide  long-term improvements in lung function and quality of life and preventing exac - erbations in patients with COPD.1–3 Long-acting bronchodilators also reduce lung  hyperinflation and dyspnea and increase exercise endurance.4,5 Airway smooth muscle relaxation (leading to bronchodilation) can be achieved  via two main routes: inhibition of acetylcholine signaling via muscarinic M3 receptors Correspondence: Nobuyuki Hizawa Department of Pulmonary Medicine,  Faculty of Medicine, University of  Tsukuba, Ibaraki 305-8575, Japan email nhizawa@md.tsukuba.ac.j p Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Hizawa Running head recto: LAMA/LABA vs ICS/LABA based on the COPD phenotype DOI: http://dx.doi.org/10.2147/COPD.S72858",Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
"Available from: http://www.goldcopd.org/Guidelines/guideline-2013- gold-report.htm l. Accessed May 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/f2/copd-10-1093.PMC4468951.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/df/copd-10-1111.PMC4468952.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1111–1121International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1111RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S4021 4The health burden of pollution: the impact  of prenatal exposure to air pollutants Sandra e vieira Pediatrics Department, Medical  School, University of São Paulo,   São Paulo, BrazilAbstract:  Exposure to atmospheric pollutants in both open and closed environments is a major  cause of morbidity and mortality that may be both controlled and minimized.",Non-OADS,/arxiv_data1/oa_pdf/f7/df/copd-10-1111.PMC4468952.pdf
"Exposure to cigarette Correspondence: Sandra e vieira Pediatrics Department, Medical School,  University of São Paulo, Av Dr eneas de  Carvalho Aguiar, 647, 05403-000   São Paulo, Brazil email sandra@hu.usp.b r Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Vieira Running head recto: Effects of air pollution during pregnancy DOI: http://dx.doi.org/10.2147/COPD.S40214",Non-OADS,/arxiv_data1/oa_pdf/f7/df/copd-10-1111.PMC4468952.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f7/df/copd-10-1111.PMC4468952.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/df/copd-10-1111.PMC4468952.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/dddt-9-2961.PMC4468953.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2961–2973Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2961Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8540 5immunostimulatory effects of the standardized  extract of Tinospora crispa  on innate immune  responses in Wistar Kyoto rats Waqas ahmad ibrahim Jantan endang Kumolosasi syed nasir abbas Bukhari Drug and herbal research centre,   Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan raja Muda  abdul aziz, Kuala lumpur, MalaysiaAbstract:  Tinospora crispa (TC) has been used in folkloric medicine for the treatment of  various diseases and has been reported for several pharmacological activities.",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/dddt-9-2961.PMC4468953.pdf
"The dysfunction of immune system  causes a number of diseases such as cancer, infectious diseases, parasitic diseases,  allergy, asthma, ulcerative colitis, and arthritis.2 The adjustment of immune responses correspondence: ibrahim Jantan Drug and herbal research centre,  Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan raja Muda  abdul aziz, 50300 Kuala lumpur,  Malaysia Tel +60 1 6288 6445 Fax +60 3 2698 3271 email profibj@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ahmad et al Running head recto: Immunostimulatory effects of extract of Tinospora crispa DOI: http://dx.doi.org/10.2147/DDDT.S85405",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/dddt-9-2961.PMC4468953.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/dddt-9-2961.PMC4468953.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/dddt-9-2961.PMC4468953.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/c4/dddt-9-3001.PMC4468954.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0f/c4/dddt-9-3001.PMC4468954.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s Drug Design, Development and Therapy 2015:9 3001Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3001CorrigenDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7896 2Involvement of NF- ΚB and HSP70 signaling pathways in the apoptosis  of MDA-MB-231 cells induced by a prenylated xanthone compound,  α-mangostin, from Cratoxylum arborescens  [Corrigendum] Ibrahim MY, Hashim NM, Mohan S, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/c4/dddt-9-3001.PMC4468954.pdf
"The American Cancer Society (ACS)  reported that breast cancer incidence has an estimation  of  26% of all new cancer cases, which is the highest in ratio  among all the cancers in American women.1 The  National  Cancer Registry (NCR) in Malaysia has  reported that one  in twenty Malaysian women are at a risk of acquiring breast Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2015 Volume: 9 Running head verso: Ibrahim et al Running head recto: <Running head recto> DOI: http://dx.doi.org/10.2147/DDDT.S78962 cancer in their lifetime.2 The incidence rate in Malaysia  is still considered low if compared to Europe and United  States.3 Up to 70% of breast cancer development causes  occur in women is reported to be of environmental factors  and lifestyle.4,5” Introduction, second paragraph, first sentence, the text  should read: “Radiation therapy has become a valuable tool  among cancer treatment strategies for the control of local  and regional diseases after 1960 with the invention of the  linear accelerator, but, like surgery, radiation therapy alone  cannot enucleate metastatic cancer.” Discussion, first paragraph, first sentence, the text should  read: “Apoptosis has a vital role in many functions, ranging  from fetal development to adult tissue homeostasis.32”",Non-OADS,/arxiv_data1/oa_pdf/0f/c4/dddt-9-3001.PMC4468954.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2911–2918Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2911Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8616 8Dose proportionality and pharmacokinetics  of carvedilol sustained-release formulation:  a single dose-ascending 10-sequence incomplete  block study Y o han Kim1 hee Y oun choi1 Y ook-hwan noh1 shi hyang lee1 hyeong-seok lim1 chin Kim2 Kyun-seop Bae1 1Department of clinical Pharmacology  and Therapeutics, college of Medicine,   University of Ulsan, asan Medical  center, 2chong Kun Dang clinical  research and clinical epidemiology  and Medical information, cKD  Pharmaceuticals, seoul, republic of  KoreaBackground:  Carvedilol is a third-generation β-blocker indicated for congestive heart failure  and high blood pressure.",Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
"It is extensively metabolized primarily by CYP2D6, and greater correspondence: Kyun-seop Bae Department of clinical Pharmacology  and Therapeutics, college of Medicine,  University of Ulsan, asan Medical  center, 88 Olympic-ro 43-gil, songpa-gu,  seoul 138-736, republic of Korea Tel +82 2 3010 4622 Fax +82 2 3010 4623 email ksbae@amc.seoul.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kim et al Running head recto: Dose proportionality of carvedilol SR formulation DOI: http://dx.doi.org/10.2147/DDDT.S86168",Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
"Available from: http://www.roche-australia.com/ content/dam/internet/corporate/roche/en_AU/files/cardiac_agents/ dilatrend-pi.pd f. Accessed February 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/82/55/dddt-9-2911.PMC4468955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/44/omv034.PMC4468958.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/6d/jmdh-8-299.PMC4468983.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 299–305Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  299Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S8448 8ethical implications of digital images for teaching  and learning purposes: an integrative review Rachel Kornhaber1–3 vasiliki Betihavas4 Rodney J Baber5 1School of Health Sciences, Faculty  of Health, University of Tasmania,   Rozelle, NSw , 2School of Nursing,   The University of Adelaide, Adelaide,   SA, 3Severe Burns injury Unit, Royal  North Shore Hospital, St Leonards,   NSw , 4School of Nursing, University  of Sydney, Sydney, NSw , 5Discipline  of Obstetrics, Gynaecology and  Neonatology, Sydney Medical School,   University of Sydney, Sydney, NSw ,   Australia Correspondence: Rachel Kornhaber   School of Health Sciences, University of  Tasmania, Locked Bag 5052, Alexandria,  NSw 2015, Australia   email rachel.kornhaber@utas.edu.a uBackground:  Digital photography has simplified the process of capturing and utilizing medical  images.",Non-OADS,/arxiv_data1/oa_pdf/77/6d/jmdh-8-299.PMC4468983.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/77/6d/jmdh-8-299.PMC4468983.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/6d/jmdh-8-299.PMC4468983.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/9c/opth-9-1057.PMC4468984.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1057–1064Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1057Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8174 9retrograde degeneration of retinal ganglion  cells in homonymous hemianopsia angela M herro Byron l lam Bascom Palmer eye institute,   Department of Ophthalmology,   University of Miami Miller school  of Medicine, Miami, Fl, UsaBackground:  The aim of this study was to demonstrate the relationship between topographic  reduction in macular ganglion cell complex (GCC) thickness as detected with spectral-domain  optical coherence tomography and visual field defects caused by ischemic occipital cortical  injury.",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/opth-9-1057.PMC4468984.pdf
"Retrograde Correspondence: angela M herro horizon eye specialists and lasik Center,  18325 n. allied Way, suite 100, Phoenix,  aZ 85054, Usa Tel +1 602 790 2261 Fax +1 480 419 5401 email angela.herro@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Herro and Lam Running head recto: Retrograde degeneration of RGCs in homonymous hemianopsia DOI: http://dx.doi.org/10.2147/OPTH.S81749",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/opth-9-1057.PMC4468984.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/opth-9-1057.PMC4468984.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/9c/opth-9-1057.PMC4468984.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/dc/opth-9-1049.PMC4468985.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1049–1056Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1049Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5972 5Potential role of lampalizumab for treatment  of geographic atrophy william Rhoades Drew Dickson Diana v Do Truhlsen eye institute, Department of  Ophthalmology and visual Sciences,    University of Nebraska Medical  Center, Omaha, N e, USAAbstract:  The purpose of this article is to review the pathways underlying age-related macular  degeneration and potential therapeutic targets, focusing on the complement pathway and the  recent MAHALO Phase II trial of the investigational drug lampalizumab.",Non-OADS,/arxiv_data1/oa_pdf/79/dc/opth-9-1049.PMC4468985.pdf
"While nongenetic factors such as age,  diet, and smoking are known to play a role in the development of AMD, recently Correspondence: Diana v Do Truhlsen eye institute, Department  of Ophthalmology and visual Sciences,  University of Nebraska Medical Center,  985540, 4400 emile Street, Omaha,  Ne 68198-5540, USA Tel +1 402 559 2020 email diana.do@unmc.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Rhoades et al Running head recto: Lampalizumab for geographic atrophy  DOI: http://dx.doi.org/10.2147/OPTH.S59725",Non-OADS,/arxiv_data1/oa_pdf/79/dc/opth-9-1049.PMC4468985.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/79/dc/opth-9-1049.PMC4468985.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/dc/opth-9-1049.PMC4468985.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/a5/ndt-11-1431.PMC4468986.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1431–1436Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1431OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7228 4are there distinct subtypes in T ourette syndrome?,Non-OADS,/arxiv_data1/oa_pdf/a5/a5/ndt-11-1431.PMC4468986.pdf
"Complex tics can include echolalia (repeated vocalizations), palilalia  (repetition of words or phrases), echopraxia (repeated actions), palipraxia (repeating the  last act), self-injurious behaviors, complex vocalizations (eg, animal sounds), coprolalia  (swearing), copropraxia (inappropriate touching) etc.4 Other associated features include correspondence: Valsamma eapen academic Unit of child Psychiatry,  south Western sydney local health  District, liverpool hospital, Mental  health centre (level 1: icaMhs),  locked Bag 7103, liverpool Bc,   NsW 1871, australia email v.eapen@unsw.edu.a u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Eapen and Robertson Running head recto: Subtypes in Tourette syndrome DOI: http://dx.doi.org/10.2147/NDT.S72284",Non-OADS,/arxiv_data1/oa_pdf/a5/a5/ndt-11-1431.PMC4468986.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a5/a5/ndt-11-1431.PMC4468986.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/a5/ndt-11-1431.PMC4468986.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/59/ijwh-7-595.PMC4468987.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 595–603International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  595OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7882 9endometriosis: alternative methods of medical  treatment leticia Muñoz-Hernando1 Jose l Muñoz-gonzalez1 laura Marqueta-Marques1 carmen alvarez-conejo1 Álvaro T ejerizo-garcía1 gregorio lopez-gonzalez1 emilia Villegas-Muñoz2 angel Martin-Jimenez3 Jesús s Jiménez-lópez1 1endometriosis Unit, service of  Obstetrics and gynecology, Hospital  Universitario 12 de Octubre, Madrid,   spain; 2endometriosis Unit, service  of Obstetrics and gynecology,   Hospital carlos Haya, Malaga, spain;  3endometriosis Unit, service of  Obstetrics and gynecology, Hospital  son llatzer, Palma de Mallorca, spainAbstract:  Endometriosis is an inflammatory estrogen-dependent disease defined by the presence  of endometrial glands and stroma at extrauterine sites.",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ijwh-7-595.PMC4468987.pdf
"Current medical treatments are based on two mechanisms of action: anti-inflammatory  and hormonal.3 Nonsteroidal anti-inflammatory drugs (NSAIDs) are used commonly  in women with dysmenorrhea, although there is not enough evidence to admit that  they are effective in the treatment of endometriosis related pain, and there is lack of  evidence to recommend one NSAID among the others.4 Hormonally active drugs act by blocking the ovarian function and creating  a more stable hormonal environment.3 Hormonal drugs currently used for the correspondence: Jesús s Jiménez-lópez endometriosis Unit, service of Obstetrics  and gynecology, Hospital Universitario  12 de Octubre, avenida de córdona s/n,  e-28041 Madrid, spain Tel +34 91 390 8376 Fax +34 91 390 8376 email jjimenez.hdoc@salud.madrid.or g;  jjimenezme35426@gmail.co mJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Muñoz-Hernando et al Running head recto: Endometriosis: medical treatment DOI: http://dx.doi.org/10.2147/IJWH.S78829",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ijwh-7-595.PMC4468987.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c1/59/ijwh-7-595.PMC4468987.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/59/ijwh-7-595.PMC4468987.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/43/ijn-10-3911.PMC4468988.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3911–3920International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3911OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8321 1engineering of lipid prodrug-based, hyaluronic  acid-decorated nanostructured lipid carriers  platform for 5-fluorouracil and cisplatin  combination gastric cancer therapy chun-Ying Qu1,* Min Zhou1,* Ying-wei chen2 Mei-mei chen3 Feng shen1 lei-Ming Xu1 1Digestive endoscopic Diagnosis and  Treatment center, Xinhua hospital,   school of Medicine, shanghai Jiaotong  University, shanghai, People’s republic  of china; 2shanghai Key laboratory  of Pediatric gastroenterology and  Nutrition, shanghai, People’s republic  of china; 3Digestive Department,   Xinhua hospital, school of medicine,   shanghai Jiaotong University, shanghai,   People’s republic of china *These authors contributed equally  to this workPurpose:  The first-line chemotherapy treatment protocol for gastric cancer is combination  chemotherapy of 5-fluorouracil (5-FU) and cisplatin (CDDP).",Non-OADS,/arxiv_data1/oa_pdf/32/43/ijn-10-3911.PMC4468988.pdf
"Because of their correspondence: lei-Ming Xu Digestive endoscopic Diagnosis and  Treatment center, Xinhua hospital,  school of Medicine, shanghai Jiaotong  University, Kongjiang road 1665,  shanghai 200092, People’s republic  of china email xuleimingsjtu@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Qu et al Running head recto: 5-fluorouracil and cisplatin combination gastric cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S83211",Non-OADS,/arxiv_data1/oa_pdf/32/43/ijn-10-3911.PMC4468988.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/32/43/ijn-10-3911.PMC4468988.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/43/ijn-10-3911.PMC4468988.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1421–1426Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1421OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7993 9Undertreatment of human immunodeficiency  virus in psychiatric inpatients: a cross-sectional  study of seroprevalence and associated factors Miguel angel gonzalez- T orres1,2 Miguel angel salazar3 Manuel imaz4 lucía inchausti1,2 Berta ibañez5 aranzazu Fernandez-rivas1,2 Javier Pastor3 Bosco anguiano3 Pedro Muñoz3 eduardo ruiz1,2 rodrigo Oraa3 sonia Bustamante1,2 sofia alvarez de eulate2 ramón cisterna4,6 1Department of Neuroscience,   University of the Basque country,   2Psychiatry service, Basurto  University hospital, Bilbao, 3Mental  health Network of Biscay, Basque  health service, Biscay, 4Microbiology  service, Basurto University hospital,   Bilbao, 5Navarra Biomed-Miguel servet  Foundation, red de investigación en  servicios sanitarios y enfermedades  crónicas (reDissec), Pamplona,   6Department of Microbiology,   University of the Basque country,   Bilbao, spainBackground:  The aims of this study were to evaluate the prevalence of HIV and its associated  demographic and clinical factors among psychiatric inpatients of a general hospital.",Non-OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
"Although variable across studies, the self-reported prevalence of HIV risk  behaviors is high among patients with severe mental illness,1 including mul - tiple partners (57%), lack of condom use (46%), injectable drug use (22%), and correspondence: Miguel angel   gonzalez-Torres Psychiatry service, Basurto University  hospital, avenida de Montevideo 18,  Bilbao 48013, spain Tel +34 944 006 066 Fax +34 944 006 213 email miguelangel.gonzaleztorres@ osakidetza.ne t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gonzalez-Torres et al Running head recto: HIV infection among psychiatric inpatients DOI: http://dx.doi.org/10.2147/NDT.S79939",Non-OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
"Available  from: http://www.who.int/classifications/icd/en/GRNBOOK.pd f.  Accessed March 16, 2015.",OADS,/arxiv_data1/oa_pdf/2c/e2/ndt-11-1421.PMC4468989.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/d4/ijn-10-3921.PMC4468990.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3921–3935International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3921OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8070 6Poly(n-butylcyanoacrylate) nanoparticles for oral  delivery of quercetin: preparation, characterization,  and pharmacokinetics and biodistribution studies  in Wistar rats Mayur Bagad Zaved ahmed Khan Medical Biotechnology Division,   school of Biosciences and  Technology, VIT University, Vellore  Tamil Nadu, IndiaBackground:  Quercetin (QT) is a potential bioflavonol and antioxidant with poor  bioavailability and very low distribution in the brain.",Non-OADS,/arxiv_data1/oa_pdf/f4/d4/ijn-10-3921.PMC4468990.pdf
"Keywords:  bioavailability, biodistribution, nanoparticles, pharmacokinetics, poly   (n-butylcyanoacrylate), quercetin Introduction Quercetin (QT) (3,3 ′,4′,5,7-pentahydroxyflavone) is a potential flavonoid and is  generally found in fruits, vegetables, leaves, and grains.1,2 QT, due to its high anti - oxidant activity, acts as a free radical scavenger and protects the cells from oxidative  stress generated as an outcome of reactive oxygen species.3 It delivers a low intrinsic  toxicity and has a surprisingly wide range of beneficial actions, such as antiplatelet,  antiradical, anti-inflammatory, antimutagenic, anticarcinogenic, anti-angiogenic,  antibacterial, antitumor, antiviral, antianxiety, and cognitive-enhancing effects on  the central nervous system.4–6 However, despite the wide spectrum of pharmaco - logical properties, the use of QT in the pharmaceutical field is obstructed due to its correspondence: Zaved ahmed Khan Medical Biotechnology Division,  school of Biosciences and Technology,  VIT University, Vellore 632014,  Tamil Nadu, India Tel +91 99 9454 6977 Fax +91 416 224 3092 email khan.zaved@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bagad and Khan Running head recto: PBCA nanoparticles for oral delivery of quercetin  DOI: http://dx.doi.org/10.2147/IJN.S80706",Non-OADS,/arxiv_data1/oa_pdf/f4/d4/ijn-10-3921.PMC4468990.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f4/d4/ijn-10-3921.PMC4468990.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/d4/ijn-10-3921.PMC4468990.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1437–1442Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1437Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8293 0anti-N-methyl- d-aspartate receptor encephalitis  in a patient with a 7-year history of being  diagnosed as schizophrenia: complexities  in diagnosis and treatment Correspondence: Wanjun Guo Mental Health Center, West China  Hospital, sichuan University, Dianxin Nan  Jie 28, Wuhou District, Chengdu, sichuan  610041, people’s republic of China Tel +86 28 8542 3561 Fax +86 28 8516 4019 email guowjcn@163.co m Chaohua Huang1,2,4,* Yukun Kang1,* Bo Zhang1 Bin Li1 Changjian Qiu1 shanming Liu1 Hongyan ren1,2 Yanchun Yang1 Xiehe Liu1 Tao Li1–3 Wanjun Guo1,2 1Mental Health Center, West China  Hospital, sichuan University, Chengdu,   sichuan, people’s republic of China;   2state Key Laboratory of Biotherapy,   psychiatric Laboratory, West China  Hospital, sichuan University, Chengdu,   sichuan, people’s republic of China;   3Mental Health education Center,   sichuan University, Chengdu, sichuan,   people’s republic of China; 4Mental  Health Center, affiliated Hospital  of Luzhou Medical College, Luzhou,   people’s republic of China *These authors contributed equally  to this workAbstract:  Anti- N-methyl- d-aspartate receptor (NMDAR) encephalitis is a form of autoimmune  encephalitis associated with antibodies against the NR1 subunits of NMDARs.",Non-OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
"Most cases progress into an unresponsive phase with catatonic  features, including severe neurological features like seizures, movement abnormalities, Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Huang et al Running head recto: Anti-NMDAR encephalitis and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S82930",Non-OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
"Neuropsychological tests, including intelligence quotient  tests,14 logical memory tests (immediate and delayed),  trail-making test (TMT) part A, TMT part B, and six tests  (pattern-recognition memory, delayed matching to sample,  rapid visual information processing, spatial working memory,  intra/extradimensional shift, and Stockings of Cambridge,  which are described in detail at http://www.cambridgec - ognition.co m) from the Cambridge Neuropsychological  Automated Test Battery were administered to assess her  cognitive function, and repeated during follow-up (Table 1).",OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/75/ndt-11-1437.PMC4468991.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/63/ppa-9-759.PMC4468992.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 759–765Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  759CAse rePortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S8150 9Umbilical cord blood transplantation supplemented  with the infusion of mesenchymal stem cell for an  adolescent patient with severe aplastic anemia: a   case report and review of literature Chengxin Luan runzhe Chen Baoan Chen Jiahua Ding Ming Ni Department of Hematology and  oncology (Key Department of Jiangsu  Medicine), Zhongda Hospital, Medical  school, southeast University, Nanjing,   Jiangsu Province, People’s republic  of ChinaAbstract:  Delayed hematopoietic recovery and increased rate of engraftment failure limit  the use of umbilical cord blood transplantation (UCBT).",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ppa-9-759.PMC4468992.pdf
"Routine  examination of blood revealed that the white blood cell (WBC) count was 2.64 ×109/L,  hemoglobin (HGB) was 66.4 g/L, platelet (PLT) count was 9 ×109/L, neutrophil count Correspondence: Baoan Chen Department of Hematology and  oncology, Zhongda Hospital, Medical  school, southeast University, Dingjiaqiao  87, Gulou District, Nanjing 210009,  Jiangsu Province, People’s republic  of China tel +86 25 8327 2006   Fax +86 25 8327 2011   email cba8888@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Luan et al Running head recto: UCBT supplemented with the MSC for an adolescent with SAA DOI: http://dx.doi.org/10.2147/PPA.S81509",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ppa-9-759.PMC4468992.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ppa-9-759.PMC4468992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/d7/opth-9-1041.PMC4468993.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1041–1047Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1041Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7972 3Visual field changes as an early indicator of  glioblastoma multiforme progression: two cases  of functional vision changes before MRI detection Kate Xie1,* Catherine Y Liu1,* anton N Hasso2 Robert Wade Crow1 1Department of Ophthalmology, Gavin  Herbert Eye Institute, University of  California, Irvine, Irvine, CA, USA,   2Department of Radiological Sciences,   University of California Irvine Medical  Center, Orange, C a, Usa *These authors contributed equally  to this workAbstract:  Glioblastoma multiforme is an aggressive tumor associated with a high rate of  recurrence even after maximal therapy.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/opth-9-1041.PMC4468993.pdf
"At the time of evaluation  in the neuro-ophthalmology clinic, he was being treated with adjuvant temozolomide Correspondence: Robert Wade Crow Gavin Herbert Eye Institute, Department  of Ophthalmology, University of  California, Irvine, 850 Health Sciences  Road, Irvine, Ca 92697, Usa Tel +1 949 824 0158 Fax +1 949 824 4015 email rcrow@uci.ed u Journal name: Clinical Ophthalmology Article Designation: Case SERIES Y ear: 2015 Volume: 9 Running head verso: Xie et al Running head recto: Visual field changes associated with glioblastoma multiforme DOI: http://dx.doi.org/10.2147/OPTH.S79723",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/opth-9-1041.PMC4468993.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/opth-9-1041.PMC4468993.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/d7/opth-9-1041.PMC4468993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 925–932Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  925Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5589 6Management of epilepsy in patients with Rett  syndrome: perspectives and considerations Natalija Krajnc Department of Child, Adolescent and  Developmental Neurology, University  Children’s Hospital, Ljubljana, SloveniaAbstract:  Rett syndrome (RTT) is a common neurodevelopmental disorder that appears in  infancy with regression of acquired motor skills, loss of purposeful activity, hand stereotypies,  loss of acquired spoken language, and seizures.",Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
"Secondary microcrania due to deceleration in the rate of head growth Correspondence: Natalija Krajnc Department of Child, Adolescent and  Developmental Neurology, University  Children’s Hospital, Bohoričeva 20, 1525  Ljubljana, Slovenia, europe Tel +386 1 522 9249 Fax +386 1 522 4070 email natalija.krajnc@mf.uni-lj.s i Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Krajnc Running head recto: Epilepsy in Rett syndrome patients DOI: http://dx.doi.org/10.2147/TCRM.S55896",Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
http://jcn.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/0b/tcrm-11-925.PMC4468994.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/ndt-11-1427.PMC4468995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1427–1430Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1427Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8141 4Creutzfeldt-Jakob disease versus anti-LGI1 limbic  encephalitis in a patient with progressive cognitive  dysfunction, psychiatric symptoms, involuntary  facio-brachio-crural movement, and an abnormal  electroencephalogram: a case report Li sun Jie Cao Chang Liu Yudan Lv Department of Neurology, The  First Hospital of JiLin University,   ChangChun, p eople’s republic  of ChinaAbstract:  Diagnosis of Creutzfeldt-Jakob disease (CJD) is often challenging in elderly individu - als, not only because of its variable clinical features but also because of nonspecific changes on  the electroencephalogram (EEG) in the early stages of the disease.",Non-OADS,/arxiv_data1/oa_pdf/ce/cf/ndt-11-1427.PMC4468995.pdf
"Therefore, a comprehensive understanding of CJD and anti-LGI1 encephalitis is criti - cal, not only with regard to clinical features, but also the investigations required, which  include cerebrospinal fluid (CSF), diffusion-weighted magnetic resonance imaging  (MRI), and an electroencephalogram (EEG).Correspondence: Yudan Lv Department of Neurology, The First  Hospital of JiLin University, 71-Xinmin  street, ChangChun, people’s republic  of China Tel +86 130 1913 5578 Fax +86 432 8878 2161 email lvyudan@sina.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Sun et al Running head recto: CJD or anti-LGI1 limbic encephalitis DOI: http://dx.doi.org/10.2147/NDT.S81414",Non-OADS,/arxiv_data1/oa_pdf/ce/cf/ndt-11-1427.PMC4468995.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ce/cf/ndt-11-1427.PMC4468995.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/ndt-11-1427.PMC4468995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 587–594International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  587OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8322 8The role of the parents’ perception of the  postpartum period and knowledge of maternal  mortality in uptake of postnatal care: a qualitative  exploration in Malawi collins F Zamawe gibson c Masache albert n Dube Parent and child Health Initiative  (PacHI), research centre, lilongwe,   MalawiBackground:  Postpartum is the most risky period for both mothers and newborn babies.",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"Keywords:  barriers to postnatal care, health belief model, health-seeking behavior, qualitative  research Background Maternal complications are the second largest cause of mortality among women of  reproductive age worldwide.1 Every year, around 300,000 women die globally during correspondence: collins F Zamawe Parent and child Health Initiative  (PacHI), research centre, lilongwe,  amina House, Off chilambula road,   PO Box 31686, Malawi Tel +265 999 393 995 email fzamawe@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Zamawe et al Running head recto: Understanding uptake of postnatal care DOI: http://dx.doi.org/10.2147/IJWH.S83228",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs334/en /.,Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"Available from: http://www.un.org/ millenniumgoals/2014 MDG report/MDG 2014 English web.pd f.  Accessed April 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"Available from: http://www.un.org/mil - lenniumgoals/pdf/MDG Report 2012.pd f. Accessed April 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
Available from: http://apps.who.int/iris/bitstream/10665/97603/ 1/9789241506649_eng.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"Available  from: http://www.nsomalawi.mw/2010-malawi-demographic-and- health-survey-preliminary-report.htm l. Accessed April 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
Available from: http://plato.stanford.edu/archives/win2013/entries/ phenomenology /.,Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/10/ijwh-7-587.PMC4468996.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 605–614International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  605RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4592 5epidemiology, diagnosis, and management  of atrial fibrillation in women Daniela Poli1 emilia Antonucci2 1Thrombosis  Centre, Department  of Heart and vessels, Azienda  Ospedaliero-Universitaria  Careggi,  Florence, Italy; 2Department of  Experimental  and Clinical Medicine,   University of Florence, Florence, ItalyAbstract:  Atrial fibrillation (AF) is the most common arrhythmia and has become a serious  public health problem.",Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
"The highest incidences  and prevalences of the disease are registered in developed countries, as opposed to Correspondence: Daniela Poli Centro Trombosi, Viale Morgagni,  85–50134 Firenze, Italy Tel +39 055 794 5453 Fax +39 055 794 6218 email polida@aou-careggi.toscana.i t Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Poli and Antonucci Running head recto: Atrial fibrillation in women DOI: http://dx.doi.org/10.2147/IJWH.S45925 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
Or use: http://youtu.be/nN1Xad9rfL 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/48/ijwh-7-605.PMC4468997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/2b/rru-7-101.PMC4468998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 101–105Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  101Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/RRU.S8328 4Cutaneous tube ureterostomy: a fast and effective  method of urinary diversion in emergency  situations tamer abdin1 Gideon Zamir2 alon pikarsky2 Ran Katz1 ezekiel H Landau1 ofer N Gofrit1 1Department of Urology, 2Department  of General surgery, Hadassah Hebrew  University Hospital, Jerusalem, Israel Correspondence: ofer N Gofrit   Department of Urology, Hadassah  Hebrew University Hospital, po Box   12000, ein Kerem, Jerusalem  91120,  Israel   email ogofrit@gmail.co mAim:  To report on a simple and rapid method of urinary diversion.",Non-OADS,/arxiv_data1/oa_pdf/cf/2b/rru-7-101.PMC4468998.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/2b/rru-7-101.PMC4468998.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/2b/rru-7-101.PMC4468998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/25/ppa-9-733.PMC4468999.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 733–744Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  733OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8425 1Patient preference and willingness to pay  for knee osteoarthritis treatments John Posnett1 sanjeev Dixit2 Brooks Oppenheimer2 sven Kili3 nazanin Mehin4 1herOnTM commercialization,   PAreXel® international, london, UK;   2reason research, Philadelphia, PA,   UsA; 3sanofi Biosurgery, Oxford, UK;   4sanofi, Paris, FrancePurpose:  To review treatments for osteoarthritis of the knee (OAK) received by patients  across five European countries, and to obtain patients’ perceptions and willingness to pay for  current treatments.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/ppa-9-733.PMC4468999.pdf
"Keywords:  osteoarthritis, treatment, survey, viscosupplementation Introduction Osteoarthritis of the knee (OAK) is the most common form of arthritis and is a  debilitating condition that is common in Europe.1,2 The condition is multifactorial, with  biochemical, mechanical, and behavioral components.1 Prevalence varies globally;  symptomatic OAK in Europe has a reported prevalence of 5.2% in France, 5.4% in  Italy, 10.2% in the UK, and 10.2% in Spain.3–6 Age and sex are important risk factors  for OAK, with higher prevalence reported in female and elderly populations.7–11 Body  mass index is another important risk factor for OAK, with risk increasing exponentially  with body mass index.12 OAK has a negative impact upon quality of life, and this impact increases with  disease progression.13 Previous studies have reported various detrimental effects of  OAK upon daily functionality, including pain, and impairments in physical functioning  and physical role.14–16 In addition to simply seeking clinical benefit for an individual correspondence: nazanin Mehin Sanofi, 9 Boulevard Romain Rolland,  75014, Paris, France Tel +33 1 53 77 88 50 email nazanin.mehin@sanofi.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Posnett et al Running head recto: Conjoint analysis of knee osteoarthritis DOI: http://dx.doi.org/10.2147/PPA.S84251",Non-OADS,/arxiv_data1/oa_pdf/a8/25/ppa-9-733.PMC4468999.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/ppa-9-733.PMC4468999.pdf
"Published by Oxford University Press on behalf of The Gerontological Society of America.809Journals of Gerontology: Biological Sciences cite as: J Geron A Biol Sci Med Sci,  2015, 809–816 doi:10.1093/gerona/glu121 Original Article Advance Access publication August 14, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/b5/glu121.PMC4469006.pdf
"For more details on  the approach, see Gold and colleagues ( 12), and the SomaLogic Inc  Web site ( http://www.somalogic.com/Products-Services/SOMAscan/ FAQs.aspx ).",Non-OADS,/arxiv_data1/oa_pdf/89/b5/glu121.PMC4469006.pdf
TUK proteomics data are publicly available upon request on the  department website ( http://www.twinsuk.ac.uk/data-access/access- management/ ).,OADS,/arxiv_data1/oa_pdf/89/b5/glu121.PMC4469006.pdf
A linear mixed model was fitted to examine age effect on gene  expression in R ( http://www.r-project.org/ ) with the lmer function in the  lme4 package ( 18).,OADS,/arxiv_data1/oa_pdf/89/b5/glu121.PMC4469006.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ad/13/40263_2015_Article_248.PMC4469086.pdf
"IntraVital 2014; 3:e28210; http://dx.doi.org/10.4161/intv.28210IMART software for correction of motion artifacts  in images collected in intravital microscopy Kenneth W d unn1,*, Kevin s l orenz2, Paul s alama3, and e dward J d elp2 1division of Nephrology; s chool of Medicine; i ndiana University; i ndianapolis, i N UsA; 2Video and i mage Processing l aboratory; s chool of e lectrical and c omputer  engineering; Purdue University; West l afayette, i N UsA; 3department of e lectrical and c omputer e ngineering; i ndiana University; i ndianapolis, i N UsA Keywords:  intravital microscopy, fluorescence microscopy, multiphoton microscopy, image processing, image registration,   motion artifact, in vivo imaging, image analysis intravital microscopy is a uniquely powerful tool, providing the ability to characterize cell and organ physiology in the  natural context of the intact, living animal.",Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Obtaining and using IMART The IMART registration software is derived from an earlier  version of the software described in 33 and demonstrated in.22  Directions for obtaining a complete version of the software and  a user’s guide may be found at http://www.medicine.iupui.edu/icbm/software/.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Cell  2011; 147:983-91;  PMID:22118457 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Methods Mol Biol 2009; 467:305-17;  PMID:19301680 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Vis Exp  2009; 28:1278;  PMID:19578330 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Nat Methods 2008; 5:1019-21; PMID:18997781 ; http://dx.doi.org/10.1038/ nmeth.1269 9.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Methods Mol Biol 2013; 931:153-67;  PMID:23027003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Am J Physiol Cell Physiol 2002; 283:C905-16;  PMID:12176747 ; http://dx.doi.org/10.1152/ ajpcell.00159.2002,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
IntraVital 2012;  1:44-53; http://dx.doi.org/10.4161/intv.21296 16.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Biomed Opt 2007;  12:014014;  PMID:17343489 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Am J Physiol Gastrointest Liver Physiol 2009; 296:G1091- 7; PMID:19246634 ; http://dx.doi.org/10.1152/ ajpgi.90681.2008 19.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Proc Natl Acad Sci U S A 2010;  107:18073-8;  PMID:20923880 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Nat Methods 2011;  8:91-6;  PMID:21151136 ; http://dx.doi.org/10.1038/ nmeth.1543 22.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Am J Pathol 2011; 179:75- 82; PMID:21703395 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Appl Physiol (1985) 2008; 104:338-46;  PMID:18006870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Biomed  Opt Express 2013; 4:2095-106; PMID:24156067 ;  http://dx.doi.org/10.1364/BOE.4.002095 25.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Leukoc Biol 2012; 92:413-9; PMID:22457365 ;  http://dx.doi.org/10.1189/jlb.0711344 26.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Cell Biol  2010; 189:111-26;  PMID:20351069 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Intravital 2012; 1:115- 21; PMID:24086796 ; http://dx.doi.org/10.4161/ intv.23017 28.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Nat Protoc 2013; 8:583-94; PMID:23429719 ; http://dx.doi.org/10.1038/ nprot.2013.026 30.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
PLoS One 2013; 8:e53942;  PMID:23326545 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
Image Vis Comput 2003; 21:977-1000; http://dx.doi.org/10.1016/S0262-8856(03)00137-933.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Microsc 2012;  245:148-60;  PMID:22092443 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
J Neurosci Methods 2009; 176:1- 15; PMID:18789968 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
IEEE Trans Med Imaging 1999;  18:712-21;  PMID:10534053 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d2/kinv-03-01-10928210.PMC4469201.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/eb/main.PMC4469241.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.019 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/eb/main.PMC4469241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/eb/main.PMC4469241.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.008 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
"3), S1 –S13http://dx.doi.org/10.1097/CCO.0000000000000017 (quiz S14-6).",Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1155/2014/421723 (Arti- cle ID: 421723).,OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1038/bmt.2014.3 (Epub 2014 Feb 17).,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1155/2013/371854 (Article ID: 371854).,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
54 –77http://dx.doi.org/10.2217/ebo.13.218 .,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/ 10.1038/onc.2012.164 .,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
"10 (1), 1 –18.http://dx.doi.org/10.1038/sj.bjc.",Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1182/ blood-2012-02-265884 .,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1172/JCI76610 .,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
http://dx.doi.org/10.1111/bjh.13306 .,Non-OADS,/arxiv_data1/oa_pdf/47/91/main.PMC4469281.pdf
National Institute for Health and Clinical Excellence (NICE) (2008) Systematic reviews of clinical effectiveness prepared for the guide-line‘Osteoporosis: assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk ’.https://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/61/53/198_2015_Article_3084.PMC4469296.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b2/2c/10549_2015_Article_3447.PMC4469298.pdf
Available from: http://globocan.iarc.fr 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/2c/10549_2015_Article_3447.PMC4469298.pdf
"Comprehensive Cancer Centre the Netherlands (IKNL) (2014) http://www.dutchcancerﬁgures.nl/ 3. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE,Willett WC, Wolk A, Hunter DJ (2000) Pooled analysis ofprospective cohort studies on height, weight, and breast cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/b2/2c/10549_2015_Article_3447.PMC4469298.pdf
http://www.cbs.nl/nl-NL/menu/ methoden/dataverzameling/permanent-onderzoek-leefsituatie-pols-deelmodule-recht-en-participatie-rep2.htm 16.,Non-OADS,/arxiv_data1/oa_pdf/b2/2c/10549_2015_Article_3447.PMC4469298.pdf
http://www.veilig heid.nl/onderzoek/ongevallen-en-bewegen-in-nederland-obin 17.,Non-OADS,/arxiv_data1/oa_pdf/b2/2c/10549_2015_Article_3447.PMC4469298.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1f/c5/10549_2015_Article_3452.PMC4469299.pdf
"Patients with inhibitors are  twice as likely to be hospitalized for a bleeding complication.4 In addition, compared with  the cost of care for patients without an inhibitor, the cost of care for those with an inhibitor  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/89/bb/nihms699357.PMC4469363.pdf
Available at http://www.ohchr.org/EN/Issues/HRAndClimateChange/Pages/ HRClimateChangeIndex.aspx 3.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at http://www.psr.org/assets/pdfs/vulnerable-populations.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
"Available at: http://www.huffingtonpost.com/2011/09/16/climate-change-poll-american-global- warming_n_966214.html Akerlof K, Debono R, Berry P, et al.",Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at:  http://www.usclimatenetwork.org/hot-topics/climate-polling Reuters.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at http://www.ipsos-na.com/download/pr.aspx?id=10987 8.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
2012 Available at: http://www.nytimes.com/2012/08/07/science/earth/extreme-heat-is-covering- more-of-the-earth-a-study-says.html 9.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at: http://www.apha.org/NR/rdonlyres/6B7B9486- E485-4473-8992-B42A73DF95BF/0/ClimateChgGuidebookApril11.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at: http://www.ama- assn.org/ama/pub/about-ama/our-people/house-delegates/policyfinder.page Shea K. Global climate  change and children’s health.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
"Available at: http://www.psr.org/ environment-and-health/climate-change/ Public Health Institute, Center for climate change and  health.",Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
Available at: http://climatehealthconnect.org/ 12.,Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
"Available at http://www.un.org/apps/news/story.asp?NewsID=45021&Cr=human +rights&Cr1=#.U4yuHy_BLxl Sheffield PE, Durante KTE, Rahona C. Zarcadoolas/Health and  Human Rights.",Non-OADS,/arxiv_data1/oa_pdf/8d/8a/nihms693946.PMC4469486.pdf
The Right Reasons” (Families Controlling & Eliminating Tobacco [FACET]; http://facet.ubc.ca/).,Non-OADS,/arxiv_data1/oa_pdf/b3/f7/10.1177_1557988314545627.PMC4469541.pdf
Retrieved from http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/b3/f7/10.1177_1557988314545627.PMC4469541.pdf
"Retrieved from http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/ctums-esutc_2011-eng.php Henwood, K., & Procter, J.",OADS,/arxiv_data1/oa_pdf/b3/f7/10.1177_1557988314545627.PMC4469541.pdf
"Retrieved from http://www.who.int/bulle-tin/volumes/89/3/10-079905/en/index.html Johansson, T. (2011).",Non-OADS,/arxiv_data1/oa_pdf/b3/f7/10.1177_1557988314545627.PMC4469541.pdf
"Retrieved from http://www.who.int/gender-/doc-uments/Gender_Tobacco_2.pdf Zhang, J., & Ratcliffe, J. M. (1993).",OADS,/arxiv_data1/oa_pdf/b3/f7/10.1177_1557988314545627.PMC4469541.pdf
"Revised planning guidance – 25/7/14 , http://www.england.nhs.uk/wp-con- tent/uploads/2014/07/bcf-rev-plan-guid.pdf (2014, accessed 30 December 2014).188 Journal of Health Services Research & Policy 20(3)",Non-OADS,/arxiv_data1/oa_pdf/28/46/10.1177_1355819614566832.PMC4469543.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Pupil dilation with drops vsgel E Moisseiev et al 819 Eye",Non-OADS,/arxiv_data1/oa_pdf/9c/fd/eye201547a.PMC4469672.pdf
A video demonstrating the use of the STRIP Assistant can be viewed at http://videodemo.stripa.eu/english/ [33].,Non-OADS,/arxiv_data1/oa_pdf/4e/b6/40266_2015_Article_270.PMC4469772.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4e/b6/40266_2015_Article_270.PMC4469772.pdf
Utrecht: Nederlands Huisartsen Genootschap; 2012. https://www.nhg.org/sites/ default/ﬁles/content/nhg_org/uploads/polyfarmacie_bij_ouderen.,Non-OADS,/arxiv_data1/oa_pdf/4e/b6/40266_2015_Article_270.PMC4469772.pdf
http://www.syntheshis.nl/archief.php?nummer=2008- 04&artikel=overzicht_in_beeld .,OADS,/arxiv_data1/oa_pdf/4e/b6/40266_2015_Article_270.PMC4469772.pdf
2011. http://www.iso.org/iso/ catalogue_detail.htm?csnumber=35733 .,Non-OADS,/arxiv_data1/oa_pdf/4e/b6/40266_2015_Article_270.PMC4469772.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3e/6b/40291_2015_Article_140.PMC4469775.pdf
http://www.nccn.org .,Non-OADS,/arxiv_data1/oa_pdf/3e/6b/40291_2015_Article_140.PMC4469775.pdf
http://www.accessdata.fda.gov/cdrh_ docs/pdf11/P110020c.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3e/6b/40291_2015_Article_140.PMC4469775.pdf
2014. http://www.cms.gov/Medicare/ Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/ clinlabhtml .,Non-OADS,/arxiv_data1/oa_pdf/3e/6b/40291_2015_Article_140.PMC4469775.pdf
2012. http://www.nice.org.uk/ guidance/TA269 .,Non-OADS,/arxiv_data1/oa_pdf/3e/6b/40291_2015_Article_140.PMC4469775.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 423 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/a1/dyu089.PMC4469794.pdf
"Cells 2015; 38(6): 475-481  http://dx.doi.org/10.14348/molcells.2015.0103                    Measuring and Reducing Off-Target Activities of  Programmable Nucleases Including CRISPR-Cas9    Taeyoung Koo1,4,5, Jungjoon Lee2,5, and Jin-Soo Kim1,3,4,*      Programmable nucleases, whic h include zinc-finger nucle- ases (ZFNs), transcription activat or-like effector nucleases  (TALENs), and RNA-guided engineered nucleases (RGENs)  repurposed from the type II clustered, regularly interspaced  short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system are now widely used for genome  editing in higher eukaryotic cells and whole organisms,  revolutionising almost every di scipline in biological re- search, medicine, and biotechnology.",OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
"RGENs consist of a target-specific  CRISPR RNA (crRNA), a target-independent trans-activating  crRNA (tracrRNA), and Cas9, the protein component originated Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
Cells http://molcells.org     from Streptococcus pyogenes.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
"Web-based tools available for guide-RNA design  Name Developer  Address  Cas-OFFinder Jin-Soo Kim l ab, Seoul National University http://www.rgenome.net/  CHOPCHOP George Church lab, Harvard Univer sity https://chopchop.rc.fas.harvard.edu/  CRISPR Design Feng Zhang lab, Massachusetts In stitute of Technology http://crispr.mit.edu/  CRISPR Design tool The Broad Institute of Harvard and MIT http://www.broadinstitute.org/mpg/crispr_design/CRISPR/Cas9 gRNA finder Jack Lin l ab, University of Colorado http ://spot.colorado.edu/~slin/cas9.html  CRISPRfinder Christine Pourcel l ab, Université Paris-Sud 11 http://crispr.u-psud.fr/Server/  E-CRISP Boutros lab, DKFZ German Cancer Research Center http://www.e-crisp.org/E-CRISP/  ZiFiT Keith Joung lab, Harvard Univer sity http://zifit.partners.org/ZiFiT        are repaired by NHEJ in cells.",Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
"A web-based  computer algorithm is available (http://www.rgenome.net/cas- offinder), which searches for potential off-target sites and unique target sequences in the genomes  of humans and 20 other organ- isms of research interest (Table 1).",OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
Alternative web-based tools  are also available: CRISPR Desi gn (http://crispr.mit.edu) intro- duces a scoring system for choosing sgRNAs with minimum off- target ites.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
Cells http://molcells.org     method is needed to confirm that certain sgRNAs do not induce  off-target mutations with indel frequencies below 0.01% in the  entire genome.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ab/eb/molce-38-6-475.PMC4469905.pdf
"Cells 2015; 38(6): 482-495  http://dx.doi.org/10.14348/molcells.2015.0118                    Role of Sphingolipids and Metabolizing Enzymes  in Hematological Malignancies     Kazuyuki Kitatani1,2, Makoto Taniguchi3, and Toshiro Okazaki3,4,*      Sphingolipids such as ceramide, sphingosine-1-phosphate  and sphingomyelin have been emerging as bioactive lipids since ceramide was reported to play a role in human leu- kemia HL-60 cell differentiation and death.",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
Individual enzyme is compartmentalized in specific subcellu-Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
"Cells http://molcells.org     2013; Clarke et al., 2006), according to the biochemical charac- teristics (Table 2).",OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
"Cells http://molcells.org     When the patients in acute myeloid leukemia (AML) and  chronic myeloid leukemia (CML) became resistant to chemo-therapy, the activities of SMS and GCS in the chemo-resistant  leukemia blasts increased higher as compared to chemo- sensitive ones, leading to a decrease of ceramide-dependent cell death (Itoh et al., 2003).",Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
Cells http://molcells.org     Malignant lymphoma   Sphingosine is synthesized by the hydrolysis of ceramide by CDase and has not been recognized as the main precursor of  ceramide synthesis because 3-keto sphinganine is a main pre- cursor for de novo  ceramide synthesis by CerSs.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
Cells http://molcells.org     ceramides induced apoptosis in human leukemia cells.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
Cells http://molcells.org     of FTY720 on the SET-PP2A complex in acute myeloid leuke- mia; SET binding drugs have ant agonistic activity.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/4e/molce-38-6-482.PMC4469906.pdf
"Cells 2015; 38(6): 496-505  http://dx.doi.org/10.14348/molcells.2015.2256                    Structural Identification of a Non-Glycosylated   Variant at Ser126 for O-Glycosylation Site from  EPO BRP, Human Recombinant Erythropoietin  by LC/MS Analysis     Jaehee Byeon1, Yu-Ri Lim2, Hyong-Ha Kim3, and Jung-Keun Suh1,4,*      A variant peak was detected in the analysis of RP-HPLC of rHu-EPO, which has about 7% relative content.",OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
"The analysis of O-glycopeptide level, EPO-alpha and EPO-beta showed different contents of O- glycopeptide from those of NESP (Giménez et al., 2012; Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
Cells http://molcells.org      Table 1.,OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
Cells http://molcells.org      A                                    B                                          UV monitoring and on-line Q-TOF mass spectrometry.,OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
Cells http://molcells.org     Table 4.,OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
Cells http://molcells.org      Peak M                          Peak V                              analysis for Peak V does not show an O-glycan profile.,OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/molce-38-6-496.PMC4469907.pdf
"Cells 2015; 38(6): 506-517  http://dx.doi.org/10.14348/molcells.2015.2323     G                Suppression of ASK /g69 (AtSK32 ), a Clade III   Arabidopsis GSK3 , Leads to the Pollen Defect   during Late Pollen Development  Xiangshu Dong1, Ill-Sup Nou2, Hankuil Yi1,*, and Yoonkang Hur1,*      Arabidopsis Shaggy-like protein kinases  (ASKs ) are Ara- bidopsis thaliana  homologs of glycogen synthase kinase  3/SHAGGY-like kinases (GSK3/SGG), which are comprised  of 10 genes with diverse functions.",OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"Of the six ASKs  (ASK /g68/  AtSK11 , ASK /g74/AtSK12 , ASK /g75/AtSK21 /BIN2, ASK /g76/AtSK22 /BIL1, Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
Cells http://molcells.org  G G bases (www.arabidopsis.org and http://brassicadb.org/brad/).,OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"The expression patterns of the iden- tified genes were examined using Arabidopsis  eFP browser  (http://bar.utoronto.ca/efp/cgi-bin/efpWeb.cgi) (Winter et al., 2007).",OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"tm4.org/mev.html) and agriGO (http://bioinfo.cau.edu.cn/agriGO/  index.php), respectively (Du et al., 2010).",OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
Cells http://molcells.org  G G                                                     difference was observed between transgenic and wild-type  plants (Fig.,OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"Cells http://molcells.org  G G A                           B       C      D              E                      lat52 gene (Abe et al., 2003; Bate and Twell, 1998), and  MYB1AT  is a CRE for MYB recognition (Filichkin et al., 2004).",OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"Cells http://molcells.org  G G                                                           pollen, is not associated with the expression level of ASK /g84 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
Cells http://molcells.org  G GKorea to Yoonkang Hur.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/07/43/molce-38-6-506.PMC4469908.pdf
"Cells 2015; 38(6): 518-527  http://dx.doi.org/10.14348/molcells.2015.2339     G                PLGA-Loaded Gold-Nanoparticles Precipitated with  Quercetin Downregulate HDAC-Akt Activities Controlling Proliferation and Activate p53-ROS Crosstalk to Induce Apoptosis in Hepatocarcinoma Cells  Kausik Bishayee1,2, Anisur Rahman Khuda-Bukhsh2,*, and Sung-Oh Huh1,*     Controlled release of medications remains the most conven- ient way to deliver drugs.",Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
"In earlier studies, we found aberrant expression of   Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
"Cells http://molcells.org  G GCD spectra obtained in the spectroscope (JASCO J720, Japan),  using Origin 8 pro software.",OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
Cells http://molcells.org  G G   A                               B                           Fig.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
Cells http://molcells.org  G G    A                     C                 D         B   E              tor) with NQ significantly nullified the effect of NQ (Figs.,OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
"Cells http://molcells.org  G G                                                                 nism behind the increase in ROS is increased rec-1 activity  (Hanahan and Weinberg, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/6e/88/molce-38-6-518.PMC4469909.pdf
"Cells 2015; 38(6): 528-534  http://dx.doi.org/10.14348/molcells.2015.0026     G                The Histone Methyltransferase Inhibitor BIX01294  Inhibits HIF-1 /g68 Stability and Angiogenesis   Su Young Oh1, Ji Yoon Seok1, Young Sun Choi1, Sung Hee Lee2, Jong-Sup Bae1, and You Mie Lee1,*      Hypoxia-inducible factor (HIF) is a key regulator of tumor  growth and angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
"BIX01294, a G9a HMT inhibitor, decreases cell mo- bility, proliferation, invasion, and migration in neuroblastoma (Lu  Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
Cells http://molcells.org  G G A                             E                 F B                       C G           D  H                         sprouting microvessels branches from each aortic ring were  photographed and the number were counted.,OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
Cells http://molcells.org  G G A                  B                  C            Fig.,Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
Cells http://molcells.org  G GNagy J.,Non-OADS,/arxiv_data1/oa_pdf/f9/49/molce-38-6-528.PMC4469910.pdf
"Cells 2015; 38(6): 535-539  http://dx.doi.org/10.14348/molcells.2015.0038                    Odorant Stimulation Promotes Survival of Rodent  Olfactory Receptor Neurons via PI3K/Akt Activation  and Bcl-2 Expression    So Yeun Kim1,4, Seung-Jun Yoo1,4, Gabriele V Ronnett1,2,3, Eun-Kyoung Kim1, and Cheil Moon1,*      Olfactory stimulation activates multiple signaling cas- cades in order to mediate activity-driven changes in gene expression that promote neuronal survival.",Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
"In our present study, we in vestigated the ability of odorant  stimulation to activate the PI3K/Akt pathway, induce sub- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
"Cells http://molcells.org     sequent Bcl-2 expression, and promote ORN survival using the  olfactory system as a model.",Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
Cells http://molcells.org      A                     B                    C                     D                   Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/22/55/molce-38-6-535.PMC4469911.pdf
"Cells 2015; 38(6): 540-547  http://dx.doi.org/10.14348/molcells.2015.0041     G               Abnormal Astrocytosis in the Basal Ganglia   Pathway of Git1−/− Mice     Soo-Yeon Lim1, and Won Mah1,2,*      Attention deficit/hyperactivity disorder (ADHD) is one of  the most common neurodevelopmental disorders, affect-ing approximately 5% of children.",Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
"In addition, a recent study has  Molecules  and  Cells  http://molcells.org     Established in 1990 G   eISSN: 0219 -1032G The Korean Society for Molecula r and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
Abnormal Astrocytosis in the Basal Ganglia of Git1−/− Mice  Soo-Yeon Lim & Won Mah    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
"Cells http://molcells.org  G G A                                   B                               C                        A                          B                                no changes were observed in the striatum, including the cau- date nucleus and putamen (Figs.",Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
Abnormal Astrocytosis in the Basal Ganglia of Git1−/− Mice  Soo-Yeon Lim & Won Mah    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
Cells http://molcells.org  G G A                     B                          Fig.,Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
Abnormal Astrocytosis in the Basal Ganglia of Git1−/− Mice  Soo-Yeon Lim & Won Mah    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
"Cells http://molcells.org  G Gits cell proliferation and migration, which suggests a role for  Rac1 in cell migration (Yoon et al., 2014).",OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
Abnormal Astrocytosis in the Basal Ganglia of Git1−/− Mice  Soo-Yeon Lim & Won Mah    G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ce/8f/molce-38-6-540.PMC4469912.pdf
"Cells 2015; 38(6): 548-561  http://dx.doi.org/10.14348/molcells.2015.0044     G                Expression Analyses Revealed Thymic Stromal  Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor   Ki Yeon Kim1, Gwanghee Lee2,4, Minsang Yoon1, Eun Hye Cho1, Chan-Sik Park3, and Moon Gyo Kim1,*     By combining conventional single cell analysis with flow  cytometry and public database searches with bioinformatics  tools, we extended the expression profiling of thymic stro- mal cotransporter (TSCOT), Slc46A2/Ly110, that was shown  to be expressed in bipotent precursor and cortical thymic  epithelial cells.",OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
These TEC stem cells were located in the small Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
"MATERIALS AND METHODS  Expression profiling using public database   The data sets were obtained from Gene Expression Omnibus  (http://www.ncbi.nlm.nih.gov/geo/), and the extension changed  as txt files to analyze in the GENESIS program (version 1.7.6)  released by Graz University of Technology Institute for Ge- nomics and Bioinformatics.",OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G GTable 1.,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Analyses were done using the  FlowJo program (http://flowjo.com).,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
"RESULTS  Gene profiling analysis verifies the tissue-specific TSCOT  expression   In order to study the expression pattern of TSCOT  at the ge- nome level, we first used Google to identify any data and down- loaded from the public database (http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G GTable 2.,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G GTable 2.,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G G A               B                              C                   Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G G A               B                          profiling (Figs.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
Cells http://molcells.org  G G3351-3360.,OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/16/81/molce-38-6-548.PMC4469913.pdf
"Cells 2015; 38(6): 562-572  http://dx.doi.org/10.14348/molcells.2015.0051     G                miR-335 Targets SIAH2 and Confers Sensitivity to  Anti-Cancer Drugs by Increasing the Expression of HDAC3   Youngmi Kim1,2, Hyuna Kim1,2, Deokbum Park1, and Dooil Jeoung1,*      We previously reported the role of histone deacetylase 3  (HDAC3) in response to anti- cancer drugs.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
"miR-146b-5p suppresses translation of EGFR, binds to the  EGFR 3 /g99-UTR, and inhibits migration of gliomas (Katakowski et Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
"Cells http://molcells.org  G Gat 37 /g113C for 16 h. The cells were fixed with methanol, and the  invaded cells were stained and counted.",Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
Cells http://molcells.org  G G A                       D                 E                 B               F C                             Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
Cells http://molcells.org  G G A              B            C                        D                                 A                          B                                                 Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
Cells http://molcells.org  G Geffect of Tip60 on the expression of HDAC3 and the response  to anti-cancer drugs.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
"Cells http://molcells.org  G GWong, C.S., Sceneay, J., House, C.M., Halse, H.M., Liu, M.C.,  George, J., Hunnam, T.C., Parker, B.S., Haviv, I., Ronai, Z., et al.",OADS,/arxiv_data1/oa_pdf/fa/7f/molce-38-6-562.PMC4469914.pdf
"Cells 2015; 38(6): 573-579  http://dx.doi.org/10.14348/molcells.2015.0052     G                Different Functional and Structural Characteristics  between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity   Jeong-Ah Yoo1,2,3,6, Eun-Young Lee1,2,3,6, Ji Yoon Park4, Seung-Taek Lee4, Sihyun Ham5, and Kyung-Hyun Cho1,2,3,*     Apolipoprotein A-I and A-IV are protein constituents of  high-density lipoproteins although their functional differ- ence in lipoprotein metabolism is still unclear.",OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
The current study was designed to investigate functional and  structural differences between apoA-I and apoA4 in regarding  to their anti-atherogenic properties in functional and structural Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
Cells http://molcells.org  G Gcorrelations.,OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
Cells http://molcells.org  G G Table 1.,OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
Cells http://molcells.org  G Gshare similar structural features.,OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/81/e5/molce-38-6-573.PMC4469915.pdf
"Cells 2015; 38(6): 580-586  http://dx.doi.org/10.14348/molcells.2015.0053     G                Proper Activity of Histone H3 Lysine 4 (H3K4)   Methyltransferase Is Required for Morphogenesis during Zebrafish Cardiogenesis   Jun-Dae Kim1,4,5, Eunmi Kim1,5, Soonil Koun1,5, Hyung-Jin Ham1, Myungchull Rhee2, Myoung-Jin Kim1,*, and   Tae-Lin Huh1,3,*     While increasing evidence indicates the important function  of histone methylation during development, how this pro- cess influences cardiac development in vertebrates has  not been explored.",Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
Recent researches showed the global decrease of histone H4  lysine 5 (H4K5) methylation in SMYD3 knock-down condition  and structural preference for histone H4 lysine 20 (H4K20) of Molecules and Cells http://molcells.org   Established in 1990 G   eISSN: 0219-1032 G The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
Cells http://molcells.org  G G   A           B           C          D           E          F           G          H               I             J           K           L           M          N           O           P           Q               R                    A           B          C           D          E             F           G          H           I           J             K                      L           M               N          O          P          Q          R             S          T           U          V          W             X                     Y                      Z            Fig.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
Cells http://molcells.org  G G A                            B                         (Fig.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
G http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
"Cells http://molcells.org  G GEstève, P.O., Chin, H.G., Benner, J., Feehery, G.R., Samaranayake,  M., Horwitz, G.A., Jacobsen, S.E., and Pradhan, S. (2009).",Non-OADS,/arxiv_data1/oa_pdf/54/dc/molce-38-6-580.PMC4469916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/12/rjv062.PMC4469942.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/31/158066 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.158066 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
"J Pathol Inform 2015, 1:31  http://www.jpathinformatics.org/content/6/1/31INTRODUCTION Breast carcinoma is the most common malignant tumor  and the leading cause of carcinoma death in women,  with more than 1,000,000 cases occurring worldwide  annually.",Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
"J Pathol Inform 2015, 1:31  http://www.jpathinformatics.org/content/6/1/31at ×20.",Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
"J Pathol Inform 2015, 1:31  http://www.jpathinformatics.org/content/6/1/31could lead to more equivocal immunohistochemical  cases, which thus would be subjected to additional FISH  testing.",Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
"J Pathol Inform 2015, 1:31  http://www.jpathinformatics.org/content/6/1/31guideline goal of 95% concordance for negative and  positive immunohistochemical results.",Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
"J Pathol Inform 2015, 1:31  http://www.jpathinformatics.org/content/6/1/318.",Non-OADS,/arxiv_data1/oa_pdf/9e/1e/JPI-6-31.PMC4470009.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/27/158052,Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27and human tissues with varying success.",Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27Facility or by the laboratory of Dr. Joan Massague of Cancer  Biology and Genetics Program.",Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27for each Alexa Fluor: Alexa488 (482/18 – 488 – 525/39),  Alexa546 (530/23 – 550 – 572/28), Alexa594  (586/15 – 594 – 631/36), Alexa647 (650/13 – 669 – 700/50).",Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27next.",Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27software (Bitplane).",OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27and tallying the number of incidences where the p27  signal was first detected.",OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
"J Pathol Inform 2015, 1:27  http://www.jpathinformatics.org/content/6/1/27of course, is the limitation in the size of the tissue that  can be cut with the diamond knife of the ultramicrotome.",Non-OADS,/arxiv_data1/oa_pdf/d5/5c/JPI-6-27.PMC4470010.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/28/158057,Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
"J Pathol Inform 2015, 1:28  http://www.jpathinformatics.org/content/6/1/28students’ viewing behavior and how it is correlated with  the correctness of the answers they give.",Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
"J Pathol Inform 2015, 1:28  http://www.jpathinformatics.org/content/6/1/28answered the given question were viewing the WSI  attached to this question.",Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
"J Pathol Inform 2015, 1:28  http://www.jpathinformatics.org/content/6/1/28detected incorrect answers in 2013 reasonably well, as it  can be seen in the confusion matrix.",Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
"J Pathol Inform 2015, 1:28  http://www.jpathinformatics.org/content/6/1/28There is an extra outcome from training a random forest  model – a list of feature importance values, which estimate  the prediction potential of each measure.",Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
Available from: http://www.cs.waikato.,Non-OADS,/arxiv_data1/oa_pdf/ca/9d/JPI-6-28.PMC4470011.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/29/158059,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/JPI-6-29.PMC4470012.pdf
"J Pathol Inform 2015, 1:29  http://www.jpathinformatics.org/content/6/1/29considering four stages of scholarly activity; the creation,  communication and dissemination, storage, and novel  utilization of knowledge.",Non-OADS,/arxiv_data1/oa_pdf/f7/d1/JPI-6-29.PMC4470012.pdf
"J Pathol Inform 2015, 1:29  http://www.jpathinformatics.org/content/6/1/29laser light and then passed through a confocal pinhole  that rejects light generated outside the focal plane as well  as scattered light.",Non-OADS,/arxiv_data1/oa_pdf/f7/d1/JPI-6-29.PMC4470012.pdf
"J Pathol Inform 2015, 1:29  http://www.jpathinformatics.org/content/6/1/29nanometer resolution (!)",Non-OADS,/arxiv_data1/oa_pdf/f7/d1/JPI-6-29.PMC4470012.pdf
A wiki was created (http://pathlab2014.wikifoundry.com) for  the Class of 2014.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/30/158063,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30moved into the digital age.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30slides are ordered or prepared, nominally of the same  pathology, but not the same slide with the same features  in the same location.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"indiana.edu/c602web/602/c602web/toc.htm), University of  Iowa (http://www.path.uiowa.edu/virtualslidebox.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
Requires  Biolucida Slide Viewer http://www.biolucida.net).,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"A Wiki was Created for the Pathology Lab for the  Class of 2014 – http://pathlab2014.wikifoundry.com  The students saved, edited and uploaded their slides.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30and edited and then added to the wiki collection (see  above).",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
Note selection of region of interest T able 5: Slide sharing E‑mail Word documents PowerPoint presentations Upload to common sites Google drive Dropbox Wiki (see text to follow) T able 6: Freely available sites for the construction  of a wiki Wikifoundry http://www.wikifoundrycentral.com Wikispaces https://www.wikispaces.com Wikidot http://www.wikidot.com,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30contents.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
http://goo.gl/17xEnf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30Boards and to consultations.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
"J Pathol Inform 2015, 1:30  http://www.jpathinformatics.org/content/6/1/30Sarah Mohammed, Kelly Noonan, Magdalene Armanious,  Nkechinyere Nwoko, Naeemah Ruffin, Sarah Cathcart, Zachary  Sax, Xiomara Okonkwu, Amanda Riley, Brittany Ciaramello,  Nam Tran, Michelle Kaufman, Elizabeth Bonarigo, Kiana  Karbasi, Brittany Mayer, Caitlin Miner, Regina Fiacco, Donal  Erickson, An Nguyen and Wei‑Jei Liao.",Non-OADS,/arxiv_data1/oa_pdf/c1/3d/JPI-6-30.PMC4470013.pdf
